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Abstract 
In recombinant protein production the expression can be optimized on several levels, including the choice 
of cultivation parameters, the expression host and the expression system. However, the optimization of the 
open reading frame of the expressed gene is too often ignored, although it may have a drastic effect on the 
expression.  
The optimization of the protein coding sequence does not have universal guidelines as little is understood 
about the contribution of different factors, and how to prioritize them. The key factors that affect the protein 
expression on gene level are GC-content, mRNA secondary structures, codon bias and rare codons, and the 
availability of charged tRNAs. However, these parameters are interdependent and changes in one affect the 
other, and they may have both local and global effects to the sequence. 
Cellulose binding modules (CBM) are interesting in the biomolecular material science as they could be used 
in cross-linking and functionalizing cellulose. In this work the expression and function of CBM1 proteins were 
optimized and studied by shuffling two putatively homologous CBM1 sequences block-wise and so detecting 
the contribution of different parts of the sequence to the expression levels and functionalities. Additionally, 
the codon optimization was studied by comparing the wild type sequence to the optimized sequence of 
Cel7A CBM. 
The CBMs were expressed as fusion proteins with alkaline phosphatase (AP) in several Escherichia coli 
expression strains. The expression levels were measured with AP enzymatic assay and sodium dodecyl 
sulfate gel electrophoresis (SDS-PAGE). The binding affinities of different CBMs were compared in binding 
experiments with nanosized cellulose and chitin.  
The production yield of Cel7Aopt was 101 mg/l cultivation at the best, whereas the original Ehux1b2 was 
only expressed 38-56 mg/l. The replacement of C block by the Cel7A sequence made the Ehux1b2C to be 
expressed the same level as Cel7Aopt. CyDisCo strain increased the expression but also caused much 
variation between clones. However, the binding tests showed that the original Ehux1b2 did not have binding 
affinity towards cellulose, but the replacement of the D-block with the sequence from Cel7A recovered the 
functionality. No other shuffled protein showed any affinity towards cellulose, and well expressed Ehux1b2C 
bound even less to either substrate than the original Ehux1b2. Additionally, the sequence analysis of natural 
CBM1 proteins revealed that the D-block contained many amino acids which are conserved especially within 
cellulose binding modules, and which are presumably essential for the binding ability. 
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Tiivistelmä 
Rekombinanttiproteiinien ekspressiota voidaan optimoida useilla eri tasoilla, kuten kasvatusolosuhteilla, 
sekä tuottoisännän ja ekspressiomekanismin valinnalla. Itse proteiinia koodaavan sekvenssin optimointi jää 
kuitenkin usein liian vähälle huomiolle, vaikka sillä voi olla suuri vaikutus ekspressioon. 
Proteiinia koodaavan sekvenssin optimoinnille ei ole selkeitä sääntöjä, sillä geenitason eri tekijöiden 
vaikutuksista ekspressioon tiedetään hyvin vähän. Avainasemassa proteiiniekspression säätelemisessä ovat 
kuitenkin GC-pitoisuus, lähetti-RNA:n sekundäärirakenteet, kodonikäyttö ja harvinaiset kodonit, sekä 
aminohapollisten siirtäjä-RNA:iden saatavuus. Nämä tekijät ovat kuitenkin sidoksissa toisiinsa, joten yhden 
tekijän muuttaminen saa aikaan muutoksia myös toisessa tekijässä, ja vaikutukset voivat esiintyä paikallisesti 
tai koko sekvenssin tasolla. 
Selluloosaan sitoutuvat proteiinit (cellulose binding module, CBM) ovat kiinnostavia 
biomolekyylimateriaalitutkimuksessa, sillä niiden kykyä tarttua selluloosaketjuun voitaisiin käyttää 
selluloosan funktionalisoinnissa ja luomaan verkkorakennetta. Tässä työssä CBM1-sekvenssejä tutkittiin 
sekoittamalla kahden CBM1-proteiinin sekvenssejä lohkoittain ja tutkimalla näiden neljän hybridiproteiinin 
avulla eri osioiden vaikutuksia proteiiniekspressioon ja proteiinien toiminnallisuuteen. Lisäksi 
kodonioptimointia tutkittiin ottamalla koeasetelmaan mukaan Cel7A-proteiinin villityyppisekvenssi 
optimoidun sekvenssin rinnalle. 
Selluloosaan sitoutuvia proteiineja tuotettiin fuusioproteiinina alkaalifosfataasin (alkaline phosphatase, AP) 
kanssa useassa eri Escherichia coli -tuottokannassa. Ekspressiotasoja mitattiin alkaalifosfataasin 
entsyymiassaylla sekä natriumdodekyylisulfaattipolyakrylamidigeelielektroforeesilla (sodium dodecyl 
sulfate polyacrylamide gel electrophoresis, SDS-PAGE). Eri proteiinien toiminnallisuutta tutkittiin 
sitoutumiskokeilla nanokokoiseen selluloosaan ja kitiiniin. 
Cel7Aopt-proteiinin saanto oli parhaimmillaan 101 mg/l kasvatusta, kun taas Ehux1b2 oli tuottotasoiltaan 
selvästi alhaisempi, vain 38-56 mg/l. Ehux1b2C, jossa C-lohko korvattiin Cel7A:n sekvenssillä, tuottui 
kuitenkin yhtä hyvin kuin verrokkina toiminut Cel7A. CyDisCo-kannan käyttö lisäsi proteiinin tuottoa, mutta 
aiheutti laajaa vaihtelua eri pesäkkeiden välillä. Alkuperäinen Ehux1b2 ei sitoutunut selluloosaan lähes 
lainkaan, mutta D-lohkon mutaatio Cel7A:n sekvenssin mukaiseksi teki proteiinin yhtä toimivaksi kuin 
verrokki. Muut substituutiot eivät lisänneet proteiinin sitoutumista, etenkään hyvin tuottunut Ehux1b2C. 
Lisäksi luonnossa esiintyvien selluloosaan tarttuvien proteiinien analyysi osoitti, että D-lohkossa on monia 
konservoituneita aminohappoja, jotka ovat oletettavasti tärkeitä juuri selluloosaan sitoutumisessa. 
Avainsanat proteiiniekspressio, Escherichia coli, rekombinanttiproteiini, selluloosaan sitoutuvat proteiinit, 
kodonioptimointi, nanoselluloosa, kitiini  
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LITERATURE PART 
1 Introduction 
1.1 Protein expression optimization 
Recombinant proteins are produced for a myriad of purposes, such as medical 
treatment, industrial use and biofuel production. To maximize the protein yield 
after downstream processing, such as extraction and purification, the protein 
expression in the cells needs to be maximized. The expression optimization can be 
divided in several levels (Figure 1, Gustafsson et al., 2012). The growth conditions, 
including nutritional and temporal variables and choices of the culture volume, 
and downstream processing are generally carefully investigated and also adjusted 
on the go. The choice of host organism and strain depends on the application of 
the protein of interest, because different organisms modify the protein in different 
ways. The expression system, such as inducibility and copy number of the 
expression vector needs to be designed and chosen based on the nature of the 
protein of interest and targeted expression levels. 
Usually relatively good care is taken of the upper level optimization. However, 
surprisingly little effort is put in the design of the open reading frame (ORF) itself, 
which has proven to affect the expression several hundredfold (H. Hu et al., 2009; 
S. Hu et al., 2013; Allert et al., 2010; Gustafsson et al., 2012). The ORF optimization 
has traditionally been mainly mimicking the codon usage of the host organism and 
avoiding rare codons (Welch et al., 2011). Nearly every biotechnology company 
has their own algorithm for the optimization, but there is no public consensus on 
which properties are characteristic for a good sequence. However, the sequences 
can be additionally adjusted by selecting the codon usage in the sense of mRNA 
secondary structures, the strength of the nucleotide binding depending on GC 
content and adjusting the sequence to the codon usage of the host organism.   
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Figure 1. Different levels of protein production optimization and variables of each 
step. Bioengineering factors include modifications inside the cell, whereas 
cultivation factors are surrounding conditions that affect the growth of the cells. 
Image adapted from Gustafsson et al. (2012). 
1.2 Cellulose and cellulose binding modules 
Cellulose is predicted to be a material of the future. It is renewable and with its 
biodegradability it meets the requirements for a novel material to replace the oil-
based polymers that are causing problems not being decomposable. Finland has 
also great raw material sources for cellulose, and the aim is to refine the cellulose 
material into more valuable products. However, to be able to use cellulose in wide 
variety of applications, it needs to be modified chemically or physically. The 
current ways to functionalize the nanocellulose surface are mainly chemical, so 
the hydroxyl groups are modified by covalent bonding. These reactions usually 
involve quite strong and toxic chemicals, such as strong acids and bases, solvents 
or reducing or oxidizing compounds. (Habibi, 2014; Arola, 2015; Abitbol et al., 
2016) 
The nature gives inspiration to new kinds of biomaterials. For example a squid 
beak is one of the hardest non-mineral materials known, consisting of a composite 
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material made of chitin that is cross-linked with chitin binding proteins (Tan et al., 
2015). The high similarity of chitin and cellulose propose the possibility to do the 
same with cellulose.  Proteins are elastic and functional by nature. Specific kind of 
proteins called cellulose binding modules (CBM) have natural ability to attach to 
cellulose by π-electron interactions. When combining the different features of 
proteins and cellulose, we could get cross-linked cellulose fibers with new 
functions. (Arola, 2015) 
Carbohydrate binding modules (CBM) have been classified into several families 
based on their function and homology, and the CBM protein family 1 mainly 
consist of cellulose binding modules. On the other hand, the carbohydrate binding 
modules may have affinity towards several polysaccharides because of their 
structural similarity. Consequently, depending on the context, the acronym “CBM” 
refers to both words, cellulose binding modules more specifically, or carbohydrate 
binding modules in general. In the nature, cellulose binding modules are usually a 
moiety of cellulose degrading enzymes, where their function is to attach the 
enzyme to cellulose surface and thus bring together the substrate and the catalytic 
domain of the enzyme. Cel7A, the reference CBM used in this study, originates 
from the fungus Trichoderma reesei, and belongs to the CBM1 family (Palonen et 
al., 1999). The binding properties of Cel7A have been attributed to 5 essential 
amino acids, especially three tyrosines which form the flat bottom surface of the 
CBM and bind to cellulose chains (Figure 2, Linder et al., 1995).  
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Figure 2. The structure of a cellulose binding module Cel7A (PDB ID: 1CBH, Kraulis 
et al., 1989). The alignment with cellulose chain reveals the possible π-stacking of 
the aromatic residues to the sugar rings. 
1.3 Protein homologues as a basis for expression optimization 
Proteins whose function is predicted to be the same or closely related based on 
relatively high sequence similarity, but which may derive from different organisms, 
are called homologous proteins. Cellulose binding modules of protein family 1 are 
naturally found in many wood-degrading organisms such as filamentous fungi, like 
Trichoderma reesei (Martinez et al., 2008). CBM1-like proteins have also been 
found in a coccolithophore Emiliania huxleyi (Figure 3), which is a unicellular 
marine phytoplankton species. E. huxleyi forms a calcite coccolith layer on top of 
its cell membrane, but otherwise it lacks cell wall. (Read et al., 2013) In E. huxleyi 
genome, six putative homologues for T. reesei cellobiohydrolase 1 CBM are found 
in 5 different type of proteins. The existence of CBM1 genes in a marine organism 
is interesting and it suggests a structural function for the cellulose. In the coccolith 
formation compartments inside the cell membrane some polysaccharides have 
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been found, although their specific role in the calcification is not fully understood 
(Brownlee et al., 2015).  
 
Figure 3. Coccolithophore Emiliania huxleyi in scanning electron micrograph. Scale 
bar 1µm (Paasche, 2001). 
As previously observed (Ikonen, unpublished data), the expression levels of 
different protein homologues may vary significantly. Shuffling of different 
homologous sequences is a way to study both codon optimization for maximal 
expression as well as the structure and function of the protein. When homologous 
sequences are shuffled, the structure and fold of the protein can be mostly 
maintained but local variations can be tested. Consequently, amino acid level 
forms one more level of optimization, although the key to the expression variation 
may lie in nucleic acid level caused by different protein sequences. 
1.4 Overview of the experimental part 
The objective of the experimental part was i) to optimize the CBM1 protein 
production in E. coli and ii) to investigate the differences of the expression and 
function of the homologous CBM1 sequences. In the experimental work, 7 
different sequences for CBM of family 1 were compared. The reference CBM1 
sequence (Cel7A, PDB ID: 1CBH) originates from the filamentous fungus 
 6 
 
Trichoderma reesei cellobiohydrolase 1. In the pan genome of Emiliania huxleyi 
coccolithophore species six putatively homologous CBM1 protein sequences have 
been found (Read et al., 2013), and one of them (UniProtKB: R1C3S1, position 325-
361, here named as Ehux1b) was compared to the reference sequence in this 
thesis. To chart the contributions of different parts of the sequence to the protein 
properties, four artificial variants were made by shuffling the sequences block-
wise. In addition, the effect of codon optimization was investigated by comparing 
the codon optimized and wild type DNA sequences of Cel7A. 
Although in this thesis the target was primarily to study how the sequence 
shuffling affects the expression levels, a bigger expression level is of no use, if the 
protein does not work for its purpose. Consequently, the binding properties of 
each protein were compared with three different substrates, nanofibrillated 
cellulose (NFC), bacterial cellulose (BC) and chitin nanocrystals (ChNC). The binding 
of different variants were compared to learn about the function and mechanism 
of binding. 
The following chapters describe different intracellular ways to optimize protein 
expression with the focus on the methods used in the experimental part of this 
thesis. The experimental part of the thesis gives a cross-section of the issues of 
protein production, concentrating especially on sequence-specific factors.  
2 Strain engineering 
2.1 Overview to strain engineering 
One way to optimize the protein yield is to maximize the production of the protein 
per cell. It obviously causes more stress for the cell, so it needs a strain, which 
rather produces protein than biomass. Enhancing the protein expression level 
stresses the cell and may result in poor growth and thus in the end reduced 
 7 
 
expression (Hu et al., 2009).  Another point of view is not to try to exhaust the cells 
by extensive production but to try to achieve higher cell densities in the specific 
culture volume. In order to make the strain suitable for any other purpose, like 
using different nutrients or deleting unwanted pathways that would interfere with 
the ones designed, the solution is to engineer the strain. The strain engineering 
defines the basics how the cell behaves and what kind of strategy will be used in 
the optimization. 
The abundancy of sequence information of whole genomes of different organisms 
and strains enables detailed tuning of microbial strains. Instead of the previous 
approach of trial and error in random mutations and screening of the best clone, 
the mutations can be targeted to a specific gene, whether the aim is to boost it or 
to delete it. To be able to make sensible changes in the genome, it requires 
information about the gene functions, which can in turn be estimated by searching 
for functions of its homologies in other organisms. (Gustafsson et al., 2012) The 
strain engineering also requires deep understanding of the cell metabolism, in 
order to make a strain that does not suffer from the modification too much. As 
traditional gene editing technologies have been time-consuming and troublesome, 
usually in protein production the strain is chosen from the selection of well-known 
and widely used industrial or laboratory strains, and the expression is tuned some 
other way. However, as the new genome editing technologies such as CRISPR-Cas9 
and CRISPR-Cpf1 are continuously studied (Jinek et al., 2012; Cong et al., 2013; 
Zetsche et al., 2015; Lander, 2016), the knowledge of genome editing is becoming 
abundant and the effort needed to edit the genome is getting much smaller. The 
reliable and more precise technologies enable quicker and less challenging 
genome modifications. Being cost- and time-effective, genome editing could be 
more widely utilized technology in the optimization of protein production. 
Creating synthetic pathways in organisms also requires efficient technologies to 
modify the genome itself instead of just plasmid-based systems, which are less 
stable. 
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2.2 Examples of E. coli production strains 
E. coli BL21 is one of the most widely used laboratory expression strains. DE3-
derivative of BL21 enables the use of T7 RNA polymerase based expression 
systems. Like every strain, BL21 also has its disadvantages, which has resulted in 
several attempts to modify the strain. T7 Express is one of the derivatives, which 
aims to be more stable in stressful growth conditions, maintain better foreign DNA, 
and be more suitable for the expression of DNA-active enzymes (E.A. Raleigh, 
personal communication, 27.6.2016). BL21 and T7 Express both have all the 
modifications in their genomes, but another way to modify a strain is to introduce 
an external plasmid, which contains additional genes that alter the metabolism. 
CyDisCo technology (Matos et al., 2014) is targeted to outcompete the previous 
disulfide bond forming strains that were made by interfering the essential genes 
in the genomes. As will be noticed in the following examples, the strain tuning is 
dependent on very slight modifications and the expression levels of single 
enzymes. Moreover, the improvements are always made to some specific 
situations and there does not exist a universal perfectly working strain, but 
different strains need to be chosen for each purpose. As discussed before, the fine-
tuning of commercial strains may increase if the CRISPR-technologies prove to be 
practical. 
2.2.1 BL21 (DE3) 
BL21 is an E. coli B strain, and a widely used laboratory expression strain (Studier 
and Moffatt, 1986). B strains are made deficient in Lon and OmpT outer cell 
membrane proteases in order to reach higher protein yields without degrading the 
protein at the purification (Grodberg and Dunn, 1988). On the other hand, as little 
protein is degraded, misfolded proteins may accumulate, so in case of problems 
in the translation or protein folding, resources of the cell are wasted.  
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BL21 (DE3) has an additional λDE3 prophage integrated into the genome. The 
prophage encodes for T7 RNA polymerase (T7 gene 1), which is controlled by 
lacUV5 promoter (Studier, 2005). The gene of interest will be placed in a plasmid 
under a T7 promoter region, and the genomic T7 RNA polymerase can start 
transcribing the gene upon induction by isopropyl β-D-1-thiogalactopyranoside 
(IPTG) or lactose, which activates the lacUV5 promoter. The simplicity of the T7 
expression system has made it almost a standard for recombinant protein 
production. Nevertheless, DNA damage in the cells activates a pathway called SOS 
cascade, which is meant to correct the damage by homologous recombination and 
allow mutagenesis and evolution (Alberts et al., 2008). However, in case of DNA 
damage, the SOS response activates the viable prophage λDE3, which in turn 
results in the cell lysis.  Another disadvantage of the λDE3 strains is that the highly 
active T7 RNA polymerase will transcribe the gene of interest even uninduced 
(Studier, 2005). In the case of toxic protein expression, this may be fatal to the cell 
growth, and the transformation of toxic protein containing plasmids may not be 
possible. In case of possible toxic proteins the use of LacI repressor is vital and 
addition of T7 lysozyme needs to be considered, as it cuts out the basal expression 
(Studier, 1991). For these cases there are naturally other BL21 strain derivatives 
commercially available. Additionally BL21(DE3) has an increased resistance 
towards a virulent bacteriophage T1 (New England Biolabs, 2016a). 
2.2.2 T7 Express 
T7 Express (C2566 or ER2566 in New England Biolabs publications) is an enhanced 
version of the traditional BL21(DE3) expression strain. To overcome the problems 
of BL21(DE3), several modifications have been made in the genome (New England 
Biolabs, 2016b). First of all, in T7 Express the genomic copy of the gene for T7 RNA 
polymerase (T7 gene 1) is located in the lac operon instead of being in the 
prophage. The removal of the λDE3 and integration of only the T7 gene1 disables 
the lysis function and the strain is more stable in stressed conditions (E.A. Raleigh, 
personal communication, 27.6.2016). As T7 Express strain also lack the Lon and 
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OmpT proteases, its capability of degrading any proteins is compromised. A cell 
division inhibitor protein SulA, which is expressed as a result of the SOS cascade, 
would thus accumulate after SOS response, preventing the cell division. T7 Express 
has a mutation in the SulA promoter, which diminishes the expression of SulA and 
makes the strain less sensitive to the consequences of the SOS response (New 
England Biolabs, 2016b). As the T7 Express strain is created mainly for better 
production of DNA active enzymes, such as restriction endonucleases and DNA 
binding proteins, several interfering elements have been removed from its 
genome. To stabilize foreign DNA in the cells the genes of methylation and 
restriction enzymes have been mutated or deleted. (E.A. Raleigh, personal 
communication, 27.6.2016) This way the other DNA active enzymes will no longer 
exist in the cytoplasm, which also makes the purification of the commercial 
protein of interest easier. 
2.2.3 Enhancing disulfide bond formation in E. coli 
An abundant bottleneck for protein production is the misfolding of the protein and 
the accumulation of the protein to inclusion bodies in the insoluble fraction. 
Especially in the case of heterologous production the protein of interest is likely to 
misfold, or to fold incompletely, as the folding machinery is not optimal for the 
protein. The disulfide bonds cannot be folded efficiently in the cell cytoplasm 
because of the reducing environment. Unlike eukaryotes, prokaryotes like E. coli 
also lack the endoplasmic reticulum, which would have a reducing environment to 
assist the disulfide formation and correct folding. (de Marco, 2009) Thus 
heterologously produced protein, which naturally folds via disulfide bond 
formation in the post-translational modification pathway, is presumably misfolded 
and not functional. 
Several different approaches have been taken to overcome this issue. The 
eukaryotic production, such as with yeast, has its own limitations, like higher 
production costs and hyperglycosylation of the proteins. The genetic modification 
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of E. coli to enhance disulfide bond formation is the other commonly used way, 
which has resulted in new commercial production strains, like Origami strains 
(Novagen). Origami strains have mutations in the key enzymes of the glutaredoxin 
system (gor/TrxB), which normally maintain the reducing environment in the cell 
cytoplasm. However, interfering the redox potential of the cell affects negatively 
the growth of the cells, and the doubling time in regular growth medium is as much 
as 300 min (Prinz et al., 1997; Åslund and Beckwith, 1999). As presumably every 
gene has its own contribution to a living organism, mutations in the genome 
unbalance the system. Therefore, adding genes rather than deleting any might be 
safer choice in some occasions. If the normal cell metabolism is not interfered and 
the growth rate is maintained relatively high, the overall production is better even 
if there are many resource-consuming genes to be expressed. 
CyDisCo technology (Cytoplasmic disulfide bond formation in E. coli) is a plasmid-
based technology, so it can be used in any strain, like previously mentioned 
BL21(DE3) and T7 Express. CyDisCo enhances the protein folding by catalyzing the 
disulfide bond formation. The technology comprises several plasmids with slight 
differences, but two enzymes form the core functions: sulfhydryl oxidase (Erv1p) 
catalyzes the disulfide formation whereas protein disulfide isomerase (PDI) 
catalyzes the disulfide bond isomerization (Matos et al., 2014). The CyDisCo 
version used in the experimental part of this thesis is pMJS205, which consists of 
the genes for Erv1p and PDI, p15A origin of replication and chloramphenicol 
resistance marker (Figure 4, full sequence available in the Appendix 1). The 
CyDisCo components, Erv1p and PDI are controlled by tac promoter, an efficient 
artificial promoter which can be repressed by the LacI repressor and activated by 
IPTG (de Boer et al., 1983). In this study the LacI is encoded in the sequence of the 
other expression plasmid, which contains the protein of interest. Consequently, 
the CyDisCo plasmid is not efficiently repressed in cases where it is the only 
plasmid in the cell. 
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Figure 4. CyDisCo plasmid pMJS205 contains genes for Erv1p and PDI, and p15A 
origin of replication and chloramphenicol resistance marker (Image by Geneious, 
Kearse et al., 2012). 
3 Expression systems 
3.1 Vector engineering 
The vectors that we use nowadays utilize known parts of natural organisms and 
their genetic pathways. However, the expression vector selection is not yet well 
categorized, and sequence level tuning of vectors is not in the priority. The vectors 
that are currently in use are constructed from natural regulatory elements, but 
the elements itself are not specifically optimized for the production. (Gustafsson 
et al., 2012) There have been many attempts to standardize and classify different 
elements of expression vectors, such as replication origins, selection markers and 
regulatory sites like promoters and terminators (Shetty et al., 2008; Silva-Rocha et 
al., 2013). There are also some studies about computational analyses which aim 
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to better classify the regulatory elements (Jonsson et al., 1993; Omotajo et al., 
2015).  
Databases containing detailed information about the properties of each 
component are useful when creating novel expression systems. As the de novo 
DNA synthesis becomes affordable to more and more researchers and less cloning 
is performed by hand, the information from such databases can be used when 
ordering custom made vectors. The ready-made vectors that several companies 
offer may remain a good starting point but supposedly will sooner or later become 
impractical. 
3.2 T7 expression system 
T7 expression system is based on a genomic T7 RNA polymerase, which upon 
induction can transcribe the gene cloned downstream of a T7 promoter region. 
Usually the T7 RNA polymerase gene T7 gene 1 is regulated by lactose or its 
analogue IPTG, or some other sugar such as arabinose. The T7 system also enables 
multiple genes being activated by the induction of T7 polymerase. The strains that 
have a mutation in the lactose permease gene lacY1 additionally enable the tuning 
of the expression level. The mutation allows uniform intake of IPTG in the cells, 
and thus the expression levels can be adjusted precisely. Lower expression rates 
may allow better folding for some proteins and that way increase the amount of 
functional protein (Novagen, 2006)  
The wide usage of T7 RNA polymerase system in recombinant protein expression 
stems from the nature of the polymerase itself. It is highly selective in producing 
the protein coded under T7 promoter regions, and the speed of T7 RNA 
polymerase can be 5 times higher than the E. coli natural RNA polymerases. In 
nature, this is an advantageous virulence property as the T7 bacteriophage has a 
way to direct the whole cell’s energy to transcribe only its own genes. This results 
in a situation where the protein of interest may constitute even half of the protein 
 14 
 
production of the cell. However, as the polymerases do not compete for the same 
templates, the effectiveness of T7 polymerase lies in its speed as it steals 
ribonucleotide construction material from other slower RNA polymerases. 
(Studier and Moffatt, 1986) The high selectivity of the promoter regions disables 
almost any expression in the absence of the T7 RNA polymerase, which is a good 
property in the case of a toxic protein overexpression (E.A. Raleigh, personal 
communication, 27.6.2016).   
4 ORF optimization 
4.1 The paradox of ORF optimization 
Due to the advances in the de novo DNA synthesis and the reduction of prices, it 
is easier to synthesize a new DNA sequence than to extract it from the native 
species as was still being done just a few years ago. As in the DNA synthesis 
virtually any sequence can be synthesized, the genes are usually optimized for the 
expression host. The challenge lies in the optimization, as there are no universal 
guidelines or knowledge how it should be done in order to maximize the 
expression. Having no thumb rule for the optimization, the different sequences 
usually simply need to be tested.  
The lack of reliable design rules to create a good protein coding sequence derives 
from the fact that the gene level biology cannot yet be predicted and simulated. 
To be able to simulate and predict the behavior, one should have plenty of data, 
based on which the simulation could be built. The difficulty in the gene level 
experiments is that testing everything in the laboratory consumes a lot of time, 
money and raw material resources, and all combinations are not even possible to 
be tested without quite heavy automatization. However, the research can be 
started for example by searching among existing data, like bacterial genomes, and 
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compare the properties and behavior of different parts of the transcripts (Allert et 
al., 2010). 
To make the optimization even more confusing, the chemistry of DNA also 
contains other information in addition to the basic amino acid sequence 
information: transposon resistance, mRNA processing and folding, DNA folding 
and packing, and RNAi regulation. These properties have not been intentionally 
coded in the DNA like nothing in the nature, but they have survived from the 
natural selection being advantageous to the host organism. (Gustafsson et al., 
2012) As not all reasons for the advantageous properties are known, it makes it 
hard to create such multilayered information in artificial genes in just a single type 
of code. 
The optimization of ORF can be roughly divided into two categories: the 
optimization of transcription and the optimization of translation. There is also a 
possible third level – the effect of amino acid substitutions to the protein and its 
expression. Nevertheless, the amino acid level optimization is rather optimizing 
the function of the protein, and with the substitutions to the amino acid sequence, 
it also affects the possible choices for a successful DNA sequence. The third level 
is of the major interest in the experimental part of this thesis.  
4.2 Studying the ORF optimization 
The simulations require experimental data about how different sequences 
perform. Nowadays the shuffling can be performed in silico, and then synthesize 
the ready genes, although being creative helps to achieve much more variation in 
the sequence just in few steps. Even though gene synthesis is becoming cheaper, 
the power of natural recombination still outcompetes the synthesis resources in 
the variation. As automation is taking place in the lab, more and more screening 
can be performed in a shorter time. However, as seen in the study of Hu et al. 
(2009) and depending of the resources available, the limiting step for the research 
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can also be the sequencing, which would only be done for the few variants 
selected for further study. 
Nowadays DNA synthesis is highly efficient and readily available, and it allows the 
creation of quite many sequences in competitive price. Allert et al., (2010) simply 
exploited the power of de novo gene synthesis and created and compared 285 
genes having synonymous codon usage. If there is no chance of synthesizing all 
the wanted variants, the choices are to modify DNA somehow. Error-prone PCR as 
well as digestion and reassembly of a gene are methods, which can cause single 
point mutations in the genes. However, the rate of getting new properties might 
be quite slow and requires many cycles (Stemmer, 1994a, 1994b; Moore and 
Arnold, 1996; Crameri et al., 1998). As the mutations can be anywhere and 
additionally cause amino acid substitutions, the point mutations are better suited 
for the directed evolution of proteins rather than studying the codon usage of a 
single amino acid sequence. Making point mutations is also a quite old technology, 
and it was more widely used when the genes were obtained from the native 
species instead of synthesis, and the whole genes could not be rewritten. Crameri 
et al., (1998) compared point mutation versus multi-gene shuffling in improving 
the protein, and the multi-gene shuffling resulted at the best in 540-fold 
enhancement in the activity, whereas point mutations gave only up to 8-fold 
increase in function.  
One way to introduce more variation in the sequence is to create sequences from 
oligonucleotides, which are slightly different (Hu et al., 2013). As the 
oligonucleotides recombine different ways, the ultimate number of different 
sequences is enormous. The mutations in the primers may be designed so that 
they will only cause synonymous codon changes, i.e. the amino acid sequence will 
remain the same, and the codon optimization can be tested. Kudla et al. (2009) 
used a combination of two methods in order to further increase the variation in 
the sequences. They created fragments of the ORF sequence by PCR from 
oligonucleotide mixes, which contain synonymous mutations at third positions.  
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After sequencing the fragments, they were digested from the ends in order to 
ligate them together as different combinations. (Kudla et al., 2009) Two steps of 
different combinations causes exponentially growing amount of variants. Varying 
the third codon positions is the simplest way to introduce synonymous mutations, 
as many amino acids are encoded by codons that differ only by the third position. 
Family shuffling is shuffling between the genes of proteins that belong to the same 
protein family, but originate from the same or different species. Just by digesting 
DNA of homologous genes with randomly digesting restriction enzyme DpnI or 
DNase and then reassembling with recombination in primerless PCR, countless 
amount of variants can be created (Stemmer, 1994a; Crameri et al., 1998; Hu et 
al., 2009). Family shuffling usually includes slightly different amino acid sequences, 
so the amino acid usage is usually also changed, and thus the changes in the 
function of the protein may be significant. However not all mutations in the 
protein sequence cause major differences in the functionality but the nucleotide 
difference may affect the expression rate. 
Although massive variation can be achieved using various techniques based on 
random mutations or combinations, the shuffling can also be made by using 
rational design. Welch et al. (2009a) studied the gene expression of synthetic 
segmentwise shuffled genes. They compared two sequences that differed by the 
synonymous codon usage, and made three chimeras having different 
combinations of the fragments. By detecting the contribution of each fragment, 
the properties of advantageous or on the other hand deleterious fragments can 
be further studied. 
4.3 Properties of a good ORF sequence 
Several factors affect the gene expression on ORF level: messenger RNA levels 
affect the translation rate, as the more there is available RNA, the more strands 
ribosomes can start translating. The amount of mRNA available is in turn 
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dependent of the variables of transcription, such as CG-content of the sequence. 
The velocity of translation is fundamentally determined by the availability of 
charged transfer RNAs (tRNA) - the rare codons are codons which are not 
frequently used in the organism and consequently there are very few or no 
charged tRNAs available for such codons. The initiation of translation is a critical 
phase, and problems in at the initiation can easily result in deficient expression. 
(Gustafsson et al., 2012) Moreover, the sequence codon choices can affect locally 
or globally. In local prevalence, the codon choices may cause rare codon clusters 
or mRNA secondary structures that may prevent the translation or cause 
premature termination. When distributed throughout the sequence, the codon 
bias is the slowing down the translation rate as not enough tRNAs of specific 
codons are available. (Welch et al., 2009a) As the codon choices have both local 
and global effects, the distinguishing of their effects is difficult. 
The codon bias of the recombinant gene has been under debate since its discovery 
as there is no overall consensus about its effects (Gustafsson et al., 2012). One 
predominant assumption has been that the codon usage of the recombinant gene 
should be biased like the codon usage of the host organism, especially mimicking 
the bias in the highly expressed genes of the host. This dates back to the research 
of Ikemura (Ikemura, 1982), who compared the codon usage of the genes to the 
availability of the tRNA molecules. Later Sharp and Li (Sharp and Li, 1987) 
proposed the Codon adaptation index (CAI) as the measure of the adjustment of 
the gene to the codon usage of the host. Value 1 is given to the codon used most 
often, so a gene using only the most frequent codons has a CAI value of 1. Whether 
the gene should only use the most frequent codons, or if the codon usage ratio 
should match the natural ratio, has been under discussion for decades (Welch et 
al., 2009b). 
Kudla et al. (2009) made experiments with 154 synonymous sequences of green 
fluorescent protein, but they found no effect of codon bias on the expression. 
Neither the frequency of the highest expressed codons nor the CAI showed any 
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correlation to the results. This suggests that rather than statistically choosing the 
right ratio of different codons, more important are the specific points, which may 
cause mRNA secondary structures or something else that hinders the translation 
significantly. However, the CAI did affect the cell growth, as the availability of all 
tRNAs affects the general fitness of the cells and possibly reduces the amount of 
misfolded proteins that need degradation. (Kudla et al., 2009) On the other hand, 
the codons that are most favored in the expression were found to be those that 
stay charged the best during the starvation in the cell (Welch et al., 2009b). 
Although the CAI itself did not correlate strongly with the expression, the CAI 
might be a good thing to keep in mind and use as secondary optimization factor. 
The so-called rare codons, which are used in the own genes of the host organism 
significantly less frequently than some others, polarize opinions as some would 
like to avoid them totally and others would bias their usage according to the 
natural bias. When positioned in a cluster they might cause serious problems like 
prevent the whole translation by premature termination or cause frameshift at 
the ribosome (Gustafsson et al., 2012).  To some extent the synthesis of specific 
tRNAs have been enhanced by introducing genes for the rare codons needed into 
the strain (Novagen, 2006). Nevertheless, their use for the research has been 
questioned as the rule for the optimization is not clear and some rare codons are 
expressed well (Gustafsson et al., 2012). It has also been proposed, that having 
slowly translated rare codons at the domain boundaries or other important 
positions might help the folding of the protein by giving it a small break to fold 
properly before continuing to the next domain (Angov et al., 2008; Tsai et al., 
2008). In prokaryotic protein synthesis the protein starts to fold immediately from 
the N-terminus while it is still being synthesized at the ribosome. As the protein 
rushes to folding, there is a risk of deficient folding or misfolding. Since the 
qualities and the production yields of proteins made from different synonymous 
genes have varied significantly (Allert et al., 2010; Hu et al., 2013), the codon usage 
must be the key to the explanation. However, no conclusion could be made about 
which codon mutations or features are critical and have the most effect.  
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The ratio of A-T and G-C nucleotides affect how tightly the nucleic acid is bound as 
a double strand. Each G-C base pair has three hydrogen bonds whereas A-T base 
pairs only have two, so more energy is needed to open a G-C bond. Therefore the 
GC content must be adjusted to the preferences of the host organism. Long 
stretches of AT nucleotides may result in too weak binding and premature 
detachment of the strands, and for example terminate the transcription too early 
(Gustafsson et al., 2012). On the other hand, high GC content especially in the ends 
of the transcript may be deleterious, as it would make the possible hairpin 
structures more stable (Allert et al., 2010). Messenger RNA can fold into secondary 
hairpin structures after transcription. If the hairpin is strong, the ribosome may 
not be able to bind the ribosomal binding site (RBS). Therefore generally strong 
mRNA secondary structures are avoided in the sequence. Although less GC 
nucleotides make the mRNA secondary structures less stable, AT-rich sequences 
have been reported to be poorly expressed in E. coli for unknown reason (Plotkin 
and Kudla, 2011). 
Allert et al., (2010) analyzed the open reading frames of over 800 bacterial 
genomes, and found out a tendency of less mRNA secondary structure in both 
ends of the transcript, especially in the 5’ end. In both ends of the mRNA the 
content of GC nucleotides was statistically lower indicating a lower energy to form 
any such 3D-structures. The codon adaptation index (CAI) values suggest that 
there were also slightly more rare codons in the beginning of the transcript. 
However as many less used codons are AT-rich, their contribution to the lesser 
mRNA-structure and higher AT-content of the 5’ end of the sequence can be seen 
as lowered CAI. (Allert et al., 2010) Kudla et al. (2009) analyzed the expression of 
synonymous genes and found out the same correlation between the expression 
levels and mRNA structure at the 5’ end. However, Hu et al. (2013) noticed that 
the 5’ sequence does not exclusively explain the yield but the following codon 
choices have equal possibility to affect the expression. In both studies the 
expression levels as well as the functionality of the protein were greatly affected 
by the synonymous codon choices (Kudla et al., 2009; Hu et al., 2013). As a 
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conclusion, strong mRNA secondary structure should be avoided especially in the 
5’ end of the ORF, but also later if possible. 
Despite the lack of knowledge of the recipe for a successful gene sequence, there 
are some sequence motifs that are generally regarded as deleterious and should 
be avoided. RNase cleavage sites and transcriptional terminators are good 
examples what kind of sequences might cause problems to the transcription as 
those sequences clearly have a role to destroy or terminate the mRNA. 
(Gustafsson et al., 2012) When creating the sequence, the susceptibility of such 
motifs need to be taken into account, and kept in mind. When optimizing the 
sequence following other design rules, there is a risk to accidentally include such 
motifs. 
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EXPERIMENTAL PART 
5 Materials and methods 
5.1 Creating of the sequences in silico 
To study the differences in expression of highly similar homologous proteins, a set 
of variants were made using Geneious version 8.1.8 software (www.geneious.com, 
Kearse et al., 2012). First the codon optimized CBM sequences of one Emiliania 
huxleyi CBM1, Ehux1b (UniProtKB: R1C3S1, position 325-361, Read et al., 2013), 
and Cel7A (Malho et al., 2015) were aligned and Ehux1b was truncated to match 
the length of Cel7A. The codon usage in matching amino acids was taken from 
Cel7A optimized sequence, and the new sequence was called Ehux1b2. The 
sequences of Cel7A and Ehux1b2 were divided in four blocks so that each block 
had 4-6 differing amino acids between Cel7A and Ehux1b2 (Figure 5). Four 
chimeric proteins were made by shuffling the blocks. Each chimeric protein 
contained one block from Cel7A and three blocks from Ehux1b2 (complete DNA 
sequences are available in the Appendix 1). The sequences supplemented with 
appropriate cloning sites were purchased as GeneArt strings DNA fragments from 
Life Technologies. 
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Figure 5. The sequences of CBMs compared in this thesis. The sequences of Cel7A 
and Ehux1b2 were divided in four blocks, which then were shuffled yielding 4 
chimeric proteins, each with one block of Cel7A CBM and the rest three blocks 
from Ehux1b2. The coloured background of residues indicates equivalence of the 
sequence compared to Cel7A. (Image by Geneious, Kearse et al., 2012) 
5.2 Designing the expression principle 
To make the production easier and to be able to detect easily the expressed 
protein, the CBM sequences were expressed as fusion proteins with alkaline 
phosphatase (AP) (Figure 6), which is well expressed in E. coli. Additional pelB 
signal sequence directed the folding protein into the periplasmic space of the cell 
to help in the folding and disulfide bond formation, and the C-terminal 
polyhistidine tag enabled the purification with affinity chromatography. The linker 
between alkaline phosphatase and the CBM contained several sites for trypsin 
cleavage in order to extract only the CBM parts if needed. The fusion proteins were 
expressed in pET28-derived pBR1a vector (Figure 7). 
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Figure 6. A) The illustration of alkaline phosphatase (PDB ID: 5C66, left) and Cel7A 
CBM1 (PDB ID: 1CBH, right) proteins (images made with UCSF Chimera). B) The 
representation of the AP-CBM-construct.  
 
Figure 7. The plasmid map of the pET28-derived expression plasmid (Image by 
Geneious, Kearse et al., 2012). 
5.3 Golden Gate cloning 
The Golden Gate cloning (Engler et al., 2008, 2009) was performed using the 
following protocol: 50 ng of vector DNA, 50 ng alkaline phosphatase fragment DNA, 
60 ng pelB-linker fragment DNA (amplified with primers MI02&MI03 following 
PelB Alkaline phosphatase Linker1 CBM1 His-tag 
A  
 
 
 
 
 
 
 
B 
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KAPA HiFi Hotstart PCR kit instructions and purified with NucleoSpin Gel and PCR 
Clean-up kit (Macherey-Nagel)), 25 ng CBM DNA, 1 µl Cutsmart buffer (New 
England Biolabs), 10 mmol ATP (diluted from ThermoFisher R0441), 0,3 µl BsaI-HF 
(New England Biolabs), and 0,5 µl T4 DNA ligase (New England Biolabs) were mixed 
and sterile Milli-Q water was added to total volume of 10 µl. The control had 
vector DNA, Cutsmart buffer, ATP and BsaI-HF and the reaction volume was filled 
to 10 µl with sterile Milli-Q water. The reaction followed the thermocycle of 5 min 
in 37 °C and 5min in 16 °C (22 repeats), final digestion of 40min in 50 °C and 
inactivation for 10min in 80 °C. The reactions were transformed into chemically 
competent Top10 E. coli cloning strain. Plasmid extraction was performed with 
NucleoSpin Plasmid kit (Macherey-Nagel). 
5.4 Transformation - chemically competent cells 
Chemically competent cells were prepared by growing 100 ml 1:100 diluted LB 
medium culture to OD600 of 0,25-0,3 in 37 °C, 250 rpm. The culture was chilled and 
the medium was separated by centrifugation in 3200 x g, 4 °C, for 10 min. The cells 
were resuspended in 0,1 M CaCl2 solution and incubated on ice for 30 min. After 
centrifugation in 3200 x g, 4 °C, for 10 min, the supernatant was removed and the 
cells were resuspended in 0,1 M CaCl2 and 15 % glycerol solution and aliquoted for 
snap freezing with liquid N2 and storing in -80 °C. 
In the cloning E. coli Top10 strain was used and in expression BL21(DE3) and T7 
Express strains were used. 50 µl CaCl2-chemically competent cells were thawed on 
ice and mixed with 10 ng of plasmid DNA (100 ng of each plasmid in double 
transformations) or 5 µl of Golden Gate reaction mixture and let to stand on ice 
for 5 min. The cells were put in 42 °C water bath for 45 seconds and then again 
incubated on ice for 2 min, after which 250 µl SOC medium was added. The cells 
were let to recover in 37 °C incubator, for 30-60 minutes (depending on antibiotic 
resistance). Appropriate dilutions were made and the cells were plated on LB agar 
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plates, containing appropriate antibiotics (50 µg/ml kanamycin and/or 50 µg/ml 
chloramphenicol), and the plates were incubated in 37 °C overnight. 
5.5 Transformation - electrocompetent cells 
Electrocompetent cells were prepared by growing 2x150 ml 1:100 diluted LB 
medium culture to OD600 of 0,5-0,6 in 37 °C, 250 rpm. The culture was chilled and 
aliquoted into eight 50 ml Falcon tubes. All the following steps were carried out 
on ice. The tubes were centrifuged 3200 x g in 4 °C for 10 min, and the supernatant 
was replaced with 30 ml ice cold MQ-water. The centrifugation was repeated and 
the cells were resuspended in 15 ml MQ-water and two tubes were combined in 
order to have four tubes left. The previous step was repeated to get two tubes. In 
the final step, the two tubes were centrifuged and the cells were resuspended in 
about 1 ml of ice cold 50 % glycerol and aliquoted. The tubes were snap frozen 
with liquid N2 and stored in -80 °C. 
A tube of 40 µl electrocompetent cells was thawed and 1 µl DNA (10 ng) was mixed 
with the cells in cooled tubes and then incubated on ice for 5 min. The mixture 
was transferred to pre-cooled 2 mm cuvettes and 2,5 V heat shock was given 
(about 5,20 ms), followed by addition of 960 µl SOC medium. The cells were let to 
recover on ice for 2 min, and then in 37 °C for 1h. Appropriate dilutions were made 
and the cells were plated on LB agar plates, containing appropriate antibiotics (50 
µg/ml kanamycin and/or 50 µg/ml chloramphenicol), and the plates were 
incubated in 37 °C overnight. 
5.6 Colony PCR 
Colony PCR was performed following the protocol of KAPA2G Robust HotStart 
ReadyMix PCR Kit (Kapa Biosystems). The AP-CBM constructs were amplified using 
pSVAR1 and pSVAF2 primers. 
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5.7 DNA electrophoresis  
The colony PCR reactions were analyzed with DNA gel electrophoresis using 1% 
UltraPure Agarose (ThermoFisher 16500-100) in 1x TAE buffer. The 50 ml gels were 
stained at casting with 5 µl 10000x SYBR™ Safe Stain (ThermoFisher). The gels 
were run with 80-130 V as long as needed for the separation, and imaged with 
BioRad GelDoc XR+ using Image Lab v. 5.1 software. 
5.8 Sequencing 
The correct-looking plasmids were sequenced as Full Service Capillary sequencing 
at the Finnish Institute of Molecular Medicine (FIMM), Meilahti, Helsinki. In the 
sequencing reaction samples 150-300 ng plasmid DNA was mixed with 1,6 µl 5µM 
primers in final volume of 6,6 µl reactions. The sequencing data was analyzed with 
Geneious software (Kearse et al., 2012). 
5.9 Cultivation 
The cultivations were made in EnPresso B medium following the commercial 
protocol for multiwell plates. The fresh transformants were inoculated in 2 ml 
precultures of LB medium supplemented with appropriate antibiotics and 
incubated in 37 °C, 230 rpm for 6-8h. The used antibiotic concentrations were 50 
µg/ml kanamycin and 50 µg/ml chloramphenicol. The EnPresso culture medium 
was prepared by dissolving one white bag in 100 ml sterile MQ-water and 
appropriate antibiotics and 25 µl Reagent A was added. The medium was aliquoted 
to the microplate wells, and the 3 ml well cultures were inoculated with 1:25 of 
the preculture. The plates were closed with porous membrane and incubated 
overnight for 15-18 h in 30 °C, 230 rpm. The cultures were boosted and induced 
with 10x boosting solution with 25 µl Reagent A per 100 ml culture volume and 
IPTG of 0,5 mM in final concentration. The incubation was continued in 30 °C, 230 
rpm for another 24 hours. 
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5.10 Cell lysis and harvest 
The plate cultivations were spun down in Eppendorf centrifuge, 3200 x g for 10 
minutes in 4 °C. The supernatants were removed and the cells were resuspended 
in 1 ml of lysis buffer (20 mM NaH2PO4 buffer, pH 7,8, 50 mM NaCl, 1 mg/ml 
lysozyme, 10 µg/ml DNase I, 10 µg/ml MgCl2, 1 tablet of protease inhibitor cocktail 
(Sigma-Aldrich S8830) in total volume 150 ml). The plates were incubated on a 
rocking shaker in 4 °C for few hours or as long as the viscosity of the solutions had 
increased substantially, and possibly additionally frozen in -20 °C and thawed on 
icy water. The wells were sonicated one at a time (20 % amplitude, 1 s on, 1 s off) 
for 20 seconds. The plates were centrifuged in Eppendorf centrifuge on 4500 x g 
for 45 minutes. 
5.11 SDS-PAGE 
The SDS-PAGE resolving gel contained 10 % acrylamide (Bio-Rad #1610146), 1,5M 
Tris-buffer (pH 8,8), 0,1 % sodium dodecyl sulfate, 0,05 % ammonium persulfate 
and 0,05 % TEMED (Bio-Rad #1610800) and the stacking gel contained 4 % 
acrylamide, 0,5M Tris-buffer (pH 6,8), 0,1 % sodium dodecyl sulfate, 0,05 % 
ammonium persulfate and 0,1 % TEMED. The resolving gel mixture (4-5 ml) was 
pipetted between the glass plates and 0,5-1 ml isopropanol was added on top of 
the gel to smooth the top surface. After the gel had solidified (after about 45 
minutes), the isopropanol was poured off and the stacking gel mixture was added 
and the combs were set. The gels were ready to use in another 45 minutes. 
15 µl of samples were boiled 10 min with 5 µl 4x SDS-PAGE sample buffer (4x 
solution contains 200 mM Tris-HCl pH 6,8, 40 % v/v glycerol, 8% SDS, 200 mM DTT 
and bromophenol blue). 10 µl of the mixture was pipetted on gel.  
The gels were run in SDS-PAGE running buffer (25mM Tris-base, 0,2M glycine, 0,1% 
SDS) with 80-130 V, until the blue line of the sample buffer had reached the 
bottom of the gel. The gels were stained with Coomassie Brilliant Blue R-250 
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staining solution for either 30 min in room temperature, or 15 min slightly heated 
up in a microwave. The gels were then destained in destaining solution (20% 
ethanol, 5% acetic acid) overnight or in destaining solution for 45 minutes and 
stored temporarily in water. The gels were imaged with BioRad GelDoc XR+ using 
Image Lab v. 5.1 software. 
5.12 Alkaline phosphatase assay  
Alkaline phosphatase assay (AP-assay) was used to measure the concentrations of 
the protein of interest in the unpurified samples. For the direct assay from cell 
suspension 50 µl of the sample was taken from a cooled multiwell plate and mixed 
with 950 µl Milli-Q water. For the assay of cell lysate or pure protein appropriate 
dilutions were made. In some measurements the solution was buffered with 50 
mM sodium acetate, pH 5, supplemented with 10 mg/ml BSA (Sigma-Aldrich 
A2153). Samples of 50 µl were pipetted on a microtiter plate, in duplicates or 
triplicates. 50 µl of liquid para-nitrophenyl phosphate substrate (Sigma-Aldrich 
N7653) was quickly added to all wells and the microtiter plate was immediately 
put in BioTek Eon/SynergyH1/ Cytation3 microplate reader (Figure 8), which 
measured the absorbance at 405 nm every minute for 60 minutes (for 
suspensions), or every 30 seconds for 5-15 minutes (clear samples), or as long as 
the pattern of the color formation was clear. Also OD600 was measured at the 
starting point for the cell suspension samples. The Gen5 v. 2.09 software 
automatically determined the maximal rate of yellow color formation (V0) as 
mAU/min within 4 time points in the beginning of the assay. The alkaline 
phosphatase activity of the protein measured as V0 corresponds to the protein 
concentration of the AP-CBM fusion protein. 
 30 
 
 
Figure 8. The AP assay was analyzed on a microplate reader. 
5.13 Cellulose and chitin binding assay 
The proteins were tested with three different substrates, nanofibrillated cellulose 
(NFC, 6-pass from birch), bacterial cellulose (BC, obtained from Pezhman 
Mohammadi, grown from Acetobacter xylinum, 6-pass) and chitin nanocrystals 
(ChNC, obtained from Maryam Borghei, made with HCl hydrolysis from 
commercial chitin, acetylation degree 0,9). In 200 µl total volume, 40 or 80 µg of 
the substrate was mixed in a tube containing 0,3 µM protein, 10 mg/ml BSA 
(Sigma-Aldrich A2153), buffered in 50 mM sodium acetate, pH 5. The tubes were 
mixed well and incubated in room temperature for 60 minutes. The tubes were 
then centrifuged for 1 min, full speed, and the supernatant was analyzed with SDS-
PAGE or alkaline phosphatase assay, in duplicates. Negative control contained 
equal amount of protein and buffer, and Milli-Q water instead of the substrate. 
The loss of alkaline phosphatase activity between the control and sample was 
interpreted to represent the part of the protein bound to the substrate. 
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6 Results and discussion 
6.1 The effect of CyDisCo 
All the seven AP-CBM constructs were built in pBR1a expression plasmid and 
verified by sequencing (ready plasmid of AP-Cel7Aopt obtained from Bart 
Rooijakkers). The constructs were transformed in BL21(DE3)  and BL21(DE3) + 
CyDisCo by electroporation. In the case of BL21(DE3) + CyDisCo, the CyDisCo 
plasmid had been earlier transformed in BL21(DE3) and electrocompetent cells 
were made of this strain (electrocompetent cells obtained from Bart Rooijakkers). 
The experiments were started by comparing the constructs in BL21(DE3) strain. 
The cultivated and induced cells of Cel7A construct in BL21(DE3) strain with and 
without CyDisCo plasmid were lysed and the supernatant was used for the AP-
assay and SDS-PAGE (Figure 9). First of all the production levels seemed to be 
greatly enhanced by the CyDisCo plasmid even though those cells were grown in 
two antibiotics. The AP-assay values for V0 seem to correlate quite well with the 
SDS-PAGE results, so the functionality of the AP-assay was verified. The presence 
of the AP-CBM protein was seen in the SDS-PAGE image as 55,4 kDa protein. 
However, the CyDisCo proteins Erv1p (21,6 kDa) and PDI (55,4 kDa) were also seen 
on the gel image, and especially the PDI caused problems in interpreting the 
results as PDI is almost exactly of the same size as AP-CBM proteins. 
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Figure 9. The A) SDS-PAGE and B) AP-assay results from the cell lysis supernatant 
of Cel7Aopt clones in BL21(DE3) strains with and without CyDisCo. The V0 values 
(marked also on the SDS-PAGE image) indicate the initial activity of the AP enzyme 
(55,4 kDa) present. The error bars represent standard deviation between 
replicates. C) The presence of the AP-CBM gene was verified with colony PCR from 
expressing and non-expressing clone from BL21(DE3) + CyDisCo strain. 
Another remarkable observation was that the variation between the clones turned 
out to be massive. The previous results of several hundredfold differences in the 
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expression of different constructs (Ikonen, unpublished data) have more likely 
been due to a poor selection of the clone, and not due to the variation caused by 
different protein or nucleotide sequences of the CBM. Additionally, in the cases 
where the AP-activity was low neither AP protein nor either of the CyDisCo 
proteins were noticed on SDS-PAGE. However, according to colony PRC made to 
amplify the AP-CBM gene, the 1949 bp coding sequence was found in both 
expressing and non-expressing clones (Figure 9). There is also a possibility that 
something else had been broken in the expression system, like the T7 RNA 
polymerase gene, which was not tested with colony PCR. However, this did not 
explain the disappearance of CyDisCo proteins as they were regulated by tac 
promoter, which is directly inducible by IPTG (de Boer et al., 1983) and not 
dependent on the T7 RNA polymerase. 
6.2 Testing the AP-assay method 
As the AP-assay proved to be a good way to measure the AP-CBM protein 
concentration in a lysate which additionally contained all other proteins and 
metabolites from the cells, the method was further developed. Cell lysis is a time-
consuming step, especially with microwell plates where every well needs to be 
resuspended to lysis buffer and sonicated separately. The AP-assay was tested 
from the cell suspension, the clear growth medium without cells, and the cell 
lysate of transformants in BL21(DE3) strain (Figure 10). 
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Figure 10. The comparison of AP-assay results using cell suspension, growth 
medium without cells of the cell lysate from BL21(DE3) strain as sample type.  
The same order in the AP-activities was maintained when measuring from 
different sample types. The growth medium would have been an ideal sample type 
as it contained no particles and was more stable compared to cell suspension. On 
the other hand, the brown-yellow color of LB medium could affect the absorbance 
readings. However, since the AP-activity was so weak in the case of growth 
medium, and the error defined by standard deviation was relatively big, the cell 
suspension was chosen as the sample type for future experiments. The challenges 
in using cell suspension are that the cells might sediment at the bottom of the 
microtiter plate preventing absorbance readings, so the plate needs to be shaken 
properly, and that the possible growth of the cells may bias the color formation 
rates. To prevent the sedimentation and optical issues due to particles and existing 
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yellow color, the cell suspensions were always diluted 1:20 to water before taking 
the sample for the assay. 
The V0 values were defined by the maximal rate of increase in yellow colour at 405 
nm within 4 time points during the first 4 minutes. The activity was determined in 
such early phase of the assay to get the initial value for the color formation rate, 
but this method also caused problems as there were false positives. When 
comparing the AP-assay results to the absorbance increase curves and SDS-PAGE 
images, the false positives could be revealed (Figure 11). As little difference as 
from 11,6 mAU/min to 10,1 mAU/min was found to be a difference between 
expressing and non-expressing clone in the V0 values. The color formation curves 
of the false positives had distinguishable shape whereas the expressing samples 
had a curve that was smooth and linear or slightly decelerating by time. 
Consequently the AP-activity values up to 10 mAU/min, measured from cell 
suspension diluted 1:20, needed further attention. Fortunately, when CyDisCo was 
not used, nearly all clones expressed the protein, so there was no such risk for 
detecting false positives. 
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Figure 11. A) The AP-activity is not unequivocal measure of the protein expression. 
The AP-activities, V0, of each sample of Ehux1b2 and Ehux1b2A are indicated on 
the top row (mAU/min). B) AP-assay activity curves of the corresponding Ehux1b2 
clones represent an example of false positive samples. Two samples (+) were 
expressing well the AP-Ehux1b2 protein and two others (-) were false positives in 
V0 values. 
6.3 The correlation of the AP-activity and protein concentration 
The correlation between AP-activity and protein concentration was determined 
by analyzing a dilution series of Cel7Aopt protein sample of known concentration 
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(made by Bart Rooijakkers) with the AP-assay (Figure 12). At first the correlation 
was studied by diluting the 100 µM protein in H2O. Upon addition of the AP 
substrate para-nitrophenyl phosphate (pNPP) to samples over 2 µM of protein, 
the solution turned yellow too fast. With such concentrated samples the 
technique to add substrate to all wells with a multipipette and then inserting the 
microtiter plate in the microplate reader is not fast enough to be able to detect 
the initial color formation rates, as the rates are already decreasing by the time of 
reading the absorbances. On the other hand, concentrations under 40 nM were 
suspicious as they give activity rates which were close to the values of false 
positives. Consequently, the range for AP-activity measurements for protein 
concentration determination was found to be between 0,2-2 µM.  
Still making a linear standard curve was difficult and the error in pipetting such 
small volumes and its accumulation in the more dilute samples may have 
accounted for a considerable proportion of the fluctuation. When having such 
dilute protein samples the unspecific binding of the protein to the tube walls and 
pipette tips was most likely a significant factor to the erroneous pipetting. 
Nevertheless, bovine serum albumin (BSA) could be used to reduce the unspecific 
binding as the BSA tends to bind to the possible targets more strongly (Linder, 
1996). Additionally the protein solution was buffered to pH 5 with a 50 mM sodium 
acetate buffer, because this way the pH of the lysates could be standardized. The 
addition of 10 mg/ml BSA turned out to help the linearity of the standard curve 
tremendously (Figure 12, Equation 1). Surprisingly also the used BSA itself seems 
to have some AP activity as the negative control without AP-CBM has AP activity 
of 2,7 mAU/min. Although BSA itself should not exhibit alkaline phosphatase 
activity, the method of purification used at the manufacturing, purification by 
ethanol fractionation, may not be precise enough to eliminate all other protein 
from the BSA. 
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Figure 12. The determination of the correlation of protein concentration and AP-
assay and the effect of BSA in the accuracy of the measurements. 
𝑐(𝑝𝑟𝑜𝑡𝑒𝑖𝑛, µM) = 0,0044 ∗ 𝑉0 + 0,0471                        (1) 
6.4 Clone variation in BL21(DE3) and T7 Express strains 
The clone variation was further studied with all 7 constructs in BL21(DE3) and T7 
Express strain without CyDisCo. To get extensive data on the clone variation, 24 
(BL21(DE3)) or 10 (T7 Express) colonies of different size per construct were 
selected to the cultivation and direct AP-assay analysis from the growth 
suspension (Figure 13). Additionally some of the samples were run on SDS-PAGE 
to verify the results of AP-assay.  
Unlike in the case of CyDisCo, where some clones did not express any recombinant 
protein, surprisingly the plain BL21(DE3) strain was quite stable in the expression 
and no significant differences were observed between clones. T7 Express had also 
quite little variation, but the poor expression of a single clone caused significant 
standard deviation in Ehux1b2D. As the plain strains did not show the variation 
previously seen with CyDisCo, it seemed that the CyDisCo had an unknown effect 
to the strains which caused some clones to express well but inhibited all 
expression from others. Nevertheless, CyDisCo proteins are unlikely to cause 
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major changes in the cell metabolism as they only assist in the folding. Even so, 
the colony picking was an important phase and several clones should be always 
tested in small scale before choosing one for larger scale production. 
 
 
Figure 13. The clone variation in different constructs in BL21(DE3) represented by 
A) variation of 24 or 10 clones per construct in direct AP-assay from growth 
suspension  of BL21(DE3) and T7 Express, respectively, and B) variation within 14 
Cel7Aopt construct from BL21(DE3) on SDS-PAGE.  
The expression of different constructs was not completely consistent in both 
strains, which indicates that the strains have some preferences for the sequences. 
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Nevertheless, the expression of Ehux1b2 was clearly enhanced by the substitution 
of the C-block from Cel7Aopt (Ehux1b2C). Additionally the wild-type sequence for 
Cel7A turned out to be expressed better than the optimized sequence. The 
difference between these synonymous sequences is not big and it is a bit more 
substantial in T7 Express. However, this proves the fact discussed in the earlier 
chapters that the optimization is not straightforward and the organisms have 
preferences that are not generally known. 
6.5 Transformation problems with CyDisCo 
As BL21(DE3) showed little clone variation between clones, but significant 
variation had been spotted with CyDisCo plasmid, a similar comprehensive study 
was tried to make. However, there were constant problems in making a CyDisCo 
containing strain, which would express. The clones transformed to the original 
batch of BL21(DE3) + CyDisCo electrocompetent cells (obtained from Bart 
Rooijakkers) used in the first experiments expressed 60% (Figure 9, Figure 14). 
Nevertheless, following the same protocols and remaking competent cells from 
the same strain resulted in no expression of any construct. For some unknown 
reason, none of the later made batches of any kind of competent cells in either of 
the E. coli strains containing CyDisCo plasmid were expressing any of the 
recombinant proteins (Table 1). Finally, the double transformation, where both 
plasmids were transformed at the same time was found to work.  
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Figure 14. The expression of clones made by electroporation of AP-CBM -plasmid 
to BL21(DE3) + CyDisCo electrocompetent cells of the first batch.  
Table 1. The success of different strategies for CyDisCo strain transformations. 
Competent cell type Plasmids to be 
transformed 
Transformation 
efficiency  
Expression 
BL21(DE3) + CyDisCo 
chemically competent 
AP-CBM +++ - 
BL21(DE3) + CyDisCo 
electrocompetent 
AP-CBM + +/- 
One batch 
expressed 60% 
T7 Express + CyDisCo 
chemically competent 
AP-CBM +++ - 
T7 Express + CyDisCo 
electrocompetent 
AP-CBM ++ - 
T7 Express 
chemically competent 
CyDisCo 
AP-CBM 
++ + 
Expressed 40% 
 
Apparently the addition of CyDisCo plasmid in the strain caused stress to the cell, 
which supposedly prevented the expression of all recombinant proteins. The 
competent cells of the CyDisCo containing strains were also tested for expression 
without the AP-CBM plasmid and unexpectedly even the CyDisCo proteins were 
not expressed (Figure 15). It is notable, that in the plasmids that were used in this 
thesis, the LacI repressor was positioned in the AP-CBM plasmid and not in 
CyDisCo. There is also available another version of CyDisCo plasmid which would 
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have the repressor, but it was not tested in this study. However, as the CyDisCo 
was transformed first, its genes may not have been repressed enough, as the tac 
promoter was not repressed in the absence of LacI. Usually the leaking is most 
harmful when the expressed proteins are toxic to the cells, which the Erv1 and PDI 
should not be. In the case the cell regards the new DNA as detrimental, there 
might be genetic rearrangements, which may splice out some elements. (L. 
Ruddock, personal communication, 18.5.2016)  
  
Figure 15. The BL21(DE3) and T7 Express strains containing CyDisCo (CDC) did not 
express even without the AP-CBM (AP) plasmid. 
In the case of the first batch of BL21(DE3) + CyDisCo competent cells, there must 
have been less stress for the cells as everything still worked in 60% of the clones. 
The double transformation is one way to prevent the leakage as the repressor is 
introduced simultaneously with the CyDisCo. Nevertheless, there was still only 40 % 
of the clones which expressed, so the quality was still not good. Transforming first 
the AP-CBM plasmid and then the CyDisCo would be worth trying to find out this 
mystery. 
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6.6 Comparison of constructs in  T7 Express + CyDisCo transformation 
As the double transformation solved the issue with CyDisCo, a proper expression 
test was made in T7 Express strain. Ten clones of each construct were analyzed 
with AP-assay (Figure 16) and SDS-PAGE (Figure 17A). The SDS-PAGE results 
showed qualitatively the same results as AP-assay but quantitatively the slight 
differences were hard to recognize. On the other hand, there were many false 
positives. When comparing the SDS-PAGE samples to the AP-activities of the 
corresponding samples, the false positives could be ruled out. 
 
Figure 16. The variation in the expression of different constructs in T7 Express + 
CyDisCo made with double transformation (blue, left axis) and the corresponding  
protein yields in the cultivations analyzed from the lysates (green, right axis).  
Based on the results, the expressing clones were selected to be lysed and their 
proteins were harvested. The clear lysates were then analyzed with AP-assay in 
50mM sodium acetate buffer, pH 5, containing 10 mg/ml BSA. Using the standard 
curve made with purified protein (Figure 12), the concentrations in each sample 
were determined and proportioned to the culture volume. At best, the clones of 
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Cel7Aopt and Ehux1b2C reached the expression of 100mg/l, which is sufficient 
protein yield for this purpose. However, the expression of other E. huxleyi 
constructs fell behind, the concentrations being mostly within 30-60 mg/l. 
When comparing the results from lysates to the results from AP-assay from cell 
suspension or SDS-PAGE gel images, the results within a sample were not always 
consistent. The pipetting was a major source of error in all steps. In the cell 
suspension the mixing of the suspension may have been inadequate and resulted 
in more or less dense solution at the dilution. The protein concentration of the 
lysates were affected by the success of cell lysis. The lysis itself was also a tricky 
process, as the cells needed to be sonicated enough to extract all the protein, but 
too intensive sonication would have caused the protein to degrade. The small 
volumes also made the relative error rate bigger. The remaining supernatant from 
the growth medium removal as well as the collecting of the lysate after cell lysis 
and centrifugation were steps that affected the volume and thus the 
concentration. Additionally, in the methods used, only the soluble fraction of the 
protein was taken into account. Although that fraction is what we were aiming for, 
a significant proportion of the protein may have been in insoluble form. 
When harvesting the proteins, an interesting observation was made as after 
removing the growth medium, the cell pellets were coloured differently – the cells 
that expressed the recombinant proteins formed more yellow cell pellet (Figure 
17). As the proteins expressed were not coloured this was likely due to a change 
in the metabolism, which caused accumulation of a yellow-coloured compound. 
Although the difference in the colour was quite vague, it could still be used as 
preliminary screening of clones to avoid the wasting of reagents to test the grey 
clones. 
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Figure 17. A) The SDS-PAGE image of the first clones of first CyDisCo + AP-CBM 
double transformations in T7 Express. B) The expression could be roughly 
identified by the color of the cell pellet after removal of the growth medium. The 
order on the SDS-PAGE gel was the same as reading order in the cultivation on 24-
well plate. 
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6.7 Comparison of different strains 
To compare the expression between strains, two separate experiments were 
performed. One contained specific information about the expression in T7 Express 
and two constructs were additionally cultivated in BL21(DE3) (Figure 18A). To 
further compare the different strains and also investigate the additional value of 
CyDisCo to T7 Express, which was expected to be a better strain than BL21(DE3), 
three constructs from the different edges of the production range where chosen 
to the reduced amount of variables. They were recultivated simultaneously to 
eliminate the differences in the growth conditions. As in the expression with 
CyDisCo some of the clones did not express at all, and the good clone would need 
to be selected anyway by expression tests before larger scale production, the 
mean values of AP activity of only the expressing clones were compared (Figure 
18B).  
In the first dataset T7 Express seemed to be significantly better strain for the 
production. The optical density of the sample gave some explanation to the 
differences as T7 Express was constantly higher in density. The optical densities 
measured on the microtiter plate from the 1:20 diluted sample, further diluted by 
1:2 upon addition of the substrate, most likely contained inaccuracy from the 
pipetting of the cell suspension, and thus the calculation of the actual cultivation 
OD was not sensible. Nevertheless, the density should have accounted for most of 
the variation between the strains. The results of the second dataset were 
ambiguous when compared to the first experiment. All the V0 values for T7 Express 
were almost cut to half. So were the densities, but the ratio of V0 and OD600 was 
still smaller. Additionally the superiority of the two plain strains was switched in 
the second experiment, albeit the difference was small. In general, the density of 
T7 Express cultures was higher. The additional value of CyDisCo to the protein 
production was rather small, but it did affect negatively to the growth of the cells, 
most likely due to the cultivation in two antibiotics and the increased stress caused 
by maintenance of two plasmids. However, the usage of CyDisCo should affect 
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positively in the folding of the AP-CBM protein and consequently the proteins 
expressed with CyDisCo should be more functional. A clear conclusion of the 
different strains is that the C-block increased the expression of Ehux1b2 to the 
level of Cel7A in all of the strains.  
 
 
Figure 18. The comparison of AP-activities and optical densities of A) T7 Express 
with BL21(DE3) with two constructs and B) three constructs in three strains. 
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6.8 Binding affinities of the proteins 
The binding properties of each CBM were tested by simple binding assays with 
several substrates. In addition to the expected substrate, nanofibrillated cellulose 
(NFC), the binding affinities towards bacterial cellulose (BC) as well as chitin 
nanocrystals (ChNC) were tested. By comparing the supernatants of samples with 
and without substrate, the percentages of the protein bound were determined 
(Figure 19).  
 
Figure 19. The binding affinities of each protein (0,3 µM) towards nanofibrillated 
cellulose (NFC), bacterial cellulose (BC) and chitin nanocrystals (ChNC), displayed 
as percentage of bound protein.  
As the alkaline phosphatase was the same in all constructs, the differences in the 
AP-assay activities resulted from the different amounts of protein instead of 
different functionalities of the proteins. In other words, the binding affinity 
towards nanocellulose was highly dependent on the CBM sequence. As expected, 
the reference protein Cel7A bound well to NFC and slightly less to BC. It was also 
clearly seen that chitin was not its primary substrate. Additionally, the substrate 
concentrations did not have significant effect on the results, which indicates that 
there was excess of the substrate and there was no competition in the binding. 
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Surprisingly, despite the similarity of the sequence to Cel7A, the coccolithophorid 
sequence Ehux1b2 did not bind at all to either type of cellulose, and the chitin 
affinity was slightly smaller. 
However, one hybrid sequence, Ehux1b2D, showed significantly enhanced 
properties in binding compared to Ehux1b2 and other hybrids, which barely bound 
at all. With just five amino acid substitutions in the C-terminus, the binding affinity 
of Ehux1b2 could be restored to the level of Cel7A. The D-segment (Figure 20) 
contained the two adjacent tyrosines, which are found to be important residues 
in the binding to cellulose, and the asparagine with a less clear contribution to the 
binding (Linder et al., 1995). These results confirm the importance of the specific 
residues in the C-terminal end of the CBM sequence. Additionally, as the function 
is recovered by just few substitutions, this result confirms that the Ehux1b2 
sequence folds the same way as Cel7A so the proteins are structurally related.  
 
Figure 20. The change of only 5 amino acids in the sequence of Ehux1b2 restored 
the binding ability. The two tyrosines supposedly play the biggest role in the 
cellulose binding (Image by Geneious, Kearse et al., 2012). 
As the coccolithophorid protein Ehux1b2 seemed not to bind either in cellulose or 
chitin, the binding affinities of the coccolithophorid CBMs towards other 
polysaccharides would be interesting to test. Reportedly unknown type of 
polysaccharides are contributing to the calcification process of E. huxleyi (Kayano 
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et al., 2011). The full binding isotherms would also tell more details about the 
binding, but making a binding isotherm would require more samples and 
consequently more protein, which could not be achieved with the cultures on 
microwell plates but require bigger culture volumes.  
6.9 Sequence analysis of the proteins 
Inspired by the significant contribution of D-block to the binding, CBM1 sequences 
were aligned to find out naturally existing mutations within cellulose binding 
enzymes. Amongst the nearly thousand CBM1 sequences available, 27 sequences 
were selected by random, based on their usage of cellulose, xylan or chitin as a 
substrate, and the ones with low sequence similarity were excluded. The 
sequences were aligned to Cel7A sequence (Figure 21, GenBank accession 
numbers in Appendix 2). 
 
Figure 21. Multiple sequence alignment of 27 CBM1 sequences selected by the 
similarity of structure to Cel7A and cellulose-related activity (Image by Geneious, 
Kearse et al., 2012). 
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The comparison revealed that the residues of D-block are highly conserved among 
cellulose binding CBM1 sequences, so that region must have an important 
contribution to the protein function. Similar conclusion could not be made from 
other segments, as the residues that were not the same in Ehux1b2 and Cel7A, 
were widely varying among different CBM1 sequences. To conclude, the 
alignment supports the observation that the addition of D-block could restore the 
function. In addition to the two tyrosines in D-block, also the asparagine is 
conserved in most of the selected sequences, and only chitin binding CBMs lack it. 
Possibly also the proline makes the structure more rigid and modifies the structure 
to better bind to cellulose. Some chitinases were also included in the multiple 
sequence alignment, but the similarity of the Ehux1b2 D-block is not significantly 
better with them either. This result suggests that the main substrate of Ehux1b2 
is some other polysaccharide, possibly not even chitin. 
In segments A and B the conservation of amino acids is approximately the same 
within Ehux1b2 and Cel7A as with all other CBM1 sequences. All of the most 
conserved residues are also present in the sequence of Ehux1b2. Nevertheless, 
most likely these highly conserved residues form the fold for the protein, as its 
structure seemed to be functional when the important residues of D-block were 
substituted. 
7 Conclusions 
The codon optimization of a gene sequence was found to be troublesome as there 
is still a lack of experimental evidence how different kinds of sequences work in 
different hosts. The desirable properties of a gene sequence are defined by several 
overlapping variables, and the simultaneous optimization of them all is challenging. 
In the experimental research the sequence optimization was studied by expressing 
shuffled CBM1 homologues in four E. coli strains and testing the binding affinities 
towards nanosized cellulose and chitin.  
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The alkaline phosphatase assay was found to be a good qualitative way to detect 
the protein expression. The AP-assay was used as a way to measure AP-CBM 
protein concentrations from cloudy cell suspensions as well as from unpurified 
lysates that contained all proteins from the cells. However, in the measurements 
with cloudy samples the assay was not robust enough and could result in false 
positives, which could be revealed on SDS-PAGE. Additionally the detection range 
was quite narrow, between 0,2-2 µM. The reliability of AP-assay could be 
enhanced by using clear samples and adding BSA to the mixture to prevent 
unspecific binding. In this production scale and type of research, the property to 
detect specifically the protein of interest from a mixture was crucial, as the 
amount of samples exceeded the number that could have possibly been purified.  
In the protein expression the wild type sequence of Cel7A was occasionally 
performing better than the optimized version, which emphasized the difficulty of 
optimization. In T7 Express strain containing CyDisCo, Cel7Aopt was expressed 101 
mg/l at the best, but the original homologue Ehux1b2 only 38-56 mg/l. The hybrid 
CBM Ehux1b2C was expressed nearly as well as Cel7A with 99 mg/l, which 
indicated that the substitution of C-block with the sequence from Cel7A brought 
favorable properties to the expression. The other block substitutions did not have 
significant effect in the expression. Although the proteins were shuffled segment-
wise, and the codon usage derived from the optimized parental sequence of the 
segment, the shuffling could still cause both global and local changes in the codon 
usage and that way it may have affected the expression. 
T7 Express and BL21(DE3) were found to be approximately equally good in the 
production, although the results were varying. According to the genotype, T7 
Express should be more stable strain, and in the experiments it grew to a slightly 
higher density. The CyDisCo system could enhance the protein production up to 
100%, but it also brought problems with it. The clone variation without CyDisCo 
plasmid was almost nonexistent compared to the situation with CyDisCo where 
only 40-60 % of clones expressed. In order to make at least some clones express, 
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the CyDisCo plasmid had to be transformed simultaneously with the AP-CBM 
plasmid to the strain. The order of the expression levels of different construct 
followed a similar pattern in all strains – both versions of Cel7A at the top 
alongside Ehux1b2C. The original coccolithophorid sequence Ehux1b2 was 
expressed the least. The other block substitutions had varying amount of positive 
contribution to the expression.  
The binding abilities of all seven proteins were tested with nanofibrillated cellulose, 
bacterial cellulose and chitin nanocrystals. About 80 % of Cel7A bound to cellulosic 
substrates, and 35-40 % bound to ChNC. On the contrary, Ehux1b2 did not bind to 
cellulose at all, and was also poor at binding to ChNC with 25 % of the protein 
bound. However, when the D-block of Ehux1b2 was substituted with the 
corresponding sequence from Cel7A, the binding affinities towards all three 
substrates were restored. No such behavior was observed with any other block 
substitutions, and the C-block substitution also diminished the chitin binding 
affinity. 
A comparison with other CBM1 sequences revealed that the D-block contained 
the most such amino acids that are conserved normally within cellulose binding 
modules, but not in Ehux1b2 sequence. Therefore they could be regarded as 
important residues for the binding. In addition, the evidence suggested that 
Ehux1b2 is not a cellulose binding module and possibly not even chitin binding 
module, but might have activity towards some other polysaccharide. However, it 
must be structurally similar to Cel7A as substitution of five amino acids could give 
it the cellulose affinity. 
To conclude, the relative expression levels were not dependent on the E. coli strain 
used, and the reference sequence Cel7A was both produced the best and it also 
had the highest affinity towards cellulose and chitin. The substitution of the D-
block from Cel7A could make the otherwise inactive Ehux1b2 to bind to cellulose. 
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DNA sequences used in the experimental research 
Primers 
>MI02 
AAGCATCGGTCTCGAGAGCCACCACCTTT 
>MI03 
AGCATCGGTCTCCATGAAATACCTATTGC 
>pSVAR1 
GATATAGGCGCCAGCAACC 
>pSVAF2 
CTTAATGCGCCGCTACAGG 
Ordered gene fragments (GeneArt Strings DNA fragments, Life Technologies) 
>Ehux1b2 (201 bp) 
CTAGCTGGCTGAAGCTGACTGAGTTAGGTCTCCCTCTCCGAACCCCGGTCCTTGGGAACAGTGTGGTGGT
AAATCGTATGAAGGTCCGACCGCCTGTCCCCGTGAATACACCTGTCAGTATCGCCGTGAAACGTTTTCACA
GTGTATTCCTGGTGGTAAAGGCGAGCGAGACCCTGATAGCGGTATGACCTAGTAGCATGC 
>Ehux1b2A (202 bp) 
CTAGCTGGCTGAAGCTGACTGAGTTAGGTCTCCCTCTCCGACCCAGAGCCATTATGGTCAGTGTGGTGGTA
AATCGTATGAAGGTCCGACCGCCTGTCCCCGTGAATACACCTGTCAGTATCGCCGTGAAACGTTTTCACAG
TGTATTCCTGGTGGTAAAGGCGAGCGAGACCCTGATAGCGGTATGACCTAGTAGCATGCA 
>Ehux1b2B (203 bp) 
CTAGCTGGCTGAAGCTGACTGAGTTAGGTCTCCCTCTCCGAACCCCGGTCCTTGGGAACAGTGTGGTGGT
ATTGGTTATAGCGGTCCGACCGTTTGTCCCCGTGAATACACCTGTCAGTATCGCCGTGAAACGTTTTCACA
GTGTATTCCTGGTGGTAAAGGCGAGCGAGACCCTGATAGCGGTATGACCTAGTAGCATGCAT 
>Ehux1b2C (204 bp) 
CTAGCTGGCTGAAGCTGACTGAGTTAGGTCTCCCTCTCCGAACCCCGGTCCTTGGGAACAGTGTGGTGGT
AAATCGTATGAAGGTCCGACCGCCTGTGCAAGCGGCACCACCTGTCAGGTTCTGCGTGAAACGTTTTCACA
GTGTATTCCTGGTGGTAAAGGCGAGCGAGACCCTGATAGCGGTATGACCTAGTAGCATGCATC 
>Ehux1b2D (205 bp) 
CTAGCTGGCTGAAGCTGACTGAGTTAGGTCTCCCTCTCCGAACCCCGGTCCTTGGGAACAGTGTGGTGGT
AAATCGTATGAAGGTCCGACCGCCTGTCCCCGTGAATACACCTGTCAGTATCGCAATCCGTATTATTCACA
GTGTCTGCCTGGTGGTAAAGGCGAGCGAGACCCTGATAGCGGTATGACCTAGTAGCATGCATCC 
 
>Cel7Awt (206 bp) 
CTAGCTGGCTGAAGCTGACTGAGTTAGGTCTCCCTCTCCGACCCAGTCTCACTACGGCCAGTGCGGCGGTA
TTGGCTACAGCGGCCCCACGGTCTGCGCCAGCGGCACAACTTGCCAGGTCCTGAACCCTTACTACTCTCAG
TGCCTGCCTGGTGGTAAAGGCGAGCGAGACCCTGATAGCGGTATGACCTAGTAGCATGCATCCG 
APPENDIX 2 (2/18) 
 
 
 
Existing fragments and the empty expression vector 
>pelB/linker1 (152 bp) 
GGTCTCCATGAAATACCTATTGCCTACGGCAGCCGCTGGATTGTTATTACTCGCGGCCCAGCCGGCCATGG
CATCTACGAGACCAAAAGGGGCCCCTTTTAAAATTTTGGTCTCCGGCGGCGGTGGTAGCAAAGGTGGTGG
CTCTCGAGACC 
 
>alkaline phosphatase (1371 bp) 
GGTCTCATCTAGGACTCCGGAAATGCCGGTTCTGGAAAATCGTGCAGCACAGGGTGATATTACCGCACCG
GGTGGTGCACGTCGTCTGACCGGTGATCAGACCGCAGCACTGCGTGATAGCCTGAGCGATAAACCGGCA
AAAAACATTATTCTGCTGATTGGTGATGGCATGGGTGATAGCGAAATTACCGCAGCACGTAATTATGCCG
AAGGTGCCGGTGGTTTTTTTAAAGGTATTGATGCACTGCCGCTGACAGGTCAGTATACCCATTATGCACTG
AATAAAAAAACCGGCAAACCGGATTATGTTACCGATAGCGCAGCAAGCGCAACCGCATGGTCAACCGGTG
TTAAAACCTATAATGGTGCACTGGGTGTGGATATTCATGAAAAAGATCATCCGACCATTCTGGAAATGGCA
AAAGCAGCAGGTCTGGCAACCGGTAATGTTAGCACCGCAGAACTGCAGGATGCAACACCGGCAGCACTG
GTTGCACATGTTACCAGCCGTAAATGTTATGGTCCGAGCGCAACCAGCGAAAAATGTCCGGGTAATGCAC
TGGAAAAAGGTGGTAAAGGTAGCATTACCGAACAGCTGCTGAATGCACGTGCAGATGTTACCCTGGGTG
GTGGTGCAAAAACCTTTGCAGAAACCGCAACCGCAGGCGAATGGCAGGGTAAAACCCTGCGTGAACAGG
CACAGGCACGTGGTTATCAGCTGGTTAGTGATGCAGCAAGCCTGAATAGCGTTACCGAAGCAAATCAGCA
GAAACCGCTGCTGGGTCTGTTTGCAGATGGTAATATGCCGGTTCGTTGGCTGGGTCCGAAAGCAACCTAT
CATGGTAATATTGATAAACCGGCTGTTACCTGTACCCCGAATCCGCAGCGTAATGATAGCGTTCCGACCCT
GGCACAGATGACCGATAAAGCAATTGAACTGCTGAGCAAAAATGAAAAAGGCTTTTTTCTGCAGGTTGAA
GGTGCCAGCATTGATAAACAGGATCATGCAGCAAATCCGTGTGGTCAGATTGGTGAAACCGTTGATCTGG
ATGAAGCAGTTCAGCGTGCACTGGAATTTGCAAAAAAAGAAGGTAATACCCTGGTTATTGTGACCGCAGA
TCATGCACATGCAAGCCAGATTGTTGCACCGGATACCAAAGCACCGGGTCTGACCCAGGCACTGAATACC
AAAGATGGTGCAGTTATGGTTATGAGCTATGGTAATAGCGAAGAAGATAGCCAGGAACATACCGGTAGC
CAGCTGCGTATTGCAGCATATGGTCCGCATGCAGCCAATGTTGTTGGTCTGACCGATCAAACCGACCTGTT
TTATACCATGAAAGCAGCACTGGGTCTGAAAGGCGCGAGACC 
 
>Empty expression plasmid pBR1a (5263 bp, pET28a+ derivative for Golden gate cloning) 
TGGCGAATGGGACGCGCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCGCAGCGTGAC
CGCTACACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCGCTTTCTTCCCTTCCTTTCTCGCCACGTTCGCCGGC
TTTCCCCGTCAAGCTCTAAATCGGGGGCTCCCTTTAGGGTTCCGATTTAGTGCTTTACGGCACCTCGACCCC
AAAAAACTTGATTAGGGTGATGGTTCACGTAGTGGGCCATCGCCCTGATAGACGGTTTTTCGCCCTTTGAC
GTTGGAGTCCACGTTCTTTAATAGTGGACTCTTGTTCCAAACTGGAACAACACTCAACCCTATCTCGGTCTA
TTCTTTTGATTTATAAGGGATTTTGCCGATTTCGGCCTATTGGTTAAAAAATGAGCTGATTTAACAAAAATT
TAACGCGAATTTTAACAAAATATTAACGCTTACAATTTAGGTGGCACTTTTCGGGGAAATGTGCGCGGAAC
CCCTATTTGTTTATTTTTCTAAATACATTCAAATATGTATCCGCTCATGAATTAATTCTTAGAAAAACTCATC
GAGCATCAAATGAAACTGCAATTTATTCATATCAGGATTATCAATACCATATTTTTGAAAAAGCCGTTTCTG
TAATGAAGGAGAAAACTCACCGAGGCAGTTCCATAGGATGGCAAGATCCTGGTATCGGTCTGCGATTCCG
ACTCGTCCAACATCAATACAACCTATTAATTTCCCCTCGTCAAAAATAAGGTTATCAAGTGAGAAATCACCA
TGAGTGACGACTGAATCCGGTGAGAATGGCAAAAGTTTATGCATTTCTTTCCAGACTTGTTCAACAGGCCA
GCCATTACGCTCGTCATCAAAATCACTCGCATCAACCAAACCGTTATTCATTCGTGATTGCGCCTGAGCGA
GACGAAATACGCGATCGCTGTTAAAAGGACAATTACAAACAGGAATCGAATGCAACCGGCGCAGGAACA
CTGCCAGCGCATCAACAATATTTTCACCTGAATCAGGATATTCTTCTAATACCTGGAATGCTGTTTTCCCGG
GGATCGCAGTGGTGAGTAACCATGCATCATCAGGAGTACGGATAAAATGCTTGATGGTCGGAAGAGGCA
TAAATTCCGTCAGCCAGTTTAGTCTGACCATCTCATCTGTAACATCATTGGCAACGCTACCTTTGCCATGTTT
CAGAAACAACTCTGGCGCATCGGGCTTCCCATACAATCGATAGATTGTCGCACCTGATTGCCCGACATTAT
CGCGAGCCCATTTATACCCATATAAATCAGCATCCATGTTGGAATTTAATCGCGGCCTAGAGCAAGACGTT
TCCCGTTGAATATGGCTCATAACACCCCTTGTATTACTGTTTATGTAAGCAGACAGTTTTATTGTTCATGACC
AAAATCCCTTAACGTGAGTTTTCGTTCCACTGAGCGTCAGACCCCGTAGAAAAGATCAAAGGATCTTCTTG
AGATCCTTTTTTTCTGCGCGTAATCTGCTGCTTGCAAACAAAAAAACCACCGCTACCAGCGGTGGTTTGTTT
GCCGGATCAAGAGCTACCAACTCTTTTTCCGAAGGTAACTGGCTTCAGCAGAGCGCAGATACCAAATACT
GTCCTTCTAGTGTAGCCGTAGTTAGGCCACCACTTCAAGAACTCTGTAGCACCGCCTACATACCTCGCTCTG
APPENDIX 2 (3/18) 
 
 
 
CTAATCCTGTTACCAGTGGCTGCTGCCAGTGGCGATAAGTCGTGTCTTACCGGGTTGGACTCAAGACGATA
GTTACCGGATAAGGCGCAGCGGTCGGGCTGAACGGGGGGTTCGTGCACACAGCCCAGCTTGGAGCGAAC
GACCTACACCGAACTGAGATACCTACAGCGTGAGCTATGAGAAAGCGCCACGCTTCCCGAAGGGAGAAA
GGCGGACAGGTATCCGGTAAGCGGCAGGGTCGGAACAGGAGAGCGCACGAGGGAGCTTCCAGGGGGA
AACGCCTGGTATCTTTATAGTCCTGTCGGGTTTCGCCACCTCTGACTTGAGCGTCGATTTTTGTGATGCTCG
TCAGGGGGGCGGAGCCTATGGAAAAACGCCAGCAACGCGGCCTTTTTACGGTTCCTGGCCTTTTGCTGGC
CTTTTGCTCACATGTTCTTTCCTGCGTTATCCCCTGATTCTGTGGATAACCGTATTACCGCCTTTGAGTGAGC
TGATACCGCTCGCCGCAGCCGAACGACCGAGCGCAGCGAGTCAGTGAGCGAGGAAGCGGAAGAGCGCC
TGATGCGGTATTTTCTCCTTACGCATCTGTGCGGTATTTCACACCGCATATATGGTGCACTCTCAGTACAAT
CTGCTCTGATGCCGCATAGTTAAGCCAGTATACACTCCGCTATCGCTACGTGACTGGGTCATGGCTGCGCC
CCGACACCCGCCAACACCCGCTGACGCGCCCTGACGGGCTTGTCTGCTCCCGGCATCCGCTTACAGACAAG
CTGTGACCGTCTCCGGGAGCTGCATGTGTCAGAGGTTTTCACCGTCATCACCGAAACGCGCGAGGCAGCT
GCGGTAAAGCTCATCAGCGTGGTCGTGAAGCGATTCACAGATGTCTGCCTGTTCATCCGCGTCCAGCTCGT
TGAGTTTCTCCAGAAGCGTTAATGTCTGGCTTCTGATAAAGCGGGCCATGTTAAGGGCGGTTTTTTCCTGT
TTGGTCACTGATGCCTCCGTGTAAGGGGGATTTCTGTTCATGGGGGTAATGATACCGATGAAACGAGAGA
GGATGCTCACGATACGGGTTACTGATGATGAACATGCCCGGTTACTGGAACGTTGTGAGGGTAAACAACT
GGCGGTATGGATGCGGCGGGACCAGAGAAAAATCACTCAGGGTCAATGCCAGCGCTTCGTTAATACAGA
TGTAGGTGTTCCACAGGGTAGCCAGCAGCATCCTGCGATGCAGATCCGGAACATAATGGTGCAGGGCGCT
GACTTCCGCGTTTCCAGACTTTACGAAACACGGAAACCGAAGACCATTCATGTTGTTGCTCAGGTCGCAGA
CGTTTTGCAGCAGCAGTCGCTTCACGTTCGCTCGCGTATCGGTGATTCATTCTGCTAACCAGTAAGGCAAC
CCCGCCAGCCTAGCCGGGTCCTCAACGACAGGAGCACGATCATGCGCACCCGTGGGGCCGCCATGCCGG
CGATAATGGCCTGCTTCTCGCCGAAACGTTTGGTGGCGGGACCAGTGACGAAGGCTTGAGCGAGGGCGT
GCAAGATTCCGAATACCGCAAGCGACAGGCCGATCATCGTCGCGCTCCAGCGAAAGCGGTCCTCGCCGAA
AATGACCCAGAGCGCTGCCGGCACCTGTCCTACGAGTTGCATGATAAAGAAGACAGTCATAAGTGCGGCG
ACGATAGTCATGCCCCGCGCCCACCGGAAGGAGCTGACTGGGTTGAAGGCTCTCAAGGGCATCGGTCGA
GATCCCGGTGCCTAATGAGTGAGCTAACTTACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGG
AAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCG
CCAGGGTGGTTTTTCTTTTCACCAGTGAGACGGGCAACAGCTGATTGCCCTTCACCGCCTGGCCCTGAGAG
AGTTGCAGCAAGCGGTCCACGCTGGTTTGCCCCAGCAGGCGAAAATCCTGTTTGATGGTGGTTAACGGCG
GGATATAACATGAGCTGTCTTCGGTATCGTCGTATCCCACTACCGAGATATCCGCACCAACGCGCAGCCCG
GACTCGGTAATGGCGCGCATTGCGCCCAGCGCCATCTGATCGTTGGCAACCAGCATCGCAGTGGGAACGA
TGCCCTCATTCAGCATTTGCATGGTTTGTTGAAAACCGGACATGGCACTCCAGTCGCCTTCCCGTTCCGCTA
TCGGCTGAATTTGATTGCGAGTGAGATATTTATGCCAGCCAGCCAGACGCAGACGCGCCGAGACAGAACT
TAATGGGCCCGCTAACAGCGCGATTTGCTGGTGACCCAATGCGACCAGATGCTCCACGCCCAGTCGCGTA
CCGTCTTCATGGGAGAAAATAATACTGTTGATGGGTGTCTGGTCAGAGACATCAAGAAATAACGCCGGAA
CATTAGTGCAGGCAGCTTCCACAGCAATGGCATCCTGGTCATCCAGCGGATAGTTAATGATCAGCCCACTG
ACGCGTTGCGCGAGAAGATTGTGCACCGCCGCTTTACAGGCTTCGACGCCGCTTCGTTCTACCATCGACAC
CACCACGCTGGCACCCAGTTGATCGGCGCGAGATTTAATCGCCGCGACAATTTGCGACGGCGCGTGCAGG
GCCAGACTGGAGGTGGCAACGCCAATCAGCAACGACTGTTTGCCCGCCAGTTGTTGTGCCACGCGGTTGG
GAATGTAATTCAGCTCCGCCATCGCCGCTTCCACTTTTTCCCGCGTTTTCGCAGAAACGTGGCTGGCCTGGT
TCACCACGCGGGAAACGGTCTGATAAGAGACACCGGCATACTCTGCGACATCGTATAACGTTACTGGTTTC
ACATTCACCACCCTGAATTGACTCTCTTCCGGGCGCTATCATGCCATACCGCGAAAGGTTTTGCGCCATTCG
ATGGTGTCCGGGATCTCGACGCTCTCCCTTATGCGACTCCTGCATTAGGAAGCAGCCCAGTAGTAGGTTGA
GGCCGTTGAGCACCGCCGCCGCAAGGAATGGTGCATGCAAGGAGATGGCGCCCAACAGTCCCCCGGCCA
CGGGGCCTGCCACCATACCCACGCCGAAACAAGCGCTCATGAGCCCGAAGTGGCGAGCCCGATCTTCCCC
ATCGGTGATGTCGGCGATATAGGCGCCAGCAACCGCACCTGTGGCGCCGGTGATGCCGGCCACGATGCG
TCCGGCGTAGAGGATCGAGATCTCGATCCCGCGAAATTAATACGACTCACTATAGGGGAATTGTGAGCGG
ATAACAATTCCCCTCTAGAAATAATTTTGTTTAACTTTAAGAAGGAGATATACCATGAGGAGACCGCGGAT
CCGAATTCGGGTCTCTCGAGCACCACCACCACCACCACTGAGATCCGGCTGCTAACAAAGCCCGAAAGGA
AGCTGAGTTGGCTGCTGCCACCGCTGAGCAATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTG
AGGGGTTTTTTGCTGAAAGGAGGAACTATATCCGGAT 
APPENDIX 2 (4/18) 
 
 
 
Expression plasmids 
>pelB-AP-Cel7Aopt._pBR1a (6804 bp) 
TGGCGAATGGGACGCGCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCGCAGCGTGAC
CGCTACACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCGCTTTCTTCCCTTCCTTTCTCGCCACGTTCGCCGGC
TTTCCCCGTCAAGCTCTAAATCGGGGGCTCCCTTTAGGGTTCCGATTTAGTGCTTTACGGCACCTCGACCCC
AAAAAACTTGATTAGGGTGATGGTTCACGTAGTGGGCCATCGCCCTGATAGACGGTTTTTCGCCCTTTGAC
GTTGGAGTCCACGTTCTTTAATAGTGGACTCTTGTTCCAAACTGGAACAACACTCAACCCTATCTCGGTCTA
TTCTTTTGATTTATAAGGGATTTTGCCGATTTCGGCCTATTGGTTAAAAAATGAGCTGATTTAACAAAAATT
TAACGCGAATTTTAACAAAATATTAACGCTTACAATTTAGGTGGCACTTTTCGGGGAAATGTGCGCGGAAC
CCCTATTTGTTTATTTTTCTAAATACATTCAAATATGTATCCGCTCATGAATTAATTCTTAGAAAAACTCATC
GAGCATCAAATGAAACTGCAATTTATTCATATCAGGATTATCAATACCATATTTTTGAAAAAGCCGTTTCTG
TAATGAAGGAGAAAACTCACCGAGGCAGTTCCATAGGATGGCAAGATCCTGGTATCGGTCTGCGATTCCG
ACTCGTCCAACATCAATACAACCTATTAATTTCCCCTCGTCAAAAATAAGGTTATCAAGTGAGAAATCACCA
TGAGTGACGACTGAATCCGGTGAGAATGGCAAAAGTTTATGCATTTCTTTCCAGACTTGTTCAACAGGCCA
GCCATTACGCTCGTCATCAAAATCACTCGCATCAACCAAACCGTTATTCATTCGTGATTGCGCCTGAGCGA
GACGAAATACGCGATCGCTGTTAAAAGGACAATTACAAACAGGAATCGAATGCAACCGGCGCAGGAACA
CTGCCAGCGCATCAACAATATTTTCACCTGAATCAGGATATTCTTCTAATACCTGGAATGCTGTTTTCCCGG
GGATCGCAGTGGTGAGTAACCATGCATCATCAGGAGTACGGATAAAATGCTTGATGGTCGGAAGAGGCA
TAAATTCCGTCAGCCAGTTTAGTCTGACCATCTCATCTGTAACATCATTGGCAACGCTACCTTTGCCATGTTT
CAGAAACAACTCTGGCGCATCGGGCTTCCCATACAATCGATAGATTGTCGCACCTGATTGCCCGACATTAT
CGCGAGCCCATTTATACCCATATAAATCAGCATCCATGTTGGAATTTAATCGCGGCCTAGAGCAAGACGTT
TCCCGTTGAATATGGCTCATAACACCCCTTGTATTACTGTTTATGTAAGCAGACAGTTTTATTGTTCATGACC
AAAATCCCTTAACGTGAGTTTTCGTTCCACTGAGCGTCAGACCCCGTAGAAAAGATCAAAGGATCTTCTTG
AGATCCTTTTTTTCTGCGCGTAATCTGCTGCTTGCAAACAAAAAAACCACCGCTACCAGCGGTGGTTTGTTT
GCCGGATCAAGAGCTACCAACTCTTTTTCCGAAGGTAACTGGCTTCAGCAGAGCGCAGATACCAAATACT
GTCCTTCTAGTGTAGCCGTAGTTAGGCCACCACTTCAAGAACTCTGTAGCACCGCCTACATACCTCGCTCTG
CTAATCCTGTTACCAGTGGCTGCTGCCAGTGGCGATAAGTCGTGTCTTACCGGGTTGGACTCAAGACGATA
GTTACCGGATAAGGCGCAGCGGTCGGGCTGAACGGGGGGTTCGTGCACACAGCCCAGCTTGGAGCGAAC
GACCTACACCGAACTGAGATACCTACAGCGTGAGCTATGAGAAAGCGCCACGCTTCCCGAAGGGAGAAA
GGCGGACAGGTATCCGGTAAGCGGCAGGGTCGGAACAGGAGAGCGCACGAGGGAGCTTCCAGGGGGA
AACGCCTGGTATCTTTATAGTCCTGTCGGGTTTCGCCACCTCTGACTTGAGCGTCGATTTTTGTGATGCTCG
TCAGGGGGGCGGAGCCTATGGAAAAACGCCAGCAACGCGGCCTTTTTACGGTTCCTGGCCTTTTGCTGGC
CTTTTGCTCACATGTTCTTTCCTGCGTTATCCCCTGATTCTGTGGATAACCGTATTACCGCCTTTGAGTGAGC
TGATACCGCTCGCCGCAGCCGAACGACCGAGCGCAGCGAGTCAGTGAGCGAGGAAGCGGAAGAGCGCC
TGATGCGGTATTTTCTCCTTACGCATCTGTGCGGTATTTCACACCGCATATATGGTGCACTCTCAGTACAAT
CTGCTCTGATGCCGCATAGTTAAGCCAGTATACACTCCGCTATCGCTACGTGACTGGGTCATGGCTGCGCC
CCGACACCCGCCAACACCCGCTGACGCGCCCTGACGGGCTTGTCTGCTCCCGGCATCCGCTTACAGACAAG
CTGTGACCGTCTCCGGGAGCTGCATGTGTCAGAGGTTTTCACCGTCATCACCGAAACGCGCGAGGCAGCT
GCGGTAAAGCTCATCAGCGTGGTCGTGAAGCGATTCACAGATGTCTGCCTGTTCATCCGCGTCCAGCTCGT
TGAGTTTCTCCAGAAGCGTTAATGTCTGGCTTCTGATAAAGCGGGCCATGTTAAGGGCGGTTTTTTCCTGT
TTGGTCACTGATGCCTCCGTGTAAGGGGGATTTCTGTTCATGGGGGTAATGATACCGATGAAACGAGAGA
GGATGCTCACGATACGGGTTACTGATGATGAACATGCCCGGTTACTGGAACGTTGTGAGGGTAAACAACT
GGCGGTATGGATGCGGCGGGACCAGAGAAAAATCACTCAGGGTCAATGCCAGCGCTTCGTTAATACAGA
TGTAGGTGTTCCACAGGGTAGCCAGCAGCATCCTGCGATGCAGATCCGGAACATAATGGTGCAGGGCGCT
GACTTCCGCGTTTCCAGACTTTACGAAACACGGAAACCGAAGACCATTCATGTTGTTGCTCAGGTCGCAGA
CGTTTTGCAGCAGCAGTCGCTTCACGTTCGCTCGCGTATCGGTGATTCATTCTGCTAACCAGTAAGGCAAC
CCCGCCAGCCTAGCCGGGTCCTCAACGACAGGAGCACGATCATGCGCACCCGTGGGGCCGCCATGCCGG
CGATAATGGCCTGCTTCTCGCCGAAACGTTTGGTGGCGGGACCAGTGACGAAGGCTTGAGCGAGGGCGT
GCAAGATTCCGAATACCGCAAGCGACAGGCCGATCATCGTCGCGCTCCAGCGAAAGCGGTCCTCGCCGAA
AATGACCCAGAGCGCTGCCGGCACCTGTCCTACGAGTTGCATGATAAAGAAGACAGTCATAAGTGCGGCG
ACGATAGTCATGCCCCGCGCCCACCGGAAGGAGCTGACTGGGTTGAAGGCTCTCAAGGGCATCGGTCGA
GATCCCGGTGCCTAATGAGTGAGCTAACTTACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGG
AAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCG
APPENDIX 2 (5/18) 
 
 
 
CCAGGGTGGTTTTTCTTTTCACCAGTGAGACGGGCAACAGCTGATTGCCCTTCACCGCCTGGCCCTGAGAG
AGTTGCAGCAAGCGGTCCACGCTGGTTTGCCCCAGCAGGCGAAAATCCTGTTTGATGGTGGTTAACGGCG
GGATATAACATGAGCTGTCTTCGGTATCGTCGTATCCCACTACCGAGATATCCGCACCAACGCGCAGCCCG
GACTCGGTAATGGCGCGCATTGCGCCCAGCGCCATCTGATCGTTGGCAACCAGCATCGCAGTGGGAACGA
TGCCCTCATTCAGCATTTGCATGGTTTGTTGAAAACCGGACATGGCACTCCAGTCGCCTTCCCGTTCCGCTA
TCGGCTGAATTTGATTGCGAGTGAGATATTTATGCCAGCCAGCCAGACGCAGACGCGCCGAGACAGAACT
TAATGGGCCCGCTAACAGCGCGATTTGCTGGTGACCCAATGCGACCAGATGCTCCACGCCCAGTCGCGTA
CCGTCTTCATGGGAGAAAATAATACTGTTGATGGGTGTCTGGTCAGAGACATCAAGAAATAACGCCGGAA
CATTAGTGCAGGCAGCTTCCACAGCAATGGCATCCTGGTCATCCAGCGGATAGTTAATGATCAGCCCACTG
ACGCGTTGCGCGAGAAGATTGTGCACCGCCGCTTTACAGGCTTCGACGCCGCTTCGTTCTACCATCGACAC
CACCACGCTGGCACCCAGTTGATCGGCGCGAGATTTAATCGCCGCGACAATTTGCGACGGCGCGTGCAGG
GCCAGACTGGAGGTGGCAACGCCAATCAGCAACGACTGTTTGCCCGCCAGTTGTTGTGCCACGCGGTTGG
GAATGTAATTCAGCTCCGCCATCGCCGCTTCCACTTTTTCCCGCGTTTTCGCAGAAACGTGGCTGGCCTGGT
TCACCACGCGGGAAACGGTCTGATAAGAGACACCGGCATACTCTGCGACATCGTATAACGTTACTGGTTTC
ACATTCACCACCCTGAATTGACTCTCTTCCGGGCGCTATCATGCCATACCGCGAAAGGTTTTGCGCCATTCG
ATGGTGTCCGGGATCTCGACGCTCTCCCTTATGCGACTCCTGCATTAGGAAGCAGCCCAGTAGTAGGTTGA
GGCCGTTGAGCACCGCCGCCGCAAGGAATGGTGCATGCAAGGAGATGGCGCCCAACAGTCCCCCGGCCA
CGGGGCCTGCCACCATACCCACGCCGAAACAAGCGCTCATGAGCCCGAAGTGGCGAGCCCGATCTTCCCC
ATCGGTGATGTCGGCGATATAGGCGCCAGCAACCGCACCTGTGGCGCCGGTGATGCCGGCCACGATGCG
TCCGGCGTAGAGGATCGAGATCTCGATCCCGCGAAATTAATACGACTCACTATAGGGGAATTGTGAGCGG
ATAACAATTCCCCTCTAGAAATAATTTTGTTTAACTTTAAGAAGGAGATATACCATGAAATACCTATTGCCT
ACGGCAGCCGCTGGATTGTTATTACTCGCGGCCCAGCCGGCCATGGCATCTAGGACTCCGGAAATGCCGG
TTCTGGAAAATCGTGCAGCACAGGGTGATATTACCGCACCGGGTGGTGCACGTCGTCTGACCGGTGATCA
GACCGCAGCACTGCGTGATAGCCTGAGCGATAAACCGGCAAAAAACATTATTCTGCTGATTGGTGATGGC
ATGGGTGATAGCGAAATTACCGCAGCACGTAATTATGCCGAAGGTGCCGGTGGTTTTTTTAAAGGTATTG
ATGCACTGCCGCTGACAGGTCAGTATACCCATTATGCACTGAATAAAAAAACCGGCAAACCGGATTATGTT
ACCGATAGCGCAGCAAGCGCAACCGCATGGTCAACCGGTGTTAAAACCTATAATGGTGCACTGGGTGTGG
ATATTCATGAAAAAGATCATCCGACCATTCTGGAAATGGCAAAAGCAGCAGGTCTGGCAACCGGTAATGT
TAGCACCGCAGAACTGCAGGATGCAACACCGGCAGCACTGGTTGCACATGTTACCAGCCGTAAATGTTAT
GGTCCGAGCGCAACCAGCGAAAAATGTCCGGGTAATGCACTGGAAAAAGGTGGTAAAGGTAGCATTACC
GAACAGCTGCTGAATGCACGTGCAGATGTTACCCTGGGTGGTGGTGCAAAAACCTTTGCAGAAACCGCAA
CCGCAGGCGAATGGCAGGGTAAAACCCTGCGTGAACAGGCACAGGCACGTGGTTATCAGCTGGTTAGTG
ATGCAGCAAGCCTGAATAGCGTTACCGAAGCAAATCAGCAGAAACCGCTGCTGGGTCTGTTTGCAGATGG
TAATATGCCGGTTCGTTGGCTGGGTCCGAAAGCAACCTATCATGGTAATATTGATAAACCGGCTGTTACCT
GTACCCCGAATCCGCAGCGTAATGATAGCGTTCCGACCCTGGCACAGATGACCGATAAAGCAATTGAACT
GCTGAGCAAAAATGAAAAAGGCTTTTTTCTGCAGGTTGAAGGTGCCAGCATTGATAAACAGGATCATGCA
GCAAATCCGTGTGGTCAGATTGGTGAAACCGTTGATCTGGATGAAGCAGTTCAGCGTGCACTGGAATTTG
CAAAAAAAGAAGGTAATACCCTGGTTATTGTGACCGCAGATCATGCACATGCAAGCCAGATTGTTGCACC
GGATACCAAAGCACCGGGTCTGACCCAGGCACTGAATACCAAAGATGGTGCAGTTATGGTTATGAGCTAT
GGTAATAGCGAAGAAGATAGCCAGGAACATACCGGTAGCCAGCTGCGTATTGCAGCATATGGTCCGCAT
GCAGCCAATGTTGTTGGTCTGACCGATCAAACCGACCTGTTTTATACCATGAAAGCAGCACTGGGTCTGAA
AGGCGGCGGTGGTAGCAAAGGTGGTGGCTCTCCGACCCAGAGCCATTATGGTCAGTGTGGTGGTATTGG
TTATAGCGGTCCGACCGTTTGTGCAAGCGGCACCACCTGTCAGGTTCTGAATCCGTATTATTCACAGTGTCT
GCCTGGTGGTAAAGGCGAGCACCACCACCACCACCACTGAGATCCGGCTGCTAACAAAGCCCGAAAGGA
AGCTGAGTTGGCTGCTGCCACCGCTGAGCAATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTG
AGGGGTTTTTTGCTGAAAGGAGGAACTATATCCGGAT 
> pelB-AP-Cel7Awt-pBR1a (6804 bp) 
TGGCGAATGGGACGCGCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCGCAGCGTGAC
CGCTACACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCGCTTTCTTCCCTTCCTTTCTCGCCACGTTCGCCGGC
TTTCCCCGTCAAGCTCTAAATCGGGGGCTCCCTTTAGGGTTCCGATTTAGTGCTTTACGGCACCTCGACCCC
AAAAAACTTGATTAGGGTGATGGTTCACGTAGTGGGCCATCGCCCTGATAGACGGTTTTTCGCCCTTTGAC
GTTGGAGTCCACGTTCTTTAATAGTGGACTCTTGTTCCAAACTGGAACAACACTCAACCCTATCTCGGTCTA
TTCTTTTGATTTATAAGGGATTTTGCCGATTTCGGCCTATTGGTTAAAAAATGAGCTGATTTAACAAAAATT
APPENDIX 2 (6/18) 
 
 
 
TAACGCGAATTTTAACAAAATATTAACGCTTACAATTTAGGTGGCACTTTTCGGGGAAATGTGCGCGGAAC
CCCTATTTGTTTATTTTTCTAAATACATTCAAATATGTATCCGCTCATGAATTAATTCTTAGAAAAACTCATC
GAGCATCAAATGAAACTGCAATTTATTCATATCAGGATTATCAATACCATATTTTTGAAAAAGCCGTTTCTG
TAATGAAGGAGAAAACTCACCGAGGCAGTTCCATAGGATGGCAAGATCCTGGTATCGGTCTGCGATTCCG
ACTCGTCCAACATCAATACAACCTATTAATTTCCCCTCGTCAAAAATAAGGTTATCAAGTGAGAAATCACCA
TGAGTGACGACTGAATCCGGTGAGAATGGCAAAAGTTTATGCATTTCTTTCCAGACTTGTTCAACAGGCCA
GCCATTACGCTCGTCATCAAAATCACTCGCATCAACCAAACCGTTATTCATTCGTGATTGCGCCTGAGCGA
GACGAAATACGCGATCGCTGTTAAAAGGACAATTACAAACAGGAATCGAATGCAACCGGCGCAGGAACA
CTGCCAGCGCATCAACAATATTTTCACCTGAATCAGGATATTCTTCTAATACCTGGAATGCTGTTTTCCCGG
GGATCGCAGTGGTGAGTAACCATGCATCATCAGGAGTACGGATAAAATGCTTGATGGTCGGAAGAGGCA
TAAATTCCGTCAGCCAGTTTAGTCTGACCATCTCATCTGTAACATCATTGGCAACGCTACCTTTGCCATGTTT
CAGAAACAACTCTGGCGCATCGGGCTTCCCATACAATCGATAGATTGTCGCACCTGATTGCCCGACATTAT
CGCGAGCCCATTTATACCCATATAAATCAGCATCCATGTTGGAATTTAATCGCGGCCTAGAGCAAGACGTT
TCCCGTTGAATATGGCTCATAACACCCCTTGTATTACTGTTTATGTAAGCAGACAGTTTTATTGTTCATGACC
AAAATCCCTTAACGTGAGTTTTCGTTCCACTGAGCGTCAGACCCCGTAGAAAAGATCAAAGGATCTTCTTG
AGATCCTTTTTTTCTGCGCGTAATCTGCTGCTTGCAAACAAAAAAACCACCGCTACCAGCGGTGGTTTGTTT
GCCGGATCAAGAGCTACCAACTCTTTTTCCGAAGGTAACTGGCTTCAGCAGAGCGCAGATACCAAATACT
GTCCTTCTAGTGTAGCCGTAGTTAGGCCACCACTTCAAGAACTCTGTAGCACCGCCTACATACCTCGCTCTG
CTAATCCTGTTACCAGTGGCTGCTGCCAGTGGCGATAAGTCGTGTCTTACCGGGTTGGACTCAAGACGATA
GTTACCGGATAAGGCGCAGCGGTCGGGCTGAACGGGGGGTTCGTGCACACAGCCCAGCTTGGAGCGAAC
GACCTACACCGAACTGAGATACCTACAGCGTGAGCTATGAGAAAGCGCCACGCTTCCCGAAGGGAGAAA
GGCGGACAGGTATCCGGTAAGCGGCAGGGTCGGAACAGGAGAGCGCACGAGGGAGCTTCCAGGGGGA
AACGCCTGGTATCTTTATAGTCCTGTCGGGTTTCGCCACCTCTGACTTGAGCGTCGATTTTTGTGATGCTCG
TCAGGGGGGCGGAGCCTATGGAAAAACGCCAGCAACGCGGCCTTTTTACGGTTCCTGGCCTTTTGCTGGC
CTTTTGCTCACATGTTCTTTCCTGCGTTATCCCCTGATTCTGTGGATAACCGTATTACCGCCTTTGAGTGAGC
TGATACCGCTCGCCGCAGCCGAACGACCGAGCGCAGCGAGTCAGTGAGCGAGGAAGCGGAAGAGCGCC
TGATGCGGTATTTTCTCCTTACGCATCTGTGCGGTATTTCACACCGCATATATGGTGCACTCTCAGTACAAT
CTGCTCTGATGCCGCATAGTTAAGCCAGTATACACTCCGCTATCGCTACGTGACTGGGTCATGGCTGCGCC
CCGACACCCGCCAACACCCGCTGACGCGCCCTGACGGGCTTGTCTGCTCCCGGCATCCGCTTACAGACAAG
CTGTGACCGTCTCCGGGAGCTGCATGTGTCAGAGGTTTTCACCGTCATCACCGAAACGCGCGAGGCAGCT
GCGGTAAAGCTCATCAGCGTGGTCGTGAAGCGATTCACAGATGTCTGCCTGTTCATCCGCGTCCAGCTCGT
TGAGTTTCTCCAGAAGCGTTAATGTCTGGCTTCTGATAAAGCGGGCCATGTTAAGGGCGGTTTTTTCCTGT
TTGGTCACTGATGCCTCCGTGTAAGGGGGATTTCTGTTCATGGGGGTAATGATACCGATGAAACGAGAGA
GGATGCTCACGATACGGGTTACTGATGATGAACATGCCCGGTTACTGGAACGTTGTGAGGGTAAACAACT
GGCGGTATGGATGCGGCGGGACCAGAGAAAAATCACTCAGGGTCAATGCCAGCGCTTCGTTAATACAGA
TGTAGGTGTTCCACAGGGTAGCCAGCAGCATCCTGCGATGCAGATCCGGAACATAATGGTGCAGGGCGCT
GACTTCCGCGTTTCCAGACTTTACGAAACACGGAAACCGAAGACCATTCATGTTGTTGCTCAGGTCGCAGA
CGTTTTGCAGCAGCAGTCGCTTCACGTTCGCTCGCGTATCGGTGATTCATTCTGCTAACCAGTAAGGCAAC
CCCGCCAGCCTAGCCGGGTCCTCAACGACAGGAGCACGATCATGCGCACCCGTGGGGCCGCCATGCCGG
CGATAATGGCCTGCTTCTCGCCGAAACGTTTGGTGGCGGGACCAGTGACGAAGGCTTGAGCGAGGGCGT
GCAAGATTCCGAATACCGCAAGCGACAGGCCGATCATCGTCGCGCTCCAGCGAAAGCGGTCCTCGCCGAA
AATGACCCAGAGCGCTGCCGGCACCTGTCCTACGAGTTGCATGATAAAGAAGACAGTCATAAGTGCGGCG
ACGATAGTCATGCCCCGCGCCCACCGGAAGGAGCTGACTGGGTTGAAGGCTCTCAAGGGCATCGGTCGA
GATCCCGGTGCCTAATGAGTGAGCTAACTTACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGG
AAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCG
CCAGGGTGGTTTTTCTTTTCACCAGTGAGACGGGCAACAGCTGATTGCCCTTCACCGCCTGGCCCTGAGAG
AGTTGCAGCAAGCGGTCCACGCTGGTTTGCCCCAGCAGGCGAAAATCCTGTTTGATGGTGGTTAACGGCG
GGATATAACATGAGCTGTCTTCGGTATCGTCGTATCCCACTACCGAGATATCCGCACCAACGCGCAGCCCG
GACTCGGTAATGGCGCGCATTGCGCCCAGCGCCATCTGATCGTTGGCAACCAGCATCGCAGTGGGAACGA
TGCCCTCATTCAGCATTTGCATGGTTTGTTGAAAACCGGACATGGCACTCCAGTCGCCTTCCCGTTCCGCTA
TCGGCTGAATTTGATTGCGAGTGAGATATTTATGCCAGCCAGCCAGACGCAGACGCGCCGAGACAGAACT
TAATGGGCCCGCTAACAGCGCGATTTGCTGGTGACCCAATGCGACCAGATGCTCCACGCCCAGTCGCGTA
CCGTCTTCATGGGAGAAAATAATACTGTTGATGGGTGTCTGGTCAGAGACATCAAGAAATAACGCCGGAA
CATTAGTGCAGGCAGCTTCCACAGCAATGGCATCCTGGTCATCCAGCGGATAGTTAATGATCAGCCCACTG
ACGCGTTGCGCGAGAAGATTGTGCACCGCCGCTTTACAGGCTTCGACGCCGCTTCGTTCTACCATCGACAC
APPENDIX 2 (7/18) 
 
 
 
CACCACGCTGGCACCCAGTTGATCGGCGCGAGATTTAATCGCCGCGACAATTTGCGACGGCGCGTGCAGG
GCCAGACTGGAGGTGGCAACGCCAATCAGCAACGACTGTTTGCCCGCCAGTTGTTGTGCCACGCGGTTGG
GAATGTAATTCAGCTCCGCCATCGCCGCTTCCACTTTTTCCCGCGTTTTCGCAGAAACGTGGCTGGCCTGGT
TCACCACGCGGGAAACGGTCTGATAAGAGACACCGGCATACTCTGCGACATCGTATAACGTTACTGGTTTC
ACATTCACCACCCTGAATTGACTCTCTTCCGGGCGCTATCATGCCATACCGCGAAAGGTTTTGCGCCATTCG
ATGGTGTCCGGGATCTCGACGCTCTCCCTTATGCGACTCCTGCATTAGGAAGCAGCCCAGTAGTAGGTTGA
GGCCGTTGAGCACCGCCGCCGCAAGGAATGGTGCATGCAAGGAGATGGCGCCCAACAGTCCCCCGGCCA
CGGGGCCTGCCACCATACCCACGCCGAAACAAGCGCTCATGAGCCCGAAGTGGCGAGCCCGATCTTCCCC
ATCGGTGATGTCGGCGATATAGGCGCCAGCAACCGCACCTGTGGCGCCGGTGATGCCGGCCACGATGCG
TCCGGCGTAGAGGATCGAGATCTCGATCCCGCGAAATTAATACGACTCACTATAGGGGAATTGTGAGCGG
ATAACAATTCCCCTCTAGAAATAATTTTGTTTAACTTTAAGAAGGAGATATACCATGAAATACCTATTGCCT
ACGGCAGCCGCTGGATTGTTATTACTCGCGGCCCAGCCGGCCATGGCATCTAGGACTCCGGAAATGCCGG
TTCTGGAAAATCGTGCAGCACAGGGTGATATTACCGCACCGGGTGGTGCACGTCGTCTGACCGGTGATCA
GACCGCAGCACTGCGTGATAGCCTGAGCGATAAACCGGCAAAAAACATTATTCTGCTGATTGGTGATGGC
ATGGGTGATAGCGAAATTACCGCAGCACGTAATTATGCCGAAGGTGCCGGTGGTTTTTTTAAAGGTATTG
ATGCACTGCCGCTGACAGGTCAGTATACCCATTATGCACTGAATAAAAAAACCGGCAAACCGGATTATGTT
ACCGATAGCGCAGCAAGCGCAACCGCATGGTCAACCGGTGTTAAAACCTATAATGGTGCACTGGGTGTGG
ATATTCATGAAAAAGATCATCCGACCATTCTGGAAATGGCAAAAGCAGCAGGTCTGGCAACCGGTAATGT
TAGCACCGCAGAACTGCAGGATGCAACACCGGCAGCACTGGTTGCACATGTTACCAGCCGTAAATGTTAT
GGTCCGAGCGCAACCAGCGAAAAATGTCCGGGTAATGCACTGGAAAAAGGTGGTAAAGGTAGCATTACC
GAACAGCTGCTGAATGCACGTGCAGATGTTACCCTGGGTGGTGGTGCAAAAACCTTTGCAGAAACCGCAA
CCGCAGGCGAATGGCAGGGTAAAACCCTGCGTGAACAGGCACAGGCACGTGGTTATCAGCTGGTTAGTG
ATGCAGCAAGCCTGAATAGCGTTACCGAAGCAAATCAGCAGAAACCGCTGCTGGGTCTGTTTGCAGATGG
TAATATGCCGGTTCGTTGGCTGGGTCCGAAAGCAACCTATCATGGTAATATTGATAAACCGGCTGTTACCT
GTACCCCGAATCCGCAGCGTAATGATAGCGTTCCGACCCTGGCACAGATGACCGATAAAGCAATTGAACT
GCTGAGCAAAAATGAAAAAGGCTTTTTTCTGCAGGTTGAAGGTGCCAGCATTGATAAACAGGATCATGCA
GCAAATCCGTGTGGTCAGATTGGTGAAACCGTTGATCTGGATGAAGCAGTTCAGCGTGCACTGGAATTTG
CAAAAAAAGAAGGTAATACCCTGGTTATTGTGACCGCAGATCATGCACATGCAAGCCAGATTGTTGCACC
GGATACCAAAGCACCGGGTCTGACCCAGGCACTGAATACCAAAGATGGTGCAGTTATGGTTATGAGCTAT
GGTAATAGCGAAGAAGATAGCCAGGAACATACCGGTAGCCAGCTGCGTATTGCAGCATATGGTCCGCAT
GCAGCCAATGTTGTTGGTCTGACCGATCAAACCGACCTGTTTTATACCATGAAAGCAGCACTGGGTCTGAA
AGGCGGCGGTGGTAGCAAAGGTGGTGGCTCTCCGACCCAGTCTCACTACGGCCAGTGCGGCGGTATTGG
CTACAGCGGCCCCACGGTCTGCGCCAGCGGCACAACTTGCCAGGTCCTGAACCCTTACTACTCTCAGTGCC
TGCCTGGTGGTAAAGGCGAGCACCACCACCACCACCACTGAGATCCGGCTGCTAACAAAGCCCGAAAGGA
AGCTGAGTTGGCTGCTGCCACCGCTGAGCAATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTG
AGGGGTTTTTTGCTGAAAGGAGGAACTATATCCGGAT 
>pelB-AP-Ehux1b2 -pBR1a (6804 bp) 
TGGCGAATGGGACGCGCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCGCAGCGTGAC
CGCTACACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCGCTTTCTTCCCTTCCTTTCTCGCCACGTTCGCCGGC
TTTCCCCGTCAAGCTCTAAATCGGGGGCTCCCTTTAGGGTTCCGATTTAGTGCTTTACGGCACCTCGACCCC
AAAAAACTTGATTAGGGTGATGGTTCACGTAGTGGGCCATCGCCCTGATAGACGGTTTTTCGCCCTTTGAC
GTTGGAGTCCACGTTCTTTAATAGTGGACTCTTGTTCCAAACTGGAACAACACTCAACCCTATCTCGGTCTA
TTCTTTTGATTTATAAGGGATTTTGCCGATTTCGGCCTATTGGTTAAAAAATGAGCTGATTTAACAAAAATT
TAACGCGAATTTTAACAAAATATTAACGCTTACAATTTAGGTGGCACTTTTCGGGGAAATGTGCGCGGAAC
CCCTATTTGTTTATTTTTCTAAATACATTCAAATATGTATCCGCTCATGAATTAATTCTTAGAAAAACTCATC
GAGCATCAAATGAAACTGCAATTTATTCATATCAGGATTATCAATACCATATTTTTGAAAAAGCCGTTTCTG
TAATGAAGGAGAAAACTCACCGAGGCAGTTCCATAGGATGGCAAGATCCTGGTATCGGTCTGCGATTCCG
ACTCGTCCAACATCAATACAACCTATTAATTTCCCCTCGTCAAAAATAAGGTTATCAAGTGAGAAATCACCA
TGAGTGACGACTGAATCCGGTGAGAATGGCAAAAGTTTATGCATTTCTTTCCAGACTTGTTCAACAGGCCA
GCCATTACGCTCGTCATCAAAATCACTCGCATCAACCAAACCGTTATTCATTCGTGATTGCGCCTGAGCGA
GACGAAATACGCGATCGCTGTTAAAAGGACAATTACAAACAGGAATCGAATGCAACCGGCGCAGGAACA
CTGCCAGCGCATCAACAATATTTTCACCTGAATCAGGATATTCTTCTAATACCTGGAATGCTGTTTTCCCGG
GGATCGCAGTGGTGAGTAACCATGCATCATCAGGAGTACGGATAAAATGCTTGATGGTCGGAAGAGGCA
APPENDIX 2 (8/18) 
 
 
 
TAAATTCCGTCAGCCAGTTTAGTCTGACCATCTCATCTGTAACATCATTGGCAACGCTACCTTTGCCATGTTT
CAGAAACAACTCTGGCGCATCGGGCTTCCCATACAATCGATAGATTGTCGCACCTGATTGCCCGACATTAT
CGCGAGCCCATTTATACCCATATAAATCAGCATCCATGTTGGAATTTAATCGCGGCCTAGAGCAAGACGTT
TCCCGTTGAATATGGCTCATAACACCCCTTGTATTACTGTTTATGTAAGCAGACAGTTTTATTGTTCATGACC
AAAATCCCTTAACGTGAGTTTTCGTTCCACTGAGCGTCAGACCCCGTAGAAAAGATCAAAGGATCTTCTTG
AGATCCTTTTTTTCTGCGCGTAATCTGCTGCTTGCAAACAAAAAAACCACCGCTACCAGCGGTGGTTTGTTT
GCCGGATCAAGAGCTACCAACTCTTTTTCCGAAGGTAACTGGCTTCAGCAGAGCGCAGATACCAAATACT
GTCCTTCTAGTGTAGCCGTAGTTAGGCCACCACTTCAAGAACTCTGTAGCACCGCCTACATACCTCGCTCTG
CTAATCCTGTTACCAGTGGCTGCTGCCAGTGGCGATAAGTCGTGTCTTACCGGGTTGGACTCAAGACGATA
GTTACCGGATAAGGCGCAGCGGTCGGGCTGAACGGGGGGTTCGTGCACACAGCCCAGCTTGGAGCGAAC
GACCTACACCGAACTGAGATACCTACAGCGTGAGCTATGAGAAAGCGCCACGCTTCCCGAAGGGAGAAA
GGCGGACAGGTATCCGGTAAGCGGCAGGGTCGGAACAGGAGAGCGCACGAGGGAGCTTCCAGGGGGA
AACGCCTGGTATCTTTATAGTCCTGTCGGGTTTCGCCACCTCTGACTTGAGCGTCGATTTTTGTGATGCTCG
TCAGGGGGGCGGAGCCTATGGAAAAACGCCAGCAACGCGGCCTTTTTACGGTTCCTGGCCTTTTGCTGGC
CTTTTGCTCACATGTTCTTTCCTGCGTTATCCCCTGATTCTGTGGATAACCGTATTACCGCCTTTGAGTGAGC
TGATACCGCTCGCCGCAGCCGAACGACCGAGCGCAGCGAGTCAGTGAGCGAGGAAGCGGAAGAGCGCC
TGATGCGGTATTTTCTCCTTACGCATCTGTGCGGTATTTCACACCGCATATATGGTGCACTCTCAGTACAAT
CTGCTCTGATGCCGCATAGTTAAGCCAGTATACACTCCGCTATCGCTACGTGACTGGGTCATGGCTGCGCC
CCGACACCCGCCAACACCCGCTGACGCGCCCTGACGGGCTTGTCTGCTCCCGGCATCCGCTTACAGACAAG
CTGTGACCGTCTCCGGGAGCTGCATGTGTCAGAGGTTTTCACCGTCATCACCGAAACGCGCGAGGCAGCT
GCGGTAAAGCTCATCAGCGTGGTCGTGAAGCGATTCACAGATGTCTGCCTGTTCATCCGCGTCCAGCTCGT
TGAGTTTCTCCAGAAGCGTTAATGTCTGGCTTCTGATAAAGCGGGCCATGTTAAGGGCGGTTTTTTCCTGT
TTGGTCACTGATGCCTCCGTGTAAGGGGGATTTCTGTTCATGGGGGTAATGATACCGATGAAACGAGAGA
GGATGCTCACGATACGGGTTACTGATGATGAACATGCCCGGTTACTGGAACGTTGTGAGGGTAAACAACT
GGCGGTATGGATGCGGCGGGACCAGAGAAAAATCACTCAGGGTCAATGCCAGCGCTTCGTTAATACAGA
TGTAGGTGTTCCACAGGGTAGCCAGCAGCATCCTGCGATGCAGATCCGGAACATAATGGTGCAGGGCGCT
GACTTCCGCGTTTCCAGACTTTACGAAACACGGAAACCGAAGACCATTCATGTTGTTGCTCAGGTCGCAGA
CGTTTTGCAGCAGCAGTCGCTTCACGTTCGCTCGCGTATCGGTGATTCATTCTGCTAACCAGTAAGGCAAC
CCCGCCAGCCTAGCCGGGTCCTCAACGACAGGAGCACGATCATGCGCACCCGTGGGGCCGCCATGCCGG
CGATAATGGCCTGCTTCTCGCCGAAACGTTTGGTGGCGGGACCAGTGACGAAGGCTTGAGCGAGGGCGT
GCAAGATTCCGAATACCGCAAGCGACAGGCCGATCATCGTCGCGCTCCAGCGAAAGCGGTCCTCGCCGAA
AATGACCCAGAGCGCTGCCGGCACCTGTCCTACGAGTTGCATGATAAAGAAGACAGTCATAAGTGCGGCG
ACGATAGTCATGCCCCGCGCCCACCGGAAGGAGCTGACTGGGTTGAAGGCTCTCAAGGGCATCGGTCGA
GATCCCGGTGCCTAATGAGTGAGCTAACTTACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGG
AAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCG
CCAGGGTGGTTTTTCTTTTCACCAGTGAGACGGGCAACAGCTGATTGCCCTTCACCGCCTGGCCCTGAGAG
AGTTGCAGCAAGCGGTCCACGCTGGTTTGCCCCAGCAGGCGAAAATCCTGTTTGATGGTGGTTAACGGCG
GGATATAACATGAGCTGTCTTCGGTATCGTCGTATCCCACTACCGAGATATCCGCACCAACGCGCAGCCCG
GACTCGGTAATGGCGCGCATTGCGCCCAGCGCCATCTGATCGTTGGCAACCAGCATCGCAGTGGGAACGA
TGCCCTCATTCAGCATTTGCATGGTTTGTTGAAAACCGGACATGGCACTCCAGTCGCCTTCCCGTTCCGCTA
TCGGCTGAATTTGATTGCGAGTGAGATATTTATGCCAGCCAGCCAGACGCAGACGCGCCGAGACAGAACT
TAATGGGCCCGCTAACAGCGCGATTTGCTGGTGACCCAATGCGACCAGATGCTCCACGCCCAGTCGCGTA
CCGTCTTCATGGGAGAAAATAATACTGTTGATGGGTGTCTGGTCAGAGACATCAAGAAATAACGCCGGAA
CATTAGTGCAGGCAGCTTCCACAGCAATGGCATCCTGGTCATCCAGCGGATAGTTAATGATCAGCCCACTG
ACGCGTTGCGCGAGAAGATTGTGCACCGCCGCTTTACAGGCTTCGACGCCGCTTCGTTCTACCATCGACAC
CACCACGCTGGCACCCAGTTGATCGGCGCGAGATTTAATCGCCGCGACAATTTGCGACGGCGCGTGCAGG
GCCAGACTGGAGGTGGCAACGCCAATCAGCAACGACTGTTTGCCCGCCAGTTGTTGTGCCACGCGGTTGG
GAATGTAATTCAGCTCCGCCATCGCCGCTTCCACTTTTTCCCGCGTTTTCGCAGAAACGTGGCTGGCCTGGT
TCACCACGCGGGAAACGGTCTGATAAGAGACACCGGCATACTCTGCGACATCGTATAACGTTACTGGTTTC
ACATTCACCACCCTGAATTGACTCTCTTCCGGGCGCTATCATGCCATACCGCGAAAGGTTTTGCGCCATTCG
ATGGTGTCCGGGATCTCGACGCTCTCCCTTATGCGACTCCTGCATTAGGAAGCAGCCCAGTAGTAGGTTGA
GGCCGTTGAGCACCGCCGCCGCAAGGAATGGTGCATGCAAGGAGATGGCGCCCAACAGTCCCCCGGCCA
CGGGGCCTGCCACCATACCCACGCCGAAACAAGCGCTCATGAGCCCGAAGTGGCGAGCCCGATCTTCCCC
ATCGGTGATGTCGGCGATATAGGCGCCAGCAACCGCACCTGTGGCGCCGGTGATGCCGGCCACGATGCG
TCCGGCGTAGAGGATCGAGATCTCGATCCCGCGAAATTAATACGACTCACTATAGGGGAATTGTGAGCGG
APPENDIX 2 (9/18) 
 
 
 
ATAACAATTCCCCTCTAGAAATAATTTTGTTTAACTTTAAGAAGGAGATATACCATGAAATACCTATTGCCT
ACGGCAGCCGCTGGATTGTTATTACTCGCGGCCCAGCCGGCCATGGCATCTAGGACTCCGGAAATGCCGG
TTCTGGAAAATCGTGCAGCACAGGGTGATATTACCGCACCGGGTGGTGCACGTCGTCTGACCGGTGATCA
GACCGCAGCACTGCGTGATAGCCTGAGCGATAAACCGGCAAAAAACATTATTCTGCTGATTGGTGATGGC
ATGGGTGATAGCGAAATTACCGCAGCACGTAATTATGCCGAAGGTGCCGGTGGTTTTTTTAAAGGTATTG
ATGCACTGCCGCTGACAGGTCAGTATACCCATTATGCACTGAATAAAAAAACCGGCAAACCGGATTATGTT
ACCGATAGCGCAGCAAGCGCAACCGCATGGTCAACCGGTGTTAAAACCTATAATGGTGCACTGGGTGTGG
ATATTCATGAAAAAGATCATCCGACCATTCTGGAAATGGCAAAAGCAGCAGGTCTGGCAACCGGTAATGT
TAGCACCGCAGAACTGCAGGATGCAACACCGGCAGCACTGGTTGCACATGTTACCAGCCGTAAATGTTAT
GGTCCGAGCGCAACCAGCGAAAAATGTCCGGGTAATGCACTGGAAAAAGGTGGTAAAGGTAGCATTACC
GAACAGCTGCTGAATGCACGTGCAGATGTTACCCTGGGTGGTGGTGCAAAAACCTTTGCAGAAACCGCAA
CCGCAGGCGAATGGCAGGGTAAAACCCTGCGTGAACAGGCACAGGCACGTGGTTATCAGCTGGTTAGTG
ATGCAGCAAGCCTGAATAGCGTTACCGAAGCAAATCAGCAGAAACCGCTGCTGGGTCTGTTTGCAGATGG
TAATATGCCGGTTCGTTGGCTGGGTCCGAAAGCAACCTATCATGGTAATATTGATAAACCGGCTGTTACCT
GTACCCCGAATCCGCAGCGTAATGATAGCGTTCCGACCCTGGCACAGATGACCGATAAAGCAATTGAACT
GCTGAGCAAAAATGAAAAAGGCTTTTTTCTGCAGGTTGAAGGTGCCAGCATTGATAAACAGGATCATGCA
GCAAATCCGTGTGGTCAGATTGGTGAAACCGTTGATCTGGATGAAGCAGTTCAGCGTGCACTGGAATTTG
CAAAAAAAGAAGGTAATACCCTGGTTATTGTGACCGCAGATCATGCACATGCAAGCCAGATTGTTGCACC
GGATACCAAAGCACCGGGTCTGACCCAGGCACTGAATACCAAAGATGGTGCAGTTATGGTTATGAGCTAT
GGTAATAGCGAAGAAGATAGCCAGGAACATACCGGTAGCCAGCTGCGTATTGCAGCATATGGTCCGCAT
GCAGCCAATGTTGTTGGTCTGACCGATCAAACCGACCTGTTTTATACCATGAAAGCAGCACTGGGTCTGAA
AGGCGGCGGTGGTAGCAAAGGTGGTGGCTCTCCGAACCCCGGTCCTTGGGAACAGTGTGGTGGTAAATC
GTATGAAGGTCCGACCGCCTGTCCCCGTGAATACACCTGTCAGTATCGCCGTGAAACGTTTTCACAGTGTA
TTCCTGGTGGTAAAGGCGAGCACCACCACCACCACCACTGAGATCCGGCTGCTAACAAAGCCCGAAAGGA
AGCTGAGTTGGCTGCTGCCACCGCTGAGCAATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTG
AGGGGTTTTTTGCTGAAAGGAGGAACTATATCCGGAT 
>pelB-AP-Ehux1b2A -pBR1a (6804 bp) 
TGGCGAATGGGACGCGCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCGCAGCGTGAC
CGCTACACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCGCTTTCTTCCCTTCCTTTCTCGCCACGTTCGCCGGC
TTTCCCCGTCAAGCTCTAAATCGGGGGCTCCCTTTAGGGTTCCGATTTAGTGCTTTACGGCACCTCGACCCC
AAAAAACTTGATTAGGGTGATGGTTCACGTAGTGGGCCATCGCCCTGATAGACGGTTTTTCGCCCTTTGAC
GTTGGAGTCCACGTTCTTTAATAGTGGACTCTTGTTCCAAACTGGAACAACACTCAACCCTATCTCGGTCTA
TTCTTTTGATTTATAAGGGATTTTGCCGATTTCGGCCTATTGGTTAAAAAATGAGCTGATTTAACAAAAATT
TAACGCGAATTTTAACAAAATATTAACGCTTACAATTTAGGTGGCACTTTTCGGGGAAATGTGCGCGGAAC
CCCTATTTGTTTATTTTTCTAAATACATTCAAATATGTATCCGCTCATGAATTAATTCTTAGAAAAACTCATC
GAGCATCAAATGAAACTGCAATTTATTCATATCAGGATTATCAATACCATATTTTTGAAAAAGCCGTTTCTG
TAATGAAGGAGAAAACTCACCGAGGCAGTTCCATAGGATGGCAAGATCCTGGTATCGGTCTGCGATTCCG
ACTCGTCCAACATCAATACAACCTATTAATTTCCCCTCGTCAAAAATAAGGTTATCAAGTGAGAAATCACCA
TGAGTGACGACTGAATCCGGTGAGAATGGCAAAAGTTTATGCATTTCTTTCCAGACTTGTTCAACAGGCCA
GCCATTACGCTCGTCATCAAAATCACTCGCATCAACCAAACCGTTATTCATTCGTGATTGCGCCTGAGCGA
GACGAAATACGCGATCGCTGTTAAAAGGACAATTACAAACAGGAATCGAATGCAACCGGCGCAGGAACA
CTGCCAGCGCATCAACAATATTTTCACCTGAATCAGGATATTCTTCTAATACCTGGAATGCTGTTTTCCCGG
GGATCGCAGTGGTGAGTAACCATGCATCATCAGGAGTACGGATAAAATGCTTGATGGTCGGAAGAGGCA
TAAATTCCGTCAGCCAGTTTAGTCTGACCATCTCATCTGTAACATCATTGGCAACGCTACCTTTGCCATGTTT
CAGAAACAACTCTGGCGCATCGGGCTTCCCATACAATCGATAGATTGTCGCACCTGATTGCCCGACATTAT
CGCGAGCCCATTTATACCCATATAAATCAGCATCCATGTTGGAATTTAATCGCGGCCTAGAGCAAGACGTT
TCCCGTTGAATATGGCTCATAACACCCCTTGTATTACTGTTTATGTAAGCAGACAGTTTTATTGTTCATGACC
AAAATCCCTTAACGTGAGTTTTCGTTCCACTGAGCGTCAGACCCCGTAGAAAAGATCAAAGGATCTTCTTG
AGATCCTTTTTTTCTGCGCGTAATCTGCTGCTTGCAAACAAAAAAACCACCGCTACCAGCGGTGGTTTGTTT
GCCGGATCAAGAGCTACCAACTCTTTTTCCGAAGGTAACTGGCTTCAGCAGAGCGCAGATACCAAATACT
GTCCTTCTAGTGTAGCCGTAGTTAGGCCACCACTTCAAGAACTCTGTAGCACCGCCTACATACCTCGCTCTG
CTAATCCTGTTACCAGTGGCTGCTGCCAGTGGCGATAAGTCGTGTCTTACCGGGTTGGACTCAAGACGATA
GTTACCGGATAAGGCGCAGCGGTCGGGCTGAACGGGGGGTTCGTGCACACAGCCCAGCTTGGAGCGAAC
APPENDIX 2 (10/18) 
 
 
 
GACCTACACCGAACTGAGATACCTACAGCGTGAGCTATGAGAAAGCGCCACGCTTCCCGAAGGGAGAAA
GGCGGACAGGTATCCGGTAAGCGGCAGGGTCGGAACAGGAGAGCGCACGAGGGAGCTTCCAGGGGGA
AACGCCTGGTATCTTTATAGTCCTGTCGGGTTTCGCCACCTCTGACTTGAGCGTCGATTTTTGTGATGCTCG
TCAGGGGGGCGGAGCCTATGGAAAAACGCCAGCAACGCGGCCTTTTTACGGTTCCTGGCCTTTTGCTGGC
CTTTTGCTCACATGTTCTTTCCTGCGTTATCCCCTGATTCTGTGGATAACCGTATTACCGCCTTTGAGTGAGC
TGATACCGCTCGCCGCAGCCGAACGACCGAGCGCAGCGAGTCAGTGAGCGAGGAAGCGGAAGAGCGCC
TGATGCGGTATTTTCTCCTTACGCATCTGTGCGGTATTTCACACCGCATATATGGTGCACTCTCAGTACAAT
CTGCTCTGATGCCGCATAGTTAAGCCAGTATACACTCCGCTATCGCTACGTGACTGGGTCATGGCTGCGCC
CCGACACCCGCCAACACCCGCTGACGCGCCCTGACGGGCTTGTCTGCTCCCGGCATCCGCTTACAGACAAG
CTGTGACCGTCTCCGGGAGCTGCATGTGTCAGAGGTTTTCACCGTCATCACCGAAACGCGCGAGGCAGCT
GCGGTAAAGCTCATCAGCGTGGTCGTGAAGCGATTCACAGATGTCTGCCTGTTCATCCGCGTCCAGCTCGT
TGAGTTTCTCCAGAAGCGTTAATGTCTGGCTTCTGATAAAGCGGGCCATGTTAAGGGCGGTTTTTTCCTGT
TTGGTCACTGATGCCTCCGTGTAAGGGGGATTTCTGTTCATGGGGGTAATGATACCGATGAAACGAGAGA
GGATGCTCACGATACGGGTTACTGATGATGAACATGCCCGGTTACTGGAACGTTGTGAGGGTAAACAACT
GGCGGTATGGATGCGGCGGGACCAGAGAAAAATCACTCAGGGTCAATGCCAGCGCTTCGTTAATACAGA
TGTAGGTGTTCCACAGGGTAGCCAGCAGCATCCTGCGATGCAGATCCGGAACATAATGGTGCAGGGCGCT
GACTTCCGCGTTTCCAGACTTTACGAAACACGGAAACCGAAGACCATTCATGTTGTTGCTCAGGTCGCAGA
CGTTTTGCAGCAGCAGTCGCTTCACGTTCGCTCGCGTATCGGTGATTCATTCTGCTAACCAGTAAGGCAAC
CCCGCCAGCCTAGCCGGGTCCTCAACGACAGGAGCACGATCATGCGCACCCGTGGGGCCGCCATGCCGG
CGATAATGGCCTGCTTCTCGCCGAAACGTTTGGTGGCGGGACCAGTGACGAAGGCTTGAGCGAGGGCGT
GCAAGATTCCGAATACCGCAAGCGACAGGCCGATCATCGTCGCGCTCCAGCGAAAGCGGTCCTCGCCGAA
AATGACCCAGAGCGCTGCCGGCACCTGTCCTACGAGTTGCATGATAAAGAAGACAGTCATAAGTGCGGCG
ACGATAGTCATGCCCCGCGCCCACCGGAAGGAGCTGACTGGGTTGAAGGCTCTCAAGGGCATCGGTCGA
GATCCCGGTGCCTAATGAGTGAGCTAACTTACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGG
AAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCG
CCAGGGTGGTTTTTCTTTTCACCAGTGAGACGGGCAACAGCTGATTGCCCTTCACCGCCTGGCCCTGAGAG
AGTTGCAGCAAGCGGTCCACGCTGGTTTGCCCCAGCAGGCGAAAATCCTGTTTGATGGTGGTTAACGGCG
GGATATAACATGAGCTGTCTTCGGTATCGTCGTATCCCACTACCGAGATATCCGCACCAACGCGCAGCCCG
GACTCGGTAATGGCGCGCATTGCGCCCAGCGCCATCTGATCGTTGGCAACCAGCATCGCAGTGGGAACGA
TGCCCTCATTCAGCATTTGCATGGTTTGTTGAAAACCGGACATGGCACTCCAGTCGCCTTCCCGTTCCGCTA
TCGGCTGAATTTGATTGCGAGTGAGATATTTATGCCAGCCAGCCAGACGCAGACGCGCCGAGACAGAACT
TAATGGGCCCGCTAACAGCGCGATTTGCTGGTGACCCAATGCGACCAGATGCTCCACGCCCAGTCGCGTA
CCGTCTTCATGGGAGAAAATAATACTGTTGATGGGTGTCTGGTCAGAGACATCAAGAAATAACGCCGGAA
CATTAGTGCAGGCAGCTTCCACAGCAATGGCATCCTGGTCATCCAGCGGATAGTTAATGATCAGCCCACTG
ACGCGTTGCGCGAGAAGATTGTGCACCGCCGCTTTACAGGCTTCGACGCCGCTTCGTTCTACCATCGACAC
CACCACGCTGGCACCCAGTTGATCGGCGCGAGATTTAATCGCCGCGACAATTTGCGACGGCGCGTGCAGG
GCCAGACTGGAGGTGGCAACGCCAATCAGCAACGACTGTTTGCCCGCCAGTTGTTGTGCCACGCGGTTGG
GAATGTAATTCAGCTCCGCCATCGCCGCTTCCACTTTTTCCCGCGTTTTCGCAGAAACGTGGCTGGCCTGGT
TCACCACGCGGGAAACGGTCTGATAAGAGACACCGGCATACTCTGCGACATCGTATAACGTTACTGGTTTC
ACATTCACCACCCTGAATTGACTCTCTTCCGGGCGCTATCATGCCATACCGCGAAAGGTTTTGCGCCATTCG
ATGGTGTCCGGGATCTCGACGCTCTCCCTTATGCGACTCCTGCATTAGGAAGCAGCCCAGTAGTAGGTTGA
GGCCGTTGAGCACCGCCGCCGCAAGGAATGGTGCATGCAAGGAGATGGCGCCCAACAGTCCCCCGGCCA
CGGGGCCTGCCACCATACCCACGCCGAAACAAGCGCTCATGAGCCCGAAGTGGCGAGCCCGATCTTCCCC
ATCGGTGATGTCGGCGATATAGGCGCCAGCAACCGCACCTGTGGCGCCGGTGATGCCGGCCACGATGCG
TCCGGCGTAGAGGATCGAGATCTCGATCCCGCGAAATTAATACGACTCACTATAGGGGAATTGTGAGCGG
ATAACAATTCCCCTCTAGAAATAATTTTGTTTAACTTTAAGAAGGAGATATACCATGAAATACCTATTGCCT
ACGGCAGCCGCTGGATTGTTATTACTCGCGGCCCAGCCGGCCATGGCATCTAGGACTCCGGAAATGCCGG
TTCTGGAAAATCGTGCAGCACAGGGTGATATTACCGCACCGGGTGGTGCACGTCGTCTGACCGGTGATCA
GACCGCAGCACTGCGTGATAGCCTGAGCGATAAACCGGCAAAAAACATTATTCTGCTGATTGGTGATGGC
ATGGGTGATAGCGAAATTACCGCAGCACGTAATTATGCCGAAGGTGCCGGTGGTTTTTTTAAAGGTATTG
ATGCACTGCCGCTGACAGGTCAGTATACCCATTATGCACTGAATAAAAAAACCGGCAAACCGGATTATGTT
ACCGATAGCGCAGCAAGCGCAACCGCATGGTCAACCGGTGTTAAAACCTATAATGGTGCACTGGGTGTGG
ATATTCATGAAAAAGATCATCCGACCATTCTGGAAATGGCAAAAGCAGCAGGTCTGGCAACCGGTAATGT
TAGCACCGCAGAACTGCAGGATGCAACACCGGCAGCACTGGTTGCACATGTTACCAGCCGTAAATGTTAT
GGTCCGAGCGCAACCAGCGAAAAATGTCCGGGTAATGCACTGGAAAAAGGTGGTAAAGGTAGCATTACC
APPENDIX 2 (11/18) 
 
 
 
GAACAGCTGCTGAATGCACGTGCAGATGTTACCCTGGGTGGTGGTGCAAAAACCTTTGCAGAAACCGCAA
CCGCAGGCGAATGGCAGGGTAAAACCCTGCGTGAACAGGCACAGGCACGTGGTTATCAGCTGGTTAGTG
ATGCAGCAAGCCTGAATAGCGTTACCGAAGCAAATCAGCAGAAACCGCTGCTGGGTCTGTTTGCAGATGG
TAATATGCCGGTTCGTTGGCTGGGTCCGAAAGCAACCTATCATGGTAATATTGATAAACCGGCTGTTACCT
GTACCCCGAATCCGCAGCGTAATGATAGCGTTCCGACCCTGGCACAGATGACCGATAAAGCAATTGAACT
GCTGAGCAAAAATGAAAAAGGCTTTTTTCTGCAGGTTGAAGGTGCCAGCATTGATAAACAGGATCATGCA
GCAAATCCGTGTGGTCAGATTGGTGAAACCGTTGATCTGGATGAAGCAGTTCAGCGTGCACTGGAATTTG
CAAAAAAAGAAGGTAATACCCTGGTTATTGTGACCGCAGATCATGCACATGCAAGCCAGATTGTTGCACC
GGATACCAAAGCACCGGGTCTGACCCAGGCACTGAATACCAAAGATGGTGCAGTTATGGTTATGAGCTAT
GGTAATAGCGAAGAAGATAGCCAGGAACATACCGGTAGCCAGCTGCGTATTGCAGCATATGGTCCGCAT
GCAGCCAATGTTGTTGGTCTGACCGATCAAACCGACCTGTTTTATACCATGAAAGCAGCACTGGGTCTGAA
AGGCGGCGGTGGTAGCAAAGGTGGTGGCTCTCCGACCCAGAGCCATTATGGTCAGTGTGGTGGTAAATC
GTATGAAGGTCCGACCGCCTGTCCCCGTGAATACACCTGTCAGTATCGCCGTGAAACGTTTTCACAGTGTA
TTCCTGGTGGTAAAGGCGAGCACCACCACCACCACCACTGAGATCCGGCTGCTAACAAAGCCCGAAAGGA
AGCTGAGTTGGCTGCTGCCACCGCTGAGCAATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTG
AGGGGTTTTTTGCTGAAAGGAGGAACTATATCCGGAT 
>pelB-AP-Ehux1b2B-pBR1a (6804 bp) 
TGGCGAATGGGACGCGCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCGCAGCGTGAC
CGCTACACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCGCTTTCTTCCCTTCCTTTCTCGCCACGTTCGCCGGC
TTTCCCCGTCAAGCTCTAAATCGGGGGCTCCCTTTAGGGTTCCGATTTAGTGCTTTACGGCACCTCGACCCC
AAAAAACTTGATTAGGGTGATGGTTCACGTAGTGGGCCATCGCCCTGATAGACGGTTTTTCGCCCTTTGAC
GTTGGAGTCCACGTTCTTTAATAGTGGACTCTTGTTCCAAACTGGAACAACACTCAACCCTATCTCGGTCTA
TTCTTTTGATTTATAAGGGATTTTGCCGATTTCGGCCTATTGGTTAAAAAATGAGCTGATTTAACAAAAATT
TAACGCGAATTTTAACAAAATATTAACGCTTACAATTTAGGTGGCACTTTTCGGGGAAATGTGCGCGGAAC
CCCTATTTGTTTATTTTTCTAAATACATTCAAATATGTATCCGCTCATGAATTAATTCTTAGAAAAACTCATC
GAGCATCAAATGAAACTGCAATTTATTCATATCAGGATTATCAATACCATATTTTTGAAAAAGCCGTTTCTG
TAATGAAGGAGAAAACTCACCGAGGCAGTTCCATAGGATGGCAAGATCCTGGTATCGGTCTGCGATTCCG
ACTCGTCCAACATCAATACAACCTATTAATTTCCCCTCGTCAAAAATAAGGTTATCAAGTGAGAAATCACCA
TGAGTGACGACTGAATCCGGTGAGAATGGCAAAAGTTTATGCATTTCTTTCCAGACTTGTTCAACAGGCCA
GCCATTACGCTCGTCATCAAAATCACTCGCATCAACCAAACCGTTATTCATTCGTGATTGCGCCTGAGCGA
GACGAAATACGCGATCGCTGTTAAAAGGACAATTACAAACAGGAATCGAATGCAACCGGCGCAGGAACA
CTGCCAGCGCATCAACAATATTTTCACCTGAATCAGGATATTCTTCTAATACCTGGAATGCTGTTTTCCCGG
GGATCGCAGTGGTGAGTAACCATGCATCATCAGGAGTACGGATAAAATGCTTGATGGTCGGAAGAGGCA
TAAATTCCGTCAGCCAGTTTAGTCTGACCATCTCATCTGTAACATCATTGGCAACGCTACCTTTGCCATGTTT
CAGAAACAACTCTGGCGCATCGGGCTTCCCATACAATCGATAGATTGTCGCACCTGATTGCCCGACATTAT
CGCGAGCCCATTTATACCCATATAAATCAGCATCCATGTTGGAATTTAATCGCGGCCTAGAGCAAGACGTT
TCCCGTTGAATATGGCTCATAACACCCCTTGTATTACTGTTTATGTAAGCAGACAGTTTTATTGTTCATGACC
AAAATCCCTTAACGTGAGTTTTCGTTCCACTGAGCGTCAGACCCCGTAGAAAAGATCAAAGGATCTTCTTG
AGATCCTTTTTTTCTGCGCGTAATCTGCTGCTTGCAAACAAAAAAACCACCGCTACCAGCGGTGGTTTGTTT
GCCGGATCAAGAGCTACCAACTCTTTTTCCGAAGGTAACTGGCTTCAGCAGAGCGCAGATACCAAATACT
GTCCTTCTAGTGTAGCCGTAGTTAGGCCACCACTTCAAGAACTCTGTAGCACCGCCTACATACCTCGCTCTG
CTAATCCTGTTACCAGTGGCTGCTGCCAGTGGCGATAAGTCGTGTCTTACCGGGTTGGACTCAAGACGATA
GTTACCGGATAAGGCGCAGCGGTCGGGCTGAACGGGGGGTTCGTGCACACAGCCCAGCTTGGAGCGAAC
GACCTACACCGAACTGAGATACCTACAGCGTGAGCTATGAGAAAGCGCCACGCTTCCCGAAGGGAGAAA
GGCGGACAGGTATCCGGTAAGCGGCAGGGTCGGAACAGGAGAGCGCACGAGGGAGCTTCCAGGGGGA
AACGCCTGGTATCTTTATAGTCCTGTCGGGTTTCGCCACCTCTGACTTGAGCGTCGATTTTTGTGATGCTCG
TCAGGGGGGCGGAGCCTATGGAAAAACGCCAGCAACGCGGCCTTTTTACGGTTCCTGGCCTTTTGCTGGC
CTTTTGCTCACATGTTCTTTCCTGCGTTATCCCCTGATTCTGTGGATAACCGTATTACCGCCTTTGAGTGAGC
TGATACCGCTCGCCGCAGCCGAACGACCGAGCGCAGCGAGTCAGTGAGCGAGGAAGCGGAAGAGCGCC
TGATGCGGTATTTTCTCCTTACGCATCTGTGCGGTATTTCACACCGCATATATGGTGCACTCTCAGTACAAT
CTGCTCTGATGCCGCATAGTTAAGCCAGTATACACTCCGCTATCGCTACGTGACTGGGTCATGGCTGCGCC
CCGACACCCGCCAACACCCGCTGACGCGCCCTGACGGGCTTGTCTGCTCCCGGCATCCGCTTACAGACAAG
CTGTGACCGTCTCCGGGAGCTGCATGTGTCAGAGGTTTTCACCGTCATCACCGAAACGCGCGAGGCAGCT
APPENDIX 2 (12/18) 
 
 
 
GCGGTAAAGCTCATCAGCGTGGTCGTGAAGCGATTCACAGATGTCTGCCTGTTCATCCGCGTCCAGCTCGT
TGAGTTTCTCCAGAAGCGTTAATGTCTGGCTTCTGATAAAGCGGGCCATGTTAAGGGCGGTTTTTTCCTGT
TTGGTCACTGATGCCTCCGTGTAAGGGGGATTTCTGTTCATGGGGGTAATGATACCGATGAAACGAGAGA
GGATGCTCACGATACGGGTTACTGATGATGAACATGCCCGGTTACTGGAACGTTGTGAGGGTAAACAACT
GGCGGTATGGATGCGGCGGGACCAGAGAAAAATCACTCAGGGTCAATGCCAGCGCTTCGTTAATACAGA
TGTAGGTGTTCCACAGGGTAGCCAGCAGCATCCTGCGATGCAGATCCGGAACATAATGGTGCAGGGCGCT
GACTTCCGCGTTTCCAGACTTTACGAAACACGGAAACCGAAGACCATTCATGTTGTTGCTCAGGTCGCAGA
CGTTTTGCAGCAGCAGTCGCTTCACGTTCGCTCGCGTATCGGTGATTCATTCTGCTAACCAGTAAGGCAAC
CCCGCCAGCCTAGCCGGGTCCTCAACGACAGGAGCACGATCATGCGCACCCGTGGGGCCGCCATGCCGG
CGATAATGGCCTGCTTCTCGCCGAAACGTTTGGTGGCGGGACCAGTGACGAAGGCTTGAGCGAGGGCGT
GCAAGATTCCGAATACCGCAAGCGACAGGCCGATCATCGTCGCGCTCCAGCGAAAGCGGTCCTCGCCGAA
AATGACCCAGAGCGCTGCCGGCACCTGTCCTACGAGTTGCATGATAAAGAAGACAGTCATAAGTGCGGCG
ACGATAGTCATGCCCCGCGCCCACCGGAAGGAGCTGACTGGGTTGAAGGCTCTCAAGGGCATCGGTCGA
GATCCCGGTGCCTAATGAGTGAGCTAACTTACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGG
AAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCG
CCAGGGTGGTTTTTCTTTTCACCAGTGAGACGGGCAACAGCTGATTGCCCTTCACCGCCTGGCCCTGAGAG
AGTTGCAGCAAGCGGTCCACGCTGGTTTGCCCCAGCAGGCGAAAATCCTGTTTGATGGTGGTTAACGGCG
GGATATAACATGAGCTGTCTTCGGTATCGTCGTATCCCACTACCGAGATATCCGCACCAACGCGCAGCCCG
GACTCGGTAATGGCGCGCATTGCGCCCAGCGCCATCTGATCGTTGGCAACCAGCATCGCAGTGGGAACGA
TGCCCTCATTCAGCATTTGCATGGTTTGTTGAAAACCGGACATGGCACTCCAGTCGCCTTCCCGTTCCGCTA
TCGGCTGAATTTGATTGCGAGTGAGATATTTATGCCAGCCAGCCAGACGCAGACGCGCCGAGACAGAACT
TAATGGGCCCGCTAACAGCGCGATTTGCTGGTGACCCAATGCGACCAGATGCTCCACGCCCAGTCGCGTA
CCGTCTTCATGGGAGAAAATAATACTGTTGATGGGTGTCTGGTCAGAGACATCAAGAAATAACGCCGGAA
CATTAGTGCAGGCAGCTTCCACAGCAATGGCATCCTGGTCATCCAGCGGATAGTTAATGATCAGCCCACTG
ACGCGTTGCGCGAGAAGATTGTGCACCGCCGCTTTACAGGCTTCGACGCCGCTTCGTTCTACCATCGACAC
CACCACGCTGGCACCCAGTTGATCGGCGCGAGATTTAATCGCCGCGACAATTTGCGACGGCGCGTGCAGG
GCCAGACTGGAGGTGGCAACGCCAATCAGCAACGACTGTTTGCCCGCCAGTTGTTGTGCCACGCGGTTGG
GAATGTAATTCAGCTCCGCCATCGCCGCTTCCACTTTTTCCCGCGTTTTCGCAGAAACGTGGCTGGCCTGGT
TCACCACGCGGGAAACGGTCTGATAAGAGACACCGGCATACTCTGCGACATCGTATAACGTTACTGGTTTC
ACATTCACCACCCTGAATTGACTCTCTTCCGGGCGCTATCATGCCATACCGCGAAAGGTTTTGCGCCATTCG
ATGGTGTCCGGGATCTCGACGCTCTCCCTTATGCGACTCCTGCATTAGGAAGCAGCCCAGTAGTAGGTTGA
GGCCGTTGAGCACCGCCGCCGCAAGGAATGGTGCATGCAAGGAGATGGCGCCCAACAGTCCCCCGGCCA
CGGGGCCTGCCACCATACCCACGCCGAAACAAGCGCTCATGAGCCCGAAGTGGCGAGCCCGATCTTCCCC
ATCGGTGATGTCGGCGATATAGGCGCCAGCAACCGCACCTGTGGCGCCGGTGATGCCGGCCACGATGCG
TCCGGCGTAGAGGATCGAGATCTCGATCCCGCGAAATTAATACGACTCACTATAGGGGAATTGTGAGCGG
ATAACAATTCCCCTCTAGAAATAATTTTGTTTAACTTTAAGAAGGAGATATACCATGAAATACCTATTGCCT
ACGGCAGCCGCTGGATTGTTATTACTCGCGGCCCAGCCGGCCATGGCATCTAGGACTCCGGAAATGCCGG
TTCTGGAAAATCGTGCAGCACAGGGTGATATTACCGCACCGGGTGGTGCACGTCGTCTGACCGGTGATCA
GACCGCAGCACTGCGTGATAGCCTGAGCGATAAACCGGCAAAAAACATTATTCTGCTGATTGGTGATGGC
ATGGGTGATAGCGAAATTACCGCAGCACGTAATTATGCCGAAGGTGCCGGTGGTTTTTTTAAAGGTATTG
ATGCACTGCCGCTGACAGGTCAGTATACCCATTATGCACTGAATAAAAAAACCGGCAAACCGGATTATGTT
ACCGATAGCGCAGCAAGCGCAACCGCATGGTCAACCGGTGTTAAAACCTATAATGGTGCACTGGGTGTGG
ATATTCATGAAAAAGATCATCCGACCATTCTGGAAATGGCAAAAGCAGCAGGTCTGGCAACCGGTAATGT
TAGCACCGCAGAACTGCAGGATGCAACACCGGCAGCACTGGTTGCACATGTTACCAGCCGTAAATGTTAT
GGTCCGAGCGCAACCAGCGAAAAATGTCCGGGTAATGCACTGGAAAAAGGTGGTAAAGGTAGCATTACC
GAACAGCTGCTGAATGCACGTGCAGATGTTACCCTGGGTGGTGGTGCAAAAACCTTTGCAGAAACCGCAA
CCGCAGGCGAATGGCAGGGTAAAACCCTGCGTGAACAGGCACAGGCACGTGGTTATCAGCTGGTTAGTG
ATGCAGCAAGCCTGAATAGCGTTACCGAAGCAAATCAGCAGAAACCGCTGCTGGGTCTGTTTGCAGATGG
TAATATGCCGGTTCGTTGGCTGGGTCCGAAAGCAACCTATCATGGTAATATTGATAAACCGGCTGTTACCT
GTACCCCGAATCCGCAGCGTAATGATAGCGTTCCGACCCTGGCACAGATGACCGATAAAGCAATTGAACT
GCTGAGCAAAAATGAAAAAGGCTTTTTTCTGCAGGTTGAAGGTGCCAGCATTGATAAACAGGATCATGCA
GCAAATCCGTGTGGTCAGATTGGTGAAACCGTTGATCTGGATGAAGCAGTTCAGCGTGCACTGGAATTTG
CAAAAAAAGAAGGTAATACCCTGGTTATTGTGACCGCAGATCATGCACATGCAAGCCAGATTGTTGCACC
GGATACCAAAGCACCGGGTCTGACCCAGGCACTGAATACCAAAGATGGTGCAGTTATGGTTATGAGCTAT
GGTAATAGCGAAGAAGATAGCCAGGAACATACCGGTAGCCAGCTGCGTATTGCAGCATATGGTCCGCAT
APPENDIX 2 (13/18) 
 
 
 
GCAGCCAATGTTGTTGGTCTGACCGATCAAACCGACCTGTTTTATACCATGAAAGCAGCACTGGGTCTGAA
AGGCGGCGGTGGTAGCAAAGGTGGTGGCTCTCCGAACCCCGGTCCTTGGGAACAGTGTGGTGGTATTGG
TTATAGCGGTCCGACCGTTTGTCCCCGTGAATACACCTGTCAGTATCGCCGTGAAACGTTTTCACAGTGTAT
TCCTGGTGGTAAAGGCGAGCACCACCACCACCACCACTGAGATCCGGCTGCTAACAAAGCCCGAAAGGAA
GCTGAGTTGGCTGCTGCCACCGCTGAGCAATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGA
GGGGTTTTTTGCTGAAAGGAGGAACTATATCCGGAT 
>pelB-AP-Ehux1b2C-pBR1a (6804 bp) 
TGGCGAATGGGACGCGCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCGCAGCGTGAC
CGCTACACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCGCTTTCTTCCCTTCCTTTCTCGCCACGTTCGCCGGC
TTTCCCCGTCAAGCTCTAAATCGGGGGCTCCCTTTAGGGTTCCGATTTAGTGCTTTACGGCACCTCGACCCC
AAAAAACTTGATTAGGGTGATGGTTCACGTAGTGGGCCATCGCCCTGATAGACGGTTTTTCGCCCTTTGAC
GTTGGAGTCCACGTTCTTTAATAGTGGACTCTTGTTCCAAACTGGAACAACACTCAACCCTATCTCGGTCTA
TTCTTTTGATTTATAAGGGATTTTGCCGATTTCGGCCTATTGGTTAAAAAATGAGCTGATTTAACAAAAATT
TAACGCGAATTTTAACAAAATATTAACGCTTACAATTTAGGTGGCACTTTTCGGGGAAATGTGCGCGGAAC
CCCTATTTGTTTATTTTTCTAAATACATTCAAATATGTATCCGCTCATGAATTAATTCTTAGAAAAACTCATC
GAGCATCAAATGAAACTGCAATTTATTCATATCAGGATTATCAATACCATATTTTTGAAAAAGCCGTTTCTG
TAATGAAGGAGAAAACTCACCGAGGCAGTTCCATAGGATGGCAAGATCCTGGTATCGGTCTGCGATTCCG
ACTCGTCCAACATCAATACAACCTATTAATTTCCCCTCGTCAAAAATAAGGTTATCAAGTGAGAAATCACCA
TGAGTGACGACTGAATCCGGTGAGAATGGCAAAAGTTTATGCATTTCTTTCCAGACTTGTTCAACAGGCCA
GCCATTACGCTCGTCATCAAAATCACTCGCATCAACCAAACCGTTATTCATTCGTGATTGCGCCTGAGCGA
GACGAAATACGCGATCGCTGTTAAAAGGACAATTACAAACAGGAATCGAATGCAACCGGCGCAGGAACA
CTGCCAGCGCATCAACAATATTTTCACCTGAATCAGGATATTCTTCTAATACCTGGAATGCTGTTTTCCCGG
GGATCGCAGTGGTGAGTAACCATGCATCATCAGGAGTACGGATAAAATGCTTGATGGTCGGAAGAGGCA
TAAATTCCGTCAGCCAGTTTAGTCTGACCATCTCATCTGTAACATCATTGGCAACGCTACCTTTGCCATGTTT
CAGAAACAACTCTGGCGCATCGGGCTTCCCATACAATCGATAGATTGTCGCACCTGATTGCCCGACATTAT
CGCGAGCCCATTTATACCCATATAAATCAGCATCCATGTTGGAATTTAATCGCGGCCTAGAGCAAGACGTT
TCCCGTTGAATATGGCTCATAACACCCCTTGTATTACTGTTTATGTAAGCAGACAGTTTTATTGTTCATGACC
AAAATCCCTTAACGTGAGTTTTCGTTCCACTGAGCGTCAGACCCCGTAGAAAAGATCAAAGGATCTTCTTG
AGATCCTTTTTTTCTGCGCGTAATCTGCTGCTTGCAAACAAAAAAACCACCGCTACCAGCGGTGGTTTGTTT
GCCGGATCAAGAGCTACCAACTCTTTTTCCGAAGGTAACTGGCTTCAGCAGAGCGCAGATACCAAATACT
GTCCTTCTAGTGTAGCCGTAGTTAGGCCACCACTTCAAGAACTCTGTAGCACCGCCTACATACCTCGCTCTG
CTAATCCTGTTACCAGTGGCTGCTGCCAGTGGCGATAAGTCGTGTCTTACCGGGTTGGACTCAAGACGATA
GTTACCGGATAAGGCGCAGCGGTCGGGCTGAACGGGGGGTTCGTGCACACAGCCCAGCTTGGAGCGAAC
GACCTACACCGAACTGAGATACCTACAGCGTGAGCTATGAGAAAGCGCCACGCTTCCCGAAGGGAGAAA
GGCGGACAGGTATCCGGTAAGCGGCAGGGTCGGAACAGGAGAGCGCACGAGGGAGCTTCCAGGGGGA
AACGCCTGGTATCTTTATAGTCCTGTCGGGTTTCGCCACCTCTGACTTGAGCGTCGATTTTTGTGATGCTCG
TCAGGGGGGCGGAGCCTATGGAAAAACGCCAGCAACGCGGCCTTTTTACGGTTCCTGGCCTTTTGCTGGC
CTTTTGCTCACATGTTCTTTCCTGCGTTATCCCCTGATTCTGTGGATAACCGTATTACCGCCTTTGAGTGAGC
TGATACCGCTCGCCGCAGCCGAACGACCGAGCGCAGCGAGTCAGTGAGCGAGGAAGCGGAAGAGCGCC
TGATGCGGTATTTTCTCCTTACGCATCTGTGCGGTATTTCACACCGCATATATGGTGCACTCTCAGTACAAT
CTGCTCTGATGCCGCATAGTTAAGCCAGTATACACTCCGCTATCGCTACGTGACTGGGTCATGGCTGCGCC
CCGACACCCGCCAACACCCGCTGACGCGCCCTGACGGGCTTGTCTGCTCCCGGCATCCGCTTACAGACAAG
CTGTGACCGTCTCCGGGAGCTGCATGTGTCAGAGGTTTTCACCGTCATCACCGAAACGCGCGAGGCAGCT
GCGGTAAAGCTCATCAGCGTGGTCGTGAAGCGATTCACAGATGTCTGCCTGTTCATCCGCGTCCAGCTCGT
TGAGTTTCTCCAGAAGCGTTAATGTCTGGCTTCTGATAAAGCGGGCCATGTTAAGGGCGGTTTTTTCCTGT
TTGGTCACTGATGCCTCCGTGTAAGGGGGATTTCTGTTCATGGGGGTAATGATACCGATGAAACGAGAGA
GGATGCTCACGATACGGGTTACTGATGATGAACATGCCCGGTTACTGGAACGTTGTGAGGGTAAACAACT
GGCGGTATGGATGCGGCGGGACCAGAGAAAAATCACTCAGGGTCAATGCCAGCGCTTCGTTAATACAGA
TGTAGGTGTTCCACAGGGTAGCCAGCAGCATCCTGCGATGCAGATCCGGAACATAATGGTGCAGGGCGCT
GACTTCCGCGTTTCCAGACTTTACGAAACACGGAAACCGAAGACCATTCATGTTGTTGCTCAGGTCGCAGA
CGTTTTGCAGCAGCAGTCGCTTCACGTTCGCTCGCGTATCGGTGATTCATTCTGCTAACCAGTAAGGCAAC
CCCGCCAGCCTAGCCGGGTCCTCAACGACAGGAGCACGATCATGCGCACCCGTGGGGCCGCCATGCCGG
CGATAATGGCCTGCTTCTCGCCGAAACGTTTGGTGGCGGGACCAGTGACGAAGGCTTGAGCGAGGGCGT
APPENDIX 2 (14/18) 
 
 
 
GCAAGATTCCGAATACCGCAAGCGACAGGCCGATCATCGTCGCGCTCCAGCGAAAGCGGTCCTCGCCGAA
AATGACCCAGAGCGCTGCCGGCACCTGTCCTACGAGTTGCATGATAAAGAAGACAGTCATAAGTGCGGCG
ACGATAGTCATGCCCCGCGCCCACCGGAAGGAGCTGACTGGGTTGAAGGCTCTCAAGGGCATCGGTCGA
GATCCCGGTGCCTAATGAGTGAGCTAACTTACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGG
AAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCG
CCAGGGTGGTTTTTCTTTTCACCAGTGAGACGGGCAACAGCTGATTGCCCTTCACCGCCTGGCCCTGAGAG
AGTTGCAGCAAGCGGTCCACGCTGGTTTGCCCCAGCAGGCGAAAATCCTGTTTGATGGTGGTTAACGGCG
GGATATAACATGAGCTGTCTTCGGTATCGTCGTATCCCACTACCGAGATATCCGCACCAACGCGCAGCCCG
GACTCGGTAATGGCGCGCATTGCGCCCAGCGCCATCTGATCGTTGGCAACCAGCATCGCAGTGGGAACGA
TGCCCTCATTCAGCATTTGCATGGTTTGTTGAAAACCGGACATGGCACTCCAGTCGCCTTCCCGTTCCGCTA
TCGGCTGAATTTGATTGCGAGTGAGATATTTATGCCAGCCAGCCAGACGCAGACGCGCCGAGACAGAACT
TAATGGGCCCGCTAACAGCGCGATTTGCTGGTGACCCAATGCGACCAGATGCTCCACGCCCAGTCGCGTA
CCGTCTTCATGGGAGAAAATAATACTGTTGATGGGTGTCTGGTCAGAGACATCAAGAAATAACGCCGGAA
CATTAGTGCAGGCAGCTTCCACAGCAATGGCATCCTGGTCATCCAGCGGATAGTTAATGATCAGCCCACTG
ACGCGTTGCGCGAGAAGATTGTGCACCGCCGCTTTACAGGCTTCGACGCCGCTTCGTTCTACCATCGACAC
CACCACGCTGGCACCCAGTTGATCGGCGCGAGATTTAATCGCCGCGACAATTTGCGACGGCGCGTGCAGG
GCCAGACTGGAGGTGGCAACGCCAATCAGCAACGACTGTTTGCCCGCCAGTTGTTGTGCCACGCGGTTGG
GAATGTAATTCAGCTCCGCCATCGCCGCTTCCACTTTTTCCCGCGTTTTCGCAGAAACGTGGCTGGCCTGGT
TCACCACGCGGGAAACGGTCTGATAAGAGACACCGGCATACTCTGCGACATCGTATAACGTTACTGGTTTC
ACATTCACCACCCTGAATTGACTCTCTTCCGGGCGCTATCATGCCATACCGCGAAAGGTTTTGCGCCATTCG
ATGGTGTCCGGGATCTCGACGCTCTCCCTTATGCGACTCCTGCATTAGGAAGCAGCCCAGTAGTAGGTTGA
GGCCGTTGAGCACCGCCGCCGCAAGGAATGGTGCATGCAAGGAGATGGCGCCCAACAGTCCCCCGGCCA
CGGGGCCTGCCACCATACCCACGCCGAAACAAGCGCTCATGAGCCCGAAGTGGCGAGCCCGATCTTCCCC
ATCGGTGATGTCGGCGATATAGGCGCCAGCAACCGCACCTGTGGCGCCGGTGATGCCGGCCACGATGCG
TCCGGCGTAGAGGATCGAGATCTCGATCCCGCGAAATTAATACGACTCACTATAGGGGAATTGTGAGCGG
ATAACAATTCCCCTCTAGAAATAATTTTGTTTAACTTTAAGAAGGAGATATACCATGAAATACCTATTGCCT
ACGGCAGCCGCTGGATTGTTATTACTCGCGGCCCAGCCGGCCATGGCATCTAGGACTCCGGAAATGCCGG
TTCTGGAAAATCGTGCAGCACAGGGTGATATTACCGCACCGGGTGGTGCACGTCGTCTGACCGGTGATCA
GACCGCAGCACTGCGTGATAGCCTGAGCGATAAACCGGCAAAAAACATTATTCTGCTGATTGGTGATGGC
ATGGGTGATAGCGAAATTACCGCAGCACGTAATTATGCCGAAGGTGCCGGTGGTTTTTTTAAAGGTATTG
ATGCACTGCCGCTGACAGGTCAGTATACCCATTATGCACTGAATAAAAAAACCGGCAAACCGGATTATGTT
ACCGATAGCGCAGCAAGCGCAACCGCATGGTCAACCGGTGTTAAAACCTATAATGGTGCACTGGGTGTGG
ATATTCATGAAAAAGATCATCCGACCATTCTGGAAATGGCAAAAGCAGCAGGTCTGGCAACCGGTAATGT
TAGCACCGCAGAACTGCAGGATGCAACACCGGCAGCACTGGTTGCACATGTTACCAGCCGTAAATGTTAT
GGTCCGAGCGCAACCAGCGAAAAATGTCCGGGTAATGCACTGGAAAAAGGTGGTAAAGGTAGCATTACC
GAACAGCTGCTGAATGCACGTGCAGATGTTACCCTGGGTGGTGGTGCAAAAACCTTTGCAGAAACCGCAA
CCGCAGGCGAATGGCAGGGTAAAACCCTGCGTGAACAGGCACAGGCACGTGGTTATCAGCTGGTTAGTG
ATGCAGCAAGCCTGAATAGCGTTACCGAAGCAAATCAGCAGAAACCGCTGCTGGGTCTGTTTGCAGATGG
TAATATGCCGGTTCGTTGGCTGGGTCCGAAAGCAACCTATCATGGTAATATTGATAAACCGGCTGTTACCT
GTACCCCGAATCCGCAGCGTAATGATAGCGTTCCGACCCTGGCACAGATGACCGATAAAGCAATTGAACT
GCTGAGCAAAAATGAAAAAGGCTTTTTTCTGCAGGTTGAAGGTGCCAGCATTGATAAACAGGATCATGCA
GCAAATCCGTGTGGTCAGATTGGTGAAACCGTTGATCTGGATGAAGCAGTTCAGCGTGCACTGGAATTTG
CAAAAAAAGAAGGTAATACCCTGGTTATTGTGACCGCAGATCATGCACATGCAAGCCAGATTGTTGCACC
GGATACCAAAGCACCGGGTCTGACCCAGGCACTGAATACCAAAGATGGTGCAGTTATGGTTATGAGCTAT
GGTAATAGCGAAGAAGATAGCCAGGAACATACCGGTAGCCAGCTGCGTATTGCAGCATATGGTCCGCAT
GCAGCCAATGTTGTTGGTCTGACCGATCAAACCGACCTGTTTTATACCATGAAAGCAGCACTGGGTCTGAA
AGGCGGCGGTGGTAGCAAAGGTGGTGGCTCTCCGAACCCCGGTCCTTGGGAACAGTGTGGTGGTAAATC
GTATGAAGGTCCGACCGCCTGTGCAAGCGGCACCACCTGTCAGGTTCTGCGTGAAACGTTTTCACAGTGT
ATTCCTGGTGGTAAAGGCGAGCACCACCACCACCACCACTGAGATCCGGCTGCTAACAAAGCCCGAAAGG
AAGCTGAGTTGGCTGCTGCCACCGCTGAGCAATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTT
GAGGGGTTTTTTGCTGAAAGGAGGAACTATATCCGGAT 
APPENDIX 2 (15/18) 
 
 
 
>pelB-AP-Ehux1b2D-pBR1a (6804 bp) 
TGGCGAATGGGACGCGCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCGCAGCGTGAC
CGCTACACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCGCTTTCTTCCCTTCCTTTCTCGCCACGTTCGCCGGC
TTTCCCCGTCAAGCTCTAAATCGGGGGCTCCCTTTAGGGTTCCGATTTAGTGCTTTACGGCACCTCGACCCC
AAAAAACTTGATTAGGGTGATGGTTCACGTAGTGGGCCATCGCCCTGATAGACGGTTTTTCGCCCTTTGAC
GTTGGAGTCCACGTTCTTTAATAGTGGACTCTTGTTCCAAACTGGAACAACACTCAACCCTATCTCGGTCTA
TTCTTTTGATTTATAAGGGATTTTGCCGATTTCGGCCTATTGGTTAAAAAATGAGCTGATTTAACAAAAATT
TAACGCGAATTTTAACAAAATATTAACGCTTACAATTTAGGTGGCACTTTTCGGGGAAATGTGCGCGGAAC
CCCTATTTGTTTATTTTTCTAAATACATTCAAATATGTATCCGCTCATGAATTAATTCTTAGAAAAACTCATC
GAGCATCAAATGAAACTGCAATTTATTCATATCAGGATTATCAATACCATATTTTTGAAAAAGCCGTTTCTG
TAATGAAGGAGAAAACTCACCGAGGCAGTTCCATAGGATGGCAAGATCCTGGTATCGGTCTGCGATTCCG
ACTCGTCCAACATCAATACAACCTATTAATTTCCCCTCGTCAAAAATAAGGTTATCAAGTGAGAAATCACCA
TGAGTGACGACTGAATCCGGTGAGAATGGCAAAAGTTTATGCATTTCTTTCCAGACTTGTTCAACAGGCCA
GCCATTACGCTCGTCATCAAAATCACTCGCATCAACCAAACCGTTATTCATTCGTGATTGCGCCTGAGCGA
GACGAAATACGCGATCGCTGTTAAAAGGACAATTACAAACAGGAATCGAATGCAACCGGCGCAGGAACA
CTGCCAGCGCATCAACAATATTTTCACCTGAATCAGGATATTCTTCTAATACCTGGAATGCTGTTTTCCCGG
GGATCGCAGTGGTGAGTAACCATGCATCATCAGGAGTACGGATAAAATGCTTGATGGTCGGAAGAGGCA
TAAATTCCGTCAGCCAGTTTAGTCTGACCATCTCATCTGTAACATCATTGGCAACGCTACCTTTGCCATGTTT
CAGAAACAACTCTGGCGCATCGGGCTTCCCATACAATCGATAGATTGTCGCACCTGATTGCCCGACATTAT
CGCGAGCCCATTTATACCCATATAAATCAGCATCCATGTTGGAATTTAATCGCGGCCTAGAGCAAGACGTT
TCCCGTTGAATATGGCTCATAACACCCCTTGTATTACTGTTTATGTAAGCAGACAGTTTTATTGTTCATGACC
AAAATCCCTTAACGTGAGTTTTCGTTCCACTGAGCGTCAGACCCCGTAGAAAAGATCAAAGGATCTTCTTG
AGATCCTTTTTTTCTGCGCGTAATCTGCTGCTTGCAAACAAAAAAACCACCGCTACCAGCGGTGGTTTGTTT
GCCGGATCAAGAGCTACCAACTCTTTTTCCGAAGGTAACTGGCTTCAGCAGAGCGCAGATACCAAATACT
GTCCTTCTAGTGTAGCCGTAGTTAGGCCACCACTTCAAGAACTCTGTAGCACCGCCTACATACCTCGCTCTG
CTAATCCTGTTACCAGTGGCTGCTGCCAGTGGCGATAAGTCGTGTCTTACCGGGTTGGACTCAAGACGATA
GTTACCGGATAAGGCGCAGCGGTCGGGCTGAACGGGGGGTTCGTGCACACAGCCCAGCTTGGAGCGAAC
GACCTACACCGAACTGAGATACCTACAGCGTGAGCTATGAGAAAGCGCCACGCTTCCCGAAGGGAGAAA
GGCGGACAGGTATCCGGTAAGCGGCAGGGTCGGAACAGGAGAGCGCACGAGGGAGCTTCCAGGGGGA
AACGCCTGGTATCTTTATAGTCCTGTCGGGTTTCGCCACCTCTGACTTGAGCGTCGATTTTTGTGATGCTCG
TCAGGGGGGCGGAGCCTATGGAAAAACGCCAGCAACGCGGCCTTTTTACGGTTCCTGGCCTTTTGCTGGC
CTTTTGCTCACATGTTCTTTCCTGCGTTATCCCCTGATTCTGTGGATAACCGTATTACCGCCTTTGAGTGAGC
TGATACCGCTCGCCGCAGCCGAACGACCGAGCGCAGCGAGTCAGTGAGCGAGGAAGCGGAAGAGCGCC
TGATGCGGTATTTTCTCCTTACGCATCTGTGCGGTATTTCACACCGCATATATGGTGCACTCTCAGTACAAT
CTGCTCTGATGCCGCATAGTTAAGCCAGTATACACTCCGCTATCGCTACGTGACTGGGTCATGGCTGCGCC
CCGACACCCGCCAACACCCGCTGACGCGCCCTGACGGGCTTGTCTGCTCCCGGCATCCGCTTACAGACAAG
CTGTGACCGTCTCCGGGAGCTGCATGTGTCAGAGGTTTTCACCGTCATCACCGAAACGCGCGAGGCAGCT
GCGGTAAAGCTCATCAGCGTGGTCGTGAAGCGATTCACAGATGTCTGCCTGTTCATCCGCGTCCAGCTCGT
TGAGTTTCTCCAGAAGCGTTAATGTCTGGCTTCTGATAAAGCGGGCCATGTTAAGGGCGGTTTTTTCCTGT
TTGGTCACTGATGCCTCCGTGTAAGGGGGATTTCTGTTCATGGGGGTAATGATACCGATGAAACGAGAGA
GGATGCTCACGATACGGGTTACTGATGATGAACATGCCCGGTTACTGGAACGTTGTGAGGGTAAACAACT
GGCGGTATGGATGCGGCGGGACCAGAGAAAAATCACTCAGGGTCAATGCCAGCGCTTCGTTAATACAGA
TGTAGGTGTTCCACAGGGTAGCCAGCAGCATCCTGCGATGCAGATCCGGAACATAATGGTGCAGGGCGCT
GACTTCCGCGTTTCCAGACTTTACGAAACACGGAAACCGAAGACCATTCATGTTGTTGCTCAGGTCGCAGA
CGTTTTGCAGCAGCAGTCGCTTCACGTTCGCTCGCGTATCGGTGATTCATTCTGCTAACCAGTAAGGCAAC
CCCGCCAGCCTAGCCGGGTCCTCAACGACAGGAGCACGATCATGCGCACCCGTGGGGCCGCCATGCCGG
CGATAATGGCCTGCTTCTCGCCGAAACGTTTGGTGGCGGGACCAGTGACGAAGGCTTGAGCGAGGGCGT
GCAAGATTCCGAATACCGCAAGCGACAGGCCGATCATCGTCGCGCTCCAGCGAAAGCGGTCCTCGCCGAA
AATGACCCAGAGCGCTGCCGGCACCTGTCCTACGAGTTGCATGATAAAGAAGACAGTCATAAGTGCGGCG
ACGATAGTCATGCCCCGCGCCCACCGGAAGGAGCTGACTGGGTTGAAGGCTCTCAAGGGCATCGGTCGA
GATCCCGGTGCCTAATGAGTGAGCTAACTTACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGG
AAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCG
CCAGGGTGGTTTTTCTTTTCACCAGTGAGACGGGCAACAGCTGATTGCCCTTCACCGCCTGGCCCTGAGAG
AGTTGCAGCAAGCGGTCCACGCTGGTTTGCCCCAGCAGGCGAAAATCCTGTTTGATGGTGGTTAACGGCG
GGATATAACATGAGCTGTCTTCGGTATCGTCGTATCCCACTACCGAGATATCCGCACCAACGCGCAGCCCG
APPENDIX 2 (16/18) 
 
 
 
GACTCGGTAATGGCGCGCATTGCGCCCAGCGCCATCTGATCGTTGGCAACCAGCATCGCAGTGGGAACGA
TGCCCTCATTCAGCATTTGCATGGTTTGTTGAAAACCGGACATGGCACTCCAGTCGCCTTCCCGTTCCGCTA
TCGGCTGAATTTGATTGCGAGTGAGATATTTATGCCAGCCAGCCAGACGCAGACGCGCCGAGACAGAACT
TAATGGGCCCGCTAACAGCGCGATTTGCTGGTGACCCAATGCGACCAGATGCTCCACGCCCAGTCGCGTA
CCGTCTTCATGGGAGAAAATAATACTGTTGATGGGTGTCTGGTCAGAGACATCAAGAAATAACGCCGGAA
CATTAGTGCAGGCAGCTTCCACAGCAATGGCATCCTGGTCATCCAGCGGATAGTTAATGATCAGCCCACTG
ACGCGTTGCGCGAGAAGATTGTGCACCGCCGCTTTACAGGCTTCGACGCCGCTTCGTTCTACCATCGACAC
CACCACGCTGGCACCCAGTTGATCGGCGCGAGATTTAATCGCCGCGACAATTTGCGACGGCGCGTGCAGG
GCCAGACTGGAGGTGGCAACGCCAATCAGCAACGACTGTTTGCCCGCCAGTTGTTGTGCCACGCGGTTGG
GAATGTAATTCAGCTCCGCCATCGCCGCTTCCACTTTTTCCCGCGTTTTCGCAGAAACGTGGCTGGCCTGGT
TCACCACGCGGGAAACGGTCTGATAAGAGACACCGGCATACTCTGCGACATCGTATAACGTTACTGGTTTC
ACATTCACCACCCTGAATTGACTCTCTTCCGGGCGCTATCATGCCATACCGCGAAAGGTTTTGCGCCATTCG
ATGGTGTCCGGGATCTCGACGCTCTCCCTTATGCGACTCCTGCATTAGGAAGCAGCCCAGTAGTAGGTTGA
GGCCGTTGAGCACCGCCGCCGCAAGGAATGGTGCATGCAAGGAGATGGCGCCCAACAGTCCCCCGGCCA
CGGGGCCTGCCACCATACCCACGCCGAAACAAGCGCTCATGAGCCCGAAGTGGCGAGCCCGATCTTCCCC
ATCGGTGATGTCGGCGATATAGGCGCCAGCAACCGCACCTGTGGCGCCGGTGATGCCGGCCACGATGCG
TCCGGCGTAGAGGATCGAGATCTCGATCCCGCGAAATTAATACGACTCACTATAGGGGAATTGTGAGCGG
ATAACAATTCCCCTCTAGAAATAATTTTGTTTAACTTTAAGAAGGAGATATACCATGAAATACCTATTGCCT
ACGGCAGCCGCTGGATTGTTATTACTCGCGGCCCAGCCGGCCATGGCATCTAGGACTCCGGAAATGCCGG
TTCTGGAAAATCGTGCAGCACAGGGTGATATTACCGCACCGGGTGGTGCACGTCGTCTGACCGGTGATCA
GACCGCAGCACTGCGTGATAGCCTGAGCGATAAACCGGCAAAAAACATTATTCTGCTGATTGGTGATGGC
ATGGGTGATAGCGAAATTACCGCAGCACGTAATTATGCCGAAGGTGCCGGTGGTTTTTTTAAAGGTATTG
ATGCACTGCCGCTGACAGGTCAGTATACCCATTATGCACTGAATAAAAAAACCGGCAAACCGGATTATGTT
ACCGATAGCGCAGCAAGCGCAACCGCATGGTCAACCGGTGTTAAAACCTATAATGGTGCACTGGGTGTGG
ATATTCATGAAAAAGATCATCCGACCATTCTGGAAATGGCAAAAGCAGCAGGTCTGGCAACCGGTAATGT
TAGCACCGCAGAACTGCAGGATGCAACACCGGCAGCACTGGTTGCACATGTTACCAGCCGTAAATGTTAT
GGTCCGAGCGCAACCAGCGAAAAATGTCCGGGTAATGCACTGGAAAAAGGTGGTAAAGGTAGCATTACC
GAACAGCTGCTGAATGCACGTGCAGATGTTACCCTGGGTGGTGGTGCAAAAACCTTTGCAGAAACCGCAA
CCGCAGGCGAATGGCAGGGTAAAACCCTGCGTGAACAGGCACAGGCACGTGGTTATCAGCTGGTTAGTG
ATGCAGCAAGCCTGAATAGCGTTACCGAAGCAAATCAGCAGAAACCGCTGCTGGGTCTGTTTGCAGATGG
TAATATGCCGGTTCGTTGGCTGGGTCCGAAAGCAACCTATCATGGTAATATTGATAAACCGGCTGTTACCT
GTACCCCGAATCCGCAGCGTAATGATAGCGTTCCGACCCTGGCACAGATGACCGATAAAGCAATTGAACT
GCTGAGCAAAAATGAAAAAGGCTTTTTTCTGCAGGTTGAAGGTGCCAGCATTGATAAACAGGATCATGCA
GCAAATCCGTGTGGTCAGATTGGTGAAACCGTTGATCTGGATGAAGCAGTTCAGCGTGCACTGGAATTTG
CAAAAAAAGAAGGTAATACCCTGGTTATTGTGACCGCAGATCATGCACATGCAAGCCAGATTGTTGCACC
GGATACCAAAGCACCGGGTCTGACCCAGGCACTGAATACCAAAGATGGTGCAGTTATGGTTATGAGCTAT
GGTAATAGCGAAGAAGATAGCCAGGAACATACCGGTAGCCAGCTGCGTATTGCAGCATATGGTCCGCAT
GCAGCCAATGTTGTTGGTCTGACCGATCAAACCGACCTGTTTTATACCATGAAAGCAGCACTGGGTCTGAA
AGGCGGCGGTGGTAGCAAAGGTGGTGGCTCTCCGAACCCCGGTCCTTGGGAACAGTGTGGTGGTAAATC
GTATGAAGGTCCGACCGCCTGTCCCCGTGAATACACCTGTCAGTATCGCAATCCGTATTATTCACAGTGTCT
GCCTGGTGGTAAAGGCGAGCACCACCACCACCACCACTGAGATCCGGCTGCTAACAAAGCCCGAAAGGA
AGCTGAGTTGGCTGCTGCCACCGCTGAGCAATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTG
AGGGGTTTTTTGCTGAAAGGAGGAACTATATCCGGAT 
CyDisCo plasmid 
>CyDisCo plasmid pMJS205 (7148 bp) 
GAATTCCGGATGAGCATTCATCAGGCGGGCAAGAATGTGAATAAAGGCCGGATAAAACTTGTGCTTATTT
TTCTTTACGGTCTTTAAAAAGGCCGTAATATCCAGCTGAACGGTCTGGTTATAGGTACATTGAGCAACTGA
CTGAAATGCCTCAAAATGTTCTTTACGATGCCATTGGGATATATCAACGGTGGTATATCCAGTGATTTTTTT
CTCCATTTTAGCTTCCTTAGCTCCTGAAAATCTCGATAACTCAAAAAATACGCCCGGTAGTGATCTTATTTCA
TTATGGTGAAAGTTGGAACCTCTTACGTGCCGATCAACGTCTCATTTTCGCCAAAAGTTGGCCCAGGGCTT
CCCGGTATCAACAGGGACACCAGGATTTATTTATTCTGCGAAGTGATCTTCCGTCACAGGTATTTATTCGG
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CGCAAAGTGCGTCGGGTGATGCTGCCAACTTACTGATTTAGTGTATGATGGTGTTTTTGAGGTGCTCCAGT
GGCTTCTGTTTCTATCAGCTGTCCCTCCTGTTCAGCTACTGACGGGGTGGTGCGTAACGGCAAAAGCACCG
CCGGACATCAGCGCTAGCGGAGTGTATACTGGCTTACTATGTTGGCACTGATGAGGGTGTCAGTGAAGTG
CTTCATGTGGCAGGAGAAAAAAGGCTGCACCGGTGCGTCAGCAGAATATGTGATACAGGATATATTCCGC
TTCCTCGCTCACTGACTCGCTACGCTCGGTCGTTCGACTGCGGCGAGCGGAAATGGCTTACGAACGGGGC
GGAGATTTCCTGGAAGATGCCAGGAAGATACTTAACAGGGAAGTGAGAGGGCCGCGGCAAAGCCGTTTT
TCCATAGGCTCCGCCCCCCTGACAAGCATCACGAAATCTGACGCTCAAATCAGTGGTGGCGAAACCCGAC
AGGACTATAAAGATACCAGGCGTTTCCCCTGGCGGCTCCCTCGTGCGCTCTCCTGTTCCTGCCTTTCGGTTT
ACCGGTGTCATTCCGCTGTTATGGCCGCGTTTGTCTCATTCCACGCCTGACACTCAGTTCCGGGTAGGCAG
TTCGCTCCAAGCTGGACTGTATGCACGAACCCCCCGTTCAGTCCGACCGCTGCGCCTTATCCGGTAACTATC
GTCTTGAGTCCAACCCGGAAAGACATGCAAAAGCACCACTGGCAGCAGCCACTGGTAATTGATTTAGAGG
AGTTAGTCTTGAAGTCATGCGCCGGTTAAGGCTAAACTGAAAGGACAAGTTTTGGTGACTGCGCTCCTCCA
AGCCAGTTACCTCGGTTCAAAGAGTTGGTAGCTCAGAGAACCTTCGAAAAACCGCCCTGCAAGGCGGTTT
TTTCGTTTTCAGAGCAAGAGATTACGCGCAGACCAAAACGATCTCAAGAAGATCATCTTATTAATCAGATA
AAATATTTCTAGATTTCAGTGCAATTTATCTCTTCAAATGTAGCACCTGAAGTCAGCCCCATACGATATAAG
TTGTAATTCTCATGTTTGACAGCTTATCATCGATAAGCTTTAATGCGGTAGTTTATCACAGTTAAATTGCTA
ACGCAGTCAGGCACCGTGTATGAAATCTAACAATGCGCTCATCGTCATCCTCGGCACCGTCACCCTGGATG
CTGTAGGCATAGGCTTGGTTATGCCGGTACTGCCGGGCCTCTTGCGGGATATCGTCCATTCCGACAGCATC
GCCAGTCACTATGGCGTGCTGCTAGCGCTATATGCGTTGATGCAATTTCTATGCGCACCCGTTCTCGGAGC
ACTGTCCGACCGCTTTGGCCGCCGCCCAGTCCTGCTCGCTTCGCTACTTGGAGCCACTATCGACTACGCGA
TCATGGCGACCACACCCGTCCTGTGGATCCGGCCCATTGGCTGCCTCCCACACTTGGATATGCCTCCTCGG
AGCCTTATAGAATTGTTTATAAGACTTGCGCATTATTTGACCTCCAATGCGAACAAAGGGAAACCGCTGTG
GTCTCCCTTTAGTGAGTTCAATTAATTATCCACGGTCAGAAGTGACCAGTTCGTTCTTCTCCCACCAACGCT
TAAGGTCGAACGAAGGGCAAGCCTTCGGCGCCACCTCATGATGGGCGCGAAGACCAGCGCCTTCGTACTT
AGCCAGCAGTGTGACAAGCAGTGAGCGAAGGGATTGCATTTGGGCTGGCGTAAAGTTAGCGTCGAACTT
ACCTTTATCGTCGATACCACCAACAAGGCAGACGCCGATAGAGTTGTGGTTGTAACCCTTAGCGTGAGAG
CCTACAGCCATCTCATCTCGTCCTGCCTCCACAGTACCGTCTCGCTTGATGATAAAGTGGTATCCCACATCG
AGCCAACCCTGCTCTTTGTGCCACTGGCGAATCTCACGGACACCAACATTCTGACTTGGCTTGGTAGCCGA
GCAGTGAACAAAGATTGCGTCAGTAGATTCACGTTGTTTAAACTGTACACGAGCCATTATTTCTTTCCTCCT
TTCCTTTTTAATCTATCAAAGGGGACCCGGATCCTCTACGCCGGACGCATCGTGGCCGGCATCACCGGCGC
CACAGGTGCGGTTGCTGGCGCCTATATCGCCGACATCACCGATGGGGAAGATCGGGCTCGCCACTTCGGG
CTCATGAGCGCTTGTTTCGGCGTGGGTATGGTGGCAGGCCCCGTGGCCGGGGGACTGTTGGGCGCCATCT
CCTTGCATGCACCATTCCTTGCGGCGGCGGTGCTCAACGGCCTCAACCTACTACTGGGCTGCTTCCTAATG
CAGGAGTCGCATAAGGGAGAGCGTCGACCGATGCCCTTGAGAGCCTTCAACCCAGTCAGCTCCTTCCGGT
GGGCGCGGGGCATGACTATCGTCGCCGCACTTATGACTGTCTTCTTTATCATGCAACTCGTAGGACAGGTG
CCGGCAGCGCTCTGGGTCATTTTCGGCGAGGACCGCTTTCGCTGGAGCGCGACGATGATCGGCCTGTCGC
TTGCGGTATTCGGAATCTTGCACGCCCTCGCTCAAGCCTTCGTCACTGGTCCCGCCACCAAACGTTTCGGC
GAGAAGCAGGCCATTATCGCATGCATCCTGGCGCCCAATACGCAAACCGCCTCTCCCCGCGCGTTGGCCG
ATTCATTAATGCAGCTGGCACGACAGGTTTCCCGACTGGAAAGCGGGCAGTGAGCGCAACGCAATTAATG
TAAGTTAGCTCACTCATTAGGCACAATTCTCATGTTTGACAGCTTATCATCGACTGCACGGTGCACCAATGC
TTCTGGCGTCAGGCAGCCATCGGAAGCTGTGGTATGGCTGTGCAGGTCGTAAATCACTGCATAATTCGTG
TCGCTCAAGGCGCACTCCCGTTCTGGATAATGTTTTTTGCGCCGACATCATAACGGTTCTGGCAAATATTCT
GAAATGAGCTGTTGACAATTAATCATCGGCTCGTATAATGTGTGGAATTGTGAGCGGATAACAATTTCACA
CAGGAAACAGCCAGTCCGTTTAGGTGTTTTCACGAGCTCTAGAAATAATTTTGTTTAACTTTAAGAAGGAG
ATACATATGAAAGCCATCGATAAAATGACCGACAATCCGCCTCAAGAGGGTCTGAGTGGTCGTAAAATCA
TCTATGATGAGGACGGCAAACCATGTCGCAGCTGCAATACCCTGCTGGACTTCCAGTATGTTACCGGGAA
AATCTCAAATGGCCTGAAAAACCTGAGCAGCAATGGTAAACTGGCGGGTACAGGTGCTCTGACTGGGGA
AGCATCTGAACTGATGCCGGGTTCTCGTACCTATCGTAAAGTCGATCCTCCGGATGTTGAACAGCTGGGAC
GTTCTTCATGGACACTGCTGCATAGCGTAGCAGCCTCTTATCCAGCTCAACCAACCGATCAGCAAAAAGGC
GAAATGAAACAGTTCCTGAACATCTTCAGCCACATCTATCCGTGTAACTGGTGCGCTAAAGACTTCGAAAA
ATATATCCGTGAGAATGCCCCTCAAGTTGAATCACGTGAGGAGCTGGGTCGCTGGATGTGTGAGGCCCAT
AACAAAGTGAACAAAAAGCTGCGCAAACCGAAGTTCGACTGTAACTTCTGGGAAAAACGCTGGAAAGAT
GGTTGGGATGAGTAATAAGGATCCGAATTCTCTAGTAATAATTTTGTTTAACTTTAAGAAGGAGATACATA
TGGATGCCCCAGAGGAGGAAGATCACGTCCTGGTTCTGCGTAAAAGCAACTTCGCTGAAGCACTGGCAGC
TCACAAATATCTGCTGGTCGAGTTCTATGCTCCGTGGTGTGGTCATTGCAAAGCCCTGGCTCCGGAATATG
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CTAAAGCAGCCGGCAAACTGAAAGCTGAGGGCAGTGAAATTCGTCTGGCCAAAGTGGACGCTACCGAAG
AATCAGATCTGGCACAACAGTATGGTGTTCGTGGTTATCCGACTATCAAATTTTTCCGTAACGGCGATACA
GCAAGCCCTAAAGAGTATACCGCTGGCCGTGAAGCTGATGATATCGTGAACTGGCTGAAAAAACGTACAG
GTCCGGCGGCAACGACTCTGCCTGATGGTGCCGCTGCCGAGTCACTGGTAGAATCATCCGAAGTGGCCGT
GATTGGCTTCTTTAAAGACGTGGAGAGCGATTCAGCAAAACAGTTCCTGCAAGCAGCTGAAGCGATTGAT
GACATCCCGTTTGGTATTACGAGCAATAGCGACGTGTTCTCCAAATATCAACTGGACAAAGACGGTGTGG
TTCTGTTCAAAAAATTCGACGAAGGCCGTAACAACTTTGAAGGTGAGGTGACCAAAGAAAACCTGCTGGA
CTTTATCAAACACAATCAACTGCCGCTGGTGATTGAGTTCACCGAACAGACAGCTCCGAAAATCTTTGGCG
GCGAGATCAAAACCCACATTCTGCTGTTTCTGCCTAAAAGTGTGTCCGACTATGACGGCAAACTGAGCAAC
TTCAAAACCGCCGCTGAGAGCTTTAAAGGCAAAATCCTGTTCATCTTCATCGACAGCGATCATACCGACAA
CCAGCGTATTCTGGAGTTTTTTGGCCTGAAAAAAGAGGAATGTCCGGCCGTTCGCCTGATTACACTGGAA
GAGGAGATGACGAAATATAAACCAGAAAGCGAGGAGCTGACAGCTGAACGTATTACCGAGTTCTGCCAC
CGTTTTCTGGAAGGCAAAATCAAACCTCATCTGATGTCCCAAGAACTGCCAGAAGATTGGGATAAACAGC
CTGTGAAAGTGCTGGTAGGCAAAAACTTCGAGGATGTGGCGTTCGACGAGAAAAAAAACGTGTTTGTGG
AGTTTTATGCCCCTTGGTGTGGACACTGCAAACAGCTGGCACCGATTTGGGATAAACTGGGCGAAACCTA
TAAAGATCATGAAAACATTGTTATTGCCAAAATGGACAGCACCGCCAATGAAGTCGAAGCCGTGAAAGTT
CATTCGTTTCCGACCCTGAAATTCTTTCCTGCCAGCGCCGATCGTACTGTGATCGATTATAACGGGGAGCG
TACCCTGGATGGTTTTAAAAAATTCCTGGAGAGCGGTGGTCAAGATGGTGCCGGTGATGATGACGATCTG
GAGGATCTGGAAGAGGCTGAAGAACCGGATATGGAGGAGGATGACGATCAGAAAGCAGTCAAAGACGA
GCTGTGATAAGGATCCGAATTCACTAGTGAGCTCCGTCGACAAGCTTGCGGCCGCACTCGAGCACCACCA
CCACCACCACTGAGATCCGGCTGCTAACAAAGCCCGAAAGGAAGCTGAGTTGGCTGCTGCCACCGCTGAG
CAATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTTGCCTAGGCACGGGTGCG
CATGATCGTGCTCCTGTCGTTGAGGACCCGGCTAGGCTGGCGGGGTTGCCTTACTGGTTAGCAGAATGAA
TCACCGATACGCGAGCGAACGTGAAGCGACTGCTGCTGCAAAACGTCTGCGACCTGAGCAACAACATGAA
TGGTCTTCGGTTTCCGTGTTTCGTAAAGTCTGGAAACGCGGAAGTCCCCTACGTGCTGCTGAAGTTGCCCG
CAACAGAGAGTGGAACCAACCGGTGATACCACGATACTATGACTGAGAGTCAACGCCATGAGCGGCCTCA
TTTCTTATTCTGAGTTACAACAGTCCGCACCGCTGTCCGGTAGCTCCTTCCGGTGGGCGCGGGGCATGACT
ATCGTCGCCGCACTTATGACTGTCTTCTTTATCATGCAACTCGTAGGACAGGTGCCGGCAGCGCCCAACAG
TCCCCCGGCCACGGGGCCTGCCACCATACCCACGCCGAAACAAGCGCCCTGCACCATTATGTTCCGGATCT
GCATCGCAGGATGCTGCTGGCTACCCTGTGGAACACCTACATCTGTATTAACGAAGCGCTAACCGTTTTTA
TCAGGCTCTGGGAGGCAGAATAAATGATCATATCGTCAATTATTACCTCCACGGGGAGAGCCTGAGCAAA
CTGGCCTCAGGCATTTGAGAAGCACACGGTCACACTGCTTCCGGTAGTCAATAAACCGGTAAACCAGCAA
TAGACATAAGCGGCTATTTAACGACCCTGCCCTGAACCGACGACCGGGTCGAATTTGCTTTCGAATTTCTG
CCATTCATCCGCTTATTATCACTTATTCAGGCGTAGCACCAGGCGTTTAAGGGCACCAATAACTGCCTTAAA
AAAATTACGCCCCGCCCTGCCACTCATCGCAGTACTGTTGTAATTCATTAAGCATTCTGCCGACATGGAAG
CCATCACAGACGGCATGATGAACCTGAATCGCCAGCGGCATCAGCACCTTGTCGCCTTGCGTATAATATTT
GCCCATGGTGAAAACGGGGGCGAAGAAGTTGTCCATATTGGCCACGTTTAAATCAAAACTGGTGAAACTC
ACCCAGGGATTGGCTGAGACGAAAAACATATTCTCAATAAACCCTTTAGGGAAATAGGCCAGGTTTTCACC
GTAACACGCCACATCTTGCGAATATATGTGTAGAAACTGCCGGAAATCGTCGTGGTATTCACTCCAGAGCG
ATGAAAACGTTTCAGTTTGCTCATGGAAAACGGTGTAACAAGGGTGAACACTATCCCATATCACCAGCTCA
CCGTCTTTCATTGCCATACG 
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CBM1 protein sequences in multiple sequence alignment   
GenBank accession numbers of the sequences aligned in Figure 21. 
1. Cel7A [Trichoderma reesei] (this study) 
2. endoglucanase 1 [Penicillium oxalicum] - AGW24293.1 
3. xylanase/cellobiohydrolase [Talaromyces funiculosus] - CAC85737.1 
4. cellobiohydrolase I, partial [Geotrichum candidum] - AIO10971.1 
5. endoglucanase I, partial [Trichoderma longibrachiatum] - AEC03714.1 
6. cellobiohydrolase I Cel7A [Talaromyces cellulolyticus] - GAM33347.1 
7. cellulase [Irpex lacteus] - BAA76365.1| 
8. cellobiohydrolase family protein 61, partial [Chaetomium thermophilum] - 
AGY80103.1 
9. cellobiohydrolase I [Penicillium granulatum] - AGU16949.1 
10. Cel7A, partial [Aspergillus fischeri] - ALE19913.1 
11. cellobiohydrolase I [Alternaria japonica] - AGU16948.1 
12. cellobiohydrolase B [Aspergillus niger] - AKH61141.1 
13. cellobiohydrolase [Aspergillus terreus] - AAW68437.2 
14. cellobiohydrolase [Penicillium oxalicum] - AKI32221.1 
15. cellobiohydrolase I [Penicillium oxalicum] - ALO81607.1 
16. cellobiohydrolase 2 [Penicillium oxalicum] - AGW24292.1 
17. exo-cellobiohydrolase [Penicillium oxalicum] - AEF33951.1 
18. cellobiohydrolase I [Chaetomium murorum] - AGU16947.1 
19. 1,4-beta-D-glucan cellobiohydrolase B precursor [Aspergillus niger] - 
AEF58998.1 
20. cellobiohydrolase family protein 45, partial [Chaetomium thermophilum] - 
AGY80101.1 
21. xylanase 4 [Penicillium oxalicum] - AGW24301.1 
22. Xylanase B [Neocallimastix patriciarum] - AAB30669.1 
23. Cellulase [Humicola grisea var. thermoidea] - BAA09785.1 
24. cellobiohydrolase I, partial [Penicillium canescens] - AIL95870.1 
APPENDIX 2 (2/2) 
 
 
 
25. chitinase [Trichoderma virens] - ACI96032.1 
26. chitinase [Beauveria bassiana] - AIT18883.1 
27. putative chitinase [Metarhizium anisopliae] - AAY34347.1 
28. Ehux1b2 (R1C3S1-CBM1-2) [Emiliania huxleyi] (this study) 
29. chitinase chi18-17 [Trichoderma citrinoviride] - ADF57311.1 
